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regeneração óssea, osteocondutividade, bioresorbabilidade  
resumo O principal objectivo deste estudo foi o desenvolvimento de cimentos à base 
de fosfatos de cálcio dopados com Mg, Sr e Zn, para aplicações clínicas. 
A síntese dos pós foi obtida através de reacções de precipitação, seguido de 
tratamento térmico de forma a obter as fases mais apropriadas, α e β-TCP. A 
caracterização dos pós envolveu a quantificação de fases e o refinamento 
estrutural de fases através da análise de difracção de raios-X por refinamento 
de Rietveld, bem como, análise da área superficial por BET, e respectivos 
tamanhos de partícula.  
Os cimentos foram preparados através da mistura dos pós com meios líquidos 
diferentes, usando ácido cítrico como acelerador de presa, e o polietilenoglicol 
(PEG) e o hidroxil propilmetilcelulose (HMPC) como agentes gelificantes. A 
formação da brushite foi um dos produtos resultantes obtidos da hidratação 
dos cimentos. Do ponto de vista de aplicação clínica, os cimentos foram 
caracterizados em termos de presa, injectabilidade, análise calorimétrica e 
resistência mecânica. 
Os presentes resultados demonstraram que a incorporação de iões nos 
cimentos levou a uma melhoria significativa das propriedades destes quando 
comparados com TCP puro. Os resultados obtidos demonstraram ainda que o 
tempo inicial de presa tende a decrescer na presença de modificadores 
reológicos, uma vez que estes aumentam a viscosidade das pastas, e 
aumenta com o acréscimo da razão L/P, tendo sido considerada a gama de 
0.30-0.34 mL g-1 como aceitável para manusear as pastas. As pastas 
cimentícias apresentaram uma boa injectabilidade, nomeadamente o seu 
comportamento após extrusão, com aplicação de uma força máxima de 100 N. 
Investigou-se ainda, com estes testes, a ausência do efeito de “filter-pressing” 
e que as pastas foram totalmente expelidas para uma razão L/P de 0.36 mLg-1.
Os testes de calorimetria isotérmica demonstraram que as pastas apresentam 
reacções exotérmicas, referentes à dissolução dos pós de partida e à 
formação de fases intermédias; e à nucleação e crescimento da brushite. 
Resistências à compressão dos cimentos estudados, após imersão numa 
solução de PBS durante 48h situam-se entre 1-30 MPa, valores reportados 
para o osso trabecular. 
Testes de citotoxicidade, bioactividade e biocompatibilidade dos cimentos 
foram obtidos através de testes de culturas celulares, mostrando a não-
toxicidade destes. A biocompatibilidade in vivo e a reabsorção dos cimentos 
foram avaliadas em estudos histológicos e histomorfométricos de secções 
descalcificadas obtidas através de ensaios de experimentação animal, usando 
o porco como modelo. Os resultados mostraram que os cimentos implantados 
são biocompatíveis e osteocondutivos, sem evidência de reacções infecciosas, 
e portanto, bons candidatos para aplicação como substitutos ósseos. 
keywords calcium phosphates cements, ions substituted, self-setting, injectability, bone 
regeneration, osteoconductivity, bioresorbability
abstract The main objective of this study was the development of cements based on 
calcium phosphates doped with Mg, Sr and Zn, for clinical applications. 
Powder synthesis was obtained through precipitation reactions, followed by 
heat treatment in order to obtain appropriate phases, α and β-TCP.  
The cements were prepared through mixing the powders with different liquids, 
using citric acid as setting accelerator, and polyethyleneglycol and hydroxyl 
propylmethylcellulose as gelling agents. Brushite was the end product of the 
hydration reaction. Injectability and setting behaviour were accessed through 
rheological measurements, extrusion, calorimetric analysis, Vicat and Gilmore 
needles. Phase quantification and the structural refinement of powders and 
cements were determined through X-ray diffraction with Rietveld refinement, as 
well as, BET specific surface area and particle size analysis. Mechanical 
strengths of wet hardened cements were evaluated. 
The results obtained showed that the incorporation of ions into cements led to a 
significant improvement of their overall properties. Initial setting time increased 
in the presence of rheological modifiers due to their specific roles at the 
solid/liquid interface and with increasing L/P ratio. Acceptable workability 
pastes were obtained for L/P ratios in the range of 0.30-0.34 mL g-1. The 
cement pastes presented good injectability even under a maximum applied 
force of 100 N.  Filter pressing effects were absent, and all cement pastes 
could be fully injected for LPR > 0.36 mL g-1. 
Isothermal calorimetry revealed that hydration reactions produce exothermic 
effects due to: (i) dissolution of the starting powders and formation of 
intermediate phases; and (ii) nucleation and growth of brushite crystals. The 
intensity of the exothermic effects depended on doping element, being stronger 
in the case of Sr.  
Wet compressive strength of the cement specimens (after immersion in PBS 
solution for 48 h) was in the range of values reported for trabecular bone (10-30 
MPa).  
Cell cultures used to evaluate citotoxicity, bioactivity and biocompatibility of 
cements revealed no toxic effects. The biocompatibility in vivo and cements 
resorption were evaluated using a pig model through histological and 
histomorphometric studies of decalcified sections. The results show that the 
implanted cements are biocompatible and osteoconductive, without foreign 
body reaction. These properties make them good candidates for applications 
as bone substitutes. 
PREFACE 
During the last century, new materials and surgical techniques have drastically 
changed the lives of millions of patients. Biomaterials have made an important 
contribution to modern health care and will expand further as musculoskeletal 
disorders, especially osteoporosis and fragility fractures, increase with an aging 
population. Each biomaterial considered for potential clinical applications has 
specific chemical, physical and mechanical properties, which might originate 
variations in host/material response. However, the biological characteristics and 
the anatomic site of implantation are also important for the behaviour and outcome 
of the implant. In surgery for fragility fractures, biomaterials are still sparsely used 
for bone repair. In about 10% of all reconstructive operations caused by traumatic, 
resectional or congenital defects, bone transplants and bone substitute materials 
are necessary. 
The discovery in early 1980s of self-setting cements based on calcium 
orthophosphate (often referred to just as calcium phosphate) has opened up a 
new era in the medical applications of bone grafting. Synthetic bone substitutes 
made of calcium phosphates have chemical compositions similar to those of bone 
and dentine and can be fitted with bone defects. They are also particularly suited 
for minimally invasive surgical techniques, hardening in situ and giving stability for 
any defect geometry. Calcium phosphate cements (CPC) are resorbable, 
biocompatible and osteoconductive. 
Nevertheless, the commercially available formulations still suffer from several 
shortcomings related to unsatisfactory levels of some properties and justify the 
continuous research effort that has been devoted to synthetic bone substitutes as 
cements. 
The purpose of the present work was developing cements based on calcium 
phosphate, doped with several ions, to be used with minimally invasive surgical 
techniques with mechanical properties comparable to trabecular bone, which will 
encourage new bone to grow in and remodel the bone defect. The incorporation of 
trace amounts of different ions on bone substitute materials is expected to have 
favourable effects related to the biological process, due to their occurrence in bone 
tissues.  
This thesis is structured in four chapters. Chapter 1 is a broad literature review that 
ranges from bone composition and structure with particular reference to bone 
remodelling process, to calcium phosphate-based cements. Chapters 2 and 3 
describe the preparation and characterisation of the starting calcium phosphate 
cement (CPC) powders doped with different ions - Mg, Zn or Sr - as well as the 
preparation and properties evaluation of the hardened CPC cements. 
Characterization was performed in terms of setting behaviour, injectability, 
mechanical testing and biocompatibility through in vitro and in vivo tests. In these 
chapters, published, accepted or submitted papers to SCI journals are presented 
reporting the studies that have been performed. Chapter 2 describes the CPCs 
doped with Mg or Sr. The evaluation of biocompatibility, resorption and new bone 
formation of Sr- and Zn-incorporated CPCs is presented in Chapter 3. 
Finally, Chapter 4 shows the overall conclusions and some suggestions for future 
work. 
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1 State of the art  
1.1 Introduction 
The human skeletal system is composed of various connective tissues (bone, 
cartilage, ligaments and tendons) with its major role providing dynamic forces to 
be distributed by muscle mass, as well as providing support and protection for 
tissues. Bone is among the body’s hardest structures; only dentin and enamel in 
the teeth are harder. It is one of the most dynamic and metabolically active tissues 
in the body and remains active throughout life. A highly vascular tissue, it has an 
excellent capacity for self-repair and can alter its properties and configuration in 
response to changes in mechanical demand. For example, changes in bone 
density are commonly observed after periods of disuse and of greatly increased 
use and changes in bone shape are noted during fracture healing and after certain 
operations. 
Many diseases and disorders have been associated with osteoporosis. For some, 
the underlying mechanism influencing the bone metabolism is straight-forward, 
whereas for others the causes are multiple or unknown. Osteoporosis is a disease 
of bone that leads to an increased risk of fracture. In osteoporosis the bone 
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mineral density is reduced, bone microarchitecture is disrupted, and the amount 
and variety of non-collagenous proteins in bone is altered. 
 Osteoporosis can be prevented with lifestyle changes and sometimes medication. 
Lifestyle change includes exercise and preventing falls, while medication includes 
calcium, vitamin D, bisphosphonates and several others. The underlying 
mechanism in all cases of osteoporosis is an imbalance between bone resorption 
and bone formation. In normal bone, there is a constant matrix remodelling of 
bone; up to 10% of all bone mass may be undergoing remodelling at any point in 
time. 
In order to understand what sort of bone substitutes could be best for reconstruct 
large defects of normal bone, it is important first to understand the complex 
structure of bone and the process of bone healing. Furthermore, the best bone 
substitutes are naturally those with biomechanical and biological properties most 
closely resembling those of normal bone. 
1.2 Bone anatomy 
Bone is a complex, highly organised and specialised connective tissue with many 
functions. All bones have a mechanical function providing attachment to various 
muscle groups. In addition, in some parts of the body, bones provide a protective 
function to vital structures — skull (brain), ribs (lungs, heart) and pelvis (bladder, 
pelvic viscera). Some bones retain their haematopoietic function in adults — 
vertebrae, iliac crests, proximal parts of femur and humerus. All bones serve as a 
reservoir of calcium and actively participate in calcium homeostasis of the body. 
1.2.1 Macrostructure of bone 
The bone is composed of two types of osseous tissue: cortical (compact) (80%) 
and trabecular (cancellous or spongy) (20%) bones [1]. Cortical bone forms the 
outer shell, or cortex, of the bone and has a dense structure. It is the primary 
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component of the long bones of the arm and leg and other bones, where its 
greater strength and rigidity are needed. Trabecular bone typically occupies the 
interior region of bones and is composed of thin plates, or trabeculae, in a loose 
mesh structure. It is highly vascular and frequently contains red bone marrow 
where hematopoiesis, which is the production of blood cells, occurs. It has a 
higher surface area but is less dense, softer, weaker, and less stiff than cortical 
bone. 
Bone can be classified as long (femur, tibia, humerus, radius), short (carpal, 
tarsal), flat (ribs, sternum, cranium, scapula) and irregular (vertebra). For example, 
it can be seen in Fig. 1.1 a schema of a long bone. It can be divided into three 
physiological regions, namely the epiphysis, the metaphysis and the diaphysis. 
The epiphysis is the rounded end of the bone. The metaphysis is the part adjacent 
to the epiphysis in the adult (the growth plate or physis being closed) and the 
diaphysis is the cylindrical shaft of the bone. Trabecular bone is found mainly in the 
metaphysis, while cortical bone includes the diaphysis. In the vertebral column, trabecular 
bone is the main constituent.
The surfaces of bone are covered by the periosteum and the endosteum as 
connective tissues. The periosteum covers the outer surface of bone, except the 
joins which are protected by articular catilage, whereas the endosteum lines the 
surface of the medullary cavity of long bones. The periosteum consists of an outer 
fibrous layer consisting of collagen fibres and fibroblasts and an inner cambium 
layer composed of flattened cells — the osteoprogenitor cells with the capacity to 
divide by mitosis and to differentiate into osteoblasts. The endosteum is composed 
of osteoprogenitor cells and a very small amount of connective tissue. The 
surfaces, periosteum and endosteum provide a continuous supply of 
osteoprogenitor cells or new osteoblasts for repair or growth of bone. 
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Fig. 1.1: Schema of a long bone, showing the structures of cortical and trabecular bone 
(adapted from [2]). 
1.2.2 Microstructure of bone 
1.2.2.1 Cellular components 
Bone tissue is constituted by four characteristic cell types: osteoblasts, osteocytes, 
osteoclasts, and undifferentiated bone mesenchymal stem cells.  
Osteoblasts are mononucleate bone-forming cells responsible for the synthesis 
and deposition on bone surfaces of the protein matrix of new intercellular material. 
They are located on the surface of osteoid seams and make a protein mixture 
known as osteoid, which mineralizes to become bone. Osteoblasts robustly 
produce alkaline phosphatase, an enzyme that has a role in the mineralisation of 
bone, as well as many matrix proteins.  
Osteocytes originate from osteoblasts that have migrated into and become 
trapped and surrounded by bone matrix that they themselves produce and they 
occupy the lacunae. Osteocytes communicate with other osteocytes, as well as 
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with free bone surfaces by means of extensive filamentous protoplasmic 
extensions that occupy the canaliculi through the bone substance. Their functions 
include the formation of bone, matrix maintenance and calcium homeostasis. They 
have also been shown to act as mechano-sensory receptors—regulating the 
bone's response to stress and mechanical load.  
Osteoclasts are large multinucleated cells responsible for bone resorption 
(remodelling of bone to reduce its volume) by direct chemical and enzymatic 
attack. Because the osteoclasts are derived from a monocyte stem-cell lineage, 
they are equipped with phagocytic like mechanisms similar to circulating 
macrophages. Osteoclasts mature and/or migrate to discrete bone surfaces. Upon 
arrival, active enzymes, such as tartrate resistant acid phosphatase, are secreted 
against the mineral substrate. 
Undifferentiated mesenchymal stem cells of the bone reside in the loose 
connective tissue between trabeculae, along vascular channels, and in the 
condensed fibrous tissue covering the outside of the bone (periosteum); they give 
rise under appropriate stimuli to osteoblasts. 
1.2.2.2 Molecular structure 
On a molecular level, bone is composed of bone matrix and woven or lamellar 
bones. The bone matrix is where the cells are placed, representing the majority of 
bone. It is composed of inorganic and organic matter. The inorganic or mineral 
portion, which account for almost 70 wt.% of compact bone, consists mainly of 
small crystals of hydroxyapatite (HA, Ca10(PO4)6(OH)2) and some amorphous 
calcium phosphate compounds [3]. The organic phase consists of Type-I collagen 
fibres (approximately 95%) embedded in the ground substance containing 
proteoglycans and glycoproteins (5%). This organic matrix, calcified by calcium 
phosphate minerals, embeds bone cells, which participate in the maintenance and 
organization of bone. The inorganic component of bone makes the tissue hard and 
rigid, while the organic component gives bone its flexibility and resilience.  
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Depending on how the protein fibrils and osteocytes of bone are arranged, bone 
consists of woven or lamellar bone (Fig. 2). Woven bone, also known as ‘coarse 
fibred’, is considered immature bone and is characterised by the presence of 
randomly oriented coarse collagen fibres. It is found in the embryo, in the fracture 
callus and in the metaphysical region of growing bone, as well as in tumours, 
osteogenesis imperfecta and pagetic bone. It is also the first tissue to appear in 
the repair of bone (fracture healing). Lamellar is a more mature bone, since it 
begins to form one month after birth and actively replaces woven bone. It is 
characterised by the presence of collagen fibres arranged in parallel layers or 
sheets (lamellae). 
Fig. 1.2: Schematic drawing and micrographs of lamellar and woven bone (adapted from 
[4]). 
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1.2.3 Osteoconduction and bone formation 
Osteoconduction is paramount to osteogenesis during the normal bone 
remodelling processes and is composed of three main processes: (i) migration of 
bone progenitor cells through a transient matrix, (ii) differentiation of the bone 
progenitor cells, and (iii) recruitment of functional differentiated cells to initiate the 
formation of new bone [5].  
Osteogenesis is a result of osteoconduction and bone formation, and occurs when 
the first layer of bone is directly secreted onto the implant’s surface [6]. During 
osteoconduction, pre-osteogenic cells are stimulated to migrate through a 
provisional matrix, which could be represented by bone grafts, implants, or a blood 
clot. The migrating cells then start a differentiation process that results in the 
secretion of the new bone matrix.  
During the bone formation, differentiating osteogenic cells first secrete globular 
accretions of a matrix devoid of collagen called cement line. These afibrillar layers 
are found at the interface of secondary osteons with the surrounding tissue and 
may also be seen at the bone-implant interface [7]. This first layer provides 
nucleation sites for calcium phosphate nano-crystals, which nucleate and grow 
within the organic matrix. After the deposition of the cement line matrix, the 
osteogenic cells differentiate into osteoblasts, which elaborate the collagenous 
extracellular matrix assembled as fibers. Finally, the collagenous fibers undergo 
calcification and are separated from the underlying substratum by a calcified non-
collagenous matrix [8, 9].  
1.2.4 Bone remodelling 
Bone has the ability to remodel, by altering its size, shape and structure to meet 
the mechanical demands placed on it. Bone remodelling is a dynamic, lifelong 
process in which old bone is removed from the skeleton and new bone is added. It 
consists of two distinct stages – resorption and formation – that involve the activity 
of special cells, as osteoclasts and osteoblasts [7]. Usually, the removal and 
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formation of bone are in balance and maintain skeletal strength and integrity. Fig. 
3 sketches the bone remodelling process. 
Fig. 1.3: Bone remodelling process: bone resorption (A), bone resorption complete (B), 
bone formation (C) and completion (D) (adapted from [4]). 
Osteoclasts act on the trabecular bone surface to erode the mineral and matrix 
and small cavities where bone has been removed are created (Fig. 3 A and B). 
Osteoblasts work to repair the surface and fill the eroded cavities with new bone 
that then has to be mineralized (calcified) (Fig. 3 C). The bone surface is restored 
and covered by a layer of protective bone cells called lining cells (Fig. 3 D). The 
new bone is calcified and the remodelling process is completed. 
During the remodelling stages, several cytokines, growth factors (IGFs, TGF-b1, 
FGF, BMP, EGF, PDGF, etc.) and hormones (PTH) participate in cell proliferation 
at remodelling sites [10].  
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1.3 Calcium phosphate-base bone substitutes 
Bone substitutes should have a good local and systemic compatibility, the 
capability of being substituted by bone and of completely filling any defect. These 
features require osteoconductive and/or osteoinductive properties of the implant 
comparable to those of the natural bone.  
Currently available bone substitutes show a variety of compositions and 
properties. Among them, compounds made of inorganic calcium phosphates 
(CaP) are frequently used. They are non toxic and do not cause cell death at the 
surrounding tissue. Biological response to these materials follows a similar 
cascade observed in fracture healing. This cascade includes hematoma formation, 
inflammation, neovascularisation, osteoclastic resorption, and new bone formation. 
They undergo processes of dissolution and precipitation resulting in a strong 
material-bone interface [11-13]. 
The first clinical attempt to use CaP compounds was reported by Albee in 1920, in 
the repair of a bony defect [14]. Only 30 years later, a second clinical report was 
published [15]. Levitt et al. [16] and Monroe et al. [17] suggested CaP ceramic 
material for bone and tooth implants. Between 1976 and 1986, serious efforts 
were made toward development and commercialization of CaP as biomaterials for 
bone repair, substitution and augmentation [18-21]. Later, tricalcium phosphate 
(TCP) was used to repair surgically-created infrabony defects in dogs [22] and for 
alveolar ridge augmentation [23], and dense hydroxyapatite (HA) cylinders were 
used as dental root implants after tooth extraction [24, 25]. 
In the past two decades, CaP biomaterials have gained acceptance in dental and 
orthopaedic applications, such as, repair of bone defects, tooth root replacements, 
ear implants, spine fusion, and coatings on orthopaedic and dental implants [18, 
23, 25-28].
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1.3.1 Calcium phosphates 
Calcium phosphates (CaPs) are found widely in the earth crust and are 
characterized as white solids unless doped or containing elements that pass in the 
lattice structure of the respective compound. CaPs are the chemical compounds of 
special interest for human beings due to their similarity with the inorganic part of 
major normal (bones, teeth and antlers) and pathological calcified tissues of 
mammals [29-31]. CaPs possess remarkable biocompatibility, osteoconductivity 
and bioresorbability. The most relevant CaPs are presented in Table 1.1. 
Table 1.1: Relevant calcium phosphates [31] 
Calcium phosphate Formula Ca/P 
Monocalcium phosphate 
monohydrate (MCPM) Ca(H2PO4)2.H2O 0.5 
Monocalcium phosphate 
anhydrous (MCPA) Ca(H2PO4)2 0.5 
Dicalcium phosphate 
dihydrate (DCPD) Ca(HPO4).2H2O 1.0 
Dicalcium phosphate 
anhydrous (DCPA) Ca(HPO4) 1.0 
Octacalcium phosphate 
(OCP) Ca8(HPO4)2(PO4)4.5H2O 1.33 
Amorphous calcium 
phosphate (ACP) 
CaxHy(PO4)z.nH2O 
n = 3 - 4.5 
1.2 - 2.2 
Calcium deficient 
hydroxyapatite (CDHA) Ca9(HPO4)(PO4)5(OH) 1.5 – 1.67 
α-Tricalcium phosphate 
(α-TCP) α-Ca3(PO4)2 1.5 
β-Tricalcium phosphate 
(β-TCP) β-Ca3(PO4)2 1.5 
Hydroxyapatite (HA) Ca10(PO4)6(OH)2 1.67 
Tetracalcium phosphate 
(TTCP) Ca4(PO4)2O 2.0 
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Monocalcium phosphate monohydrate (MCPM) is the most acidic CaP and the 
most soluble CaP at almost all pH values. Due to its acidity and solubility, MCPM 
is not biocompatible and thus can not be used alone as a bone substitute, but 
combined with several self-hardening CaPs cements [32-34]. In addition, MCPM is 
used as a nutrient, acidulate and mineral supplement for dry baking powders, 
food, feed and some beverages [35]. 
Dicalcium phosphate dihydrate (DCPD, or the mineral brushite) can be easily 
crystallized from aqueous solutions. DCPD has been detected in fracture callus, 
bone and kidney stones [36-38]. DCPC is biocompatible, biodegradable and 
osteoconductive, being easily converted into HA in vivo [39].  
β-Tricalcium phosphate (β-TCP) is a high temperature phase of CaP, which only 
can be obtained by its thermal decomposition at temperatures above 800ºC. β-
TCP is biodegradable and has been extensively used as bone substitute, either as 
granules or blocks or even, in CaP bone cements [31]. In combination with HA, β-
TCP forms the biphasic CaP (BCP), being both widely used as a bone substitution 
bioceramics [40, 41]. 
α-Tricalcium phosphate (α-TCP) is usually prepared from β-TCP phase at heat 
treatment above 1125ºC, and quenching it prevents the reverse transformation 
[42]. α and β-TCP phases have exactly the same chemical composition but 
dissimilar crystallographic structure and solubility. α-TCP is biocompatible and 
more biodegradable than β-TCP, but less stable than β-phase [43]. For that 
reason, α-TCP is more reactive in aqueous systems, has a higher specific energy 
and it can be hydrolyzed to a mixture of other CaPs. It never occurs in biological 
ossifications but, due to its hydraulic power, is used in CaP bone cements [44, 45]. 
Calcium-deficient hydroxyapatite (CDHA) chemistry is very complex, because it 
can have a Ca/P molar ratio from 1.50 to 1.67 [46], and sometimes even outside 
this range [47]. CDHA is usually obtained by precipitation in an aqueous solution 
above a pH of 7 [48]. Their crystals are in general poorly crystalline and of 
submicron dimensions. The solubility of CDHA increases with a decrease of Ca/P 
molar ratio, crystallinity and size. CDHA decomposes on heating, above 700ºC, 
into β-TCP (Ca/P = 1.50), into a mixture of HA and β-TCP (1.50 < Ca/P < 1.67) or 
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into pure HA (Ca/P = 1.67) [41, 49]. As a first approximation, CDHA may be 
considered as HA with some ions missing [46]. Unsubstituted CDHA does not 
exist in biological systems, but the substitution of Ca2+ by Na+, K+, Mg2+ or Sr2+; 
HPO42- or PO43- by CO32-; OH- by F-, Cl-, CO32- plus some water forms biological 
apatite [37, 38]. Thus, CDHA is a promising compound to produce synthetic bone 
substitutes. 
Hydroxyapatite (HA) is highly crystalline and is the most stable and least soluble 
CaP in an aqueous solution down to a pH of 4.2. Some impurities, as partial 
substitution of hydroxide by fluoride or chloride, stabilize the hexagonal structure 
of HA at room temperature. HA can be prepared using wet methods, such as 
precipitation [50-52], hydrothermal [53] and hydrolysis of other CaPs. HA can be 
also obtained from a solid-state reaction of, for example, MCPM, DCPA, DCPD, 
OCP with CaO, Ca(OH)2 or CaCO3, above 1200ºC. The detailed information on 
HA synthesis is reported and available elsewhere [54]. HA can be prepared in 
dense or macroporous forms, as granules or blocks [55, 56]. In addition to being 
used as bone substitutes, HA granules are also used as the source material for 
depositing coatings on commercial dental and orthopaedic implants using the 
plasma spray technique [19, 55-57]. Moreover, due to the very large specific 
surface area, HA is used in liquid chromatograpy of proteins and other biological 
compounds and for drug delivery purposes [58-60]. Tensile strengths for dense 
and porous HA are, respectively, 79 to 106 MPa, and 42 MPa [55]. The resorption 
of ceramic HA is believed to be slow (1 to 2% per year) and a result of surface 
macrophage attack, which creates a roughened surface and forms an apatitic 
layer similar to the biological apatite [61]. The new surface then serves as a 
substrate onto which bone is deposited. However, these dense materials are too 
brittle and degrade too slowly to be considered for orthopedic procedures.  
Tetracalcium phosphate (TTCP) is the most basic and soluble CaP. It is obtained 
by a solid-state reaction above 1300 ºC, usually between equimolar quantities of 
dicalcium phosphate (DCP) and CaCO3 [62]. TTCP is not very stable in aqueous 
solutions, since it hydrolyses to HA and Ca(OH)2 [53]. Therefore, TTCP is never 
found in biological calcifications. TTCP is broadly used for self-setting CaP 
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cements preparation, such as in commercial BoneSource and Cementek (see 
Table 1.3 in section 1.3.3). 
Attention in the biomedical field is generally focused on MCPM, DCPD, OCP and 
precipitated HA (PHA), because their respective solubility products are well 
established [63]. It should be noted that DCP is rarely obtained by precipitation 
from an aqueous solution [64] at room temperature. It is usually obtained by 
heating DCPD at temperatures between 120ºC and 170ºC. Likewise, the hydration 
processes of DCP are usually effective at temperatures higher than 50ºC [65].  
According to solubility, CaPs can be ranked in order of increasing the in situ
degradation rate as: MCPM > TTCP ≈ α-TCP > DCPD > OCP > β-TCP > HA.  
CaPs can be categorized into bioactive and bioresorbable materials. A bioactive 
biomaterial enables establishing direct chemical bonds with bone with surrounding 
tissues, and could provide good stabilization for materials that are subject to 
mechanical loading. Bioresorbable materials allow a newly formed tissue to grow 
into any surface irregularities but may not necessarily interface directly with the 
material [66-68]. Examples of bioactive materials are bioceramics made of dense 
HA, while porous scaffolds made of biphasic CaP, or bone grafts made of CDHA 
appear to be good examples of bioresorbable materials. Unfortunately, CaP 
biomaterials have poor mechanical properties that do not allow them to be used in 
load-bearing applications. For that reason, clinical applications of CaPs are 
focused on the production of non-load-bearing implants, such as pieces for middle 
ear surgery, scaffold materials for bone filling defects, or coating of dental implants 
and metallic prostheses [69].  
Biomaterials and bioceramics of CaP are available in diverse forms, like particles, 
granules and blocks (dense or porous), coatings on metal implants, composites 
with polymers, etc. [70]. The properties of these materials depend on the 
conditions under which they were formed and on their inherent chemistry and final 
porosity. Porosity has been intentionally introduced in solid biomaterials, since a 
porous surface provides mechanical fixation that allows chemical bonding between 
biomaterials and bone. However, the presence of macroporosity leads to weaker 
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biomaterials and can be a rather complicated process for manufacturing. 
Interested readers are referred to special literature reports [71-74].  
General requirements for the ideal bone grafts are: (i) pores of some 100 µm size, 
(ii) biodegradation rate similar to that of bone tissue formation, and (iii) enough 
mechanical stability.  
CaP-based hydraulic cements that harden inside bone defects are other bone 
grafts usually used [26, 66, 75, 76]. Concept and properties of these types of 
materials are intensely discussed in section 1.3.3.
1.3.2 Ionic co-substitutions in calcium phosphates 
It is well known that the mineral component of bone is similar to HA but contains 
other ions in composition, as illustrated in Table 1.2. Regarding cations, sodium 
(Na) has been detected as an abundant trace element next to the presence of Ca 
and P in natural bone and tooth mineral.  
Table 1.2: Composition of inorganic phases of adult human calcified tissues 
Composition 
(wt.%) Bone Enamel Dentin 
Calcium 34.8 36.5 35.1 
Phosphorus 15.2 17.7 16.9 
Sodium (Na) 0.9 0.50 0.60 
Magnesium (Mg) 0.72 0.44 1.23 
Potassium (K) 0.03 0.08 0.05 
Zinc (Zn) 0.0126 - 0.0217 [77, 78] - - 
Fluoride (F) 0.03 0.01 0.06 
Chloride (Cl) 0.13 0.30 0.01 
Carbonates 7.4 3.5 5.6 
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Each of the aforementioned elements plays an essential part in biological action 
course: (a) Na has a potential role in cell adhesion and in the bone metabolism 
and resorption processes [79, 80]; (b) Mg has its own significance in the 
calcification process and on bone fragility, and has indirect influence on mineral 
metabolism [81]; (c) K has a versatile nature in the regulation of biochemical 
process and also an important role in the apatite mineral nucleation process [82-
84]; (d) Zn is an essential trace element for promoting osteoblast cell proliferation 
and differentiation [85, 86]; (e) Sr has beneficial effects in the treatment of 
osteoporosis due to the prevention of bone loss by mechanism of depressing bone 
resorption and maintaining bone formation [87-89]; (f) F is well-recognized for its 
potential behaviour relating to the stability of the apatite and for its prevention role 
in dental caries [90]; (g) Cl has the ability to develop an acidic environment on the 
surface of bone that activates osteoclasts in the bone resorption process [91, 92]. 
The presence of foreign ions into the synthetic apatites structure can alter a series 
of structural, physico-chemical and biological properties of CaP, such as, lattice 
parameters, crystallinity, solubility, dissolution, resorption and bone bonding 
capability [50, 93-95]. Under this perspective, a number of research results have 
been reported so far on the trace elemental incorporation into the synthetic 
apatites, such as, Mg, Sr, Zn, Na, K, F and carbonates. For example, carbonate 
substitution causes the formation of smaller and more soluble apatite, while 
fluoride incorporation has the opposite effects [96-98]. Mg incorporation in apatite 
is limited but causes reduction in crystallinity (smaller crystal size) and increases 
its extent of dissolution [99]. On the other hand, Sr causes an increase in solubility 
[100, 101]. 
It is also interesting to note, that chemical elements not found in natural bones can 
be intentionally incorporated into CaP biomaterials to get special properties. 
Examples are addition of Ag and Cu [102, 103], that have been used for imparting 
antimicrobial effects, while radioactive Sm-153 and Re-186 have been 
incorporated into HA microspheres and injected into knee joints to treat 
rheumatoid joint synovitis [104]. 
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1.3.3 Calcium phosphate cements 
In 1832, Ostermann prepared a CaP biomaterial in the form of a paste that set in 
situ to form a solid material. Nevertheless, Brown and Chow in 1986 [76] were the 
first to present this new form of CaPs, currently known as calcium phosphate 
cements (CPCs).  
CPCs are made of an aqueous solution and of one or several CaPs, which upon 
mixing, dissolve and precipitate into a less soluble CaP and sets by the 
entanglement of the growth crystals, providing a mechanical rigidity to the cement. 
When the paste becomes sufficiently stiff, it can be placed into a defect as a 
substitute for the damaged part of bone, where it hardens in situ within the 
operating theatre. It hardens in generally < 20 min at body temperature (37ºC) and 
then displays limited solubility. The relative stability and solubility of various CaPs 
is the major driving force for the setting reactions that occur in CPCs. Depending 
upon the pH value of a cement paste, after setting, the CPCs can be denominated, 
according to the end product, into apatite (AP) cements and DCPD  (or brushite) 
cements. AP is formed above pH 4.2, while brushite is preferentially formed in 
CPCs when pH value of the paste is < 4.2 [105], although it may grow even up to 
pH 6.5, due to kinetics reasons [105]. Given that water is not a reactant in the 
setting reaction of AP cements, a less amount of water is needed [106, 107] than 
when water participates in the chemical transformations such in the case of 
brushite cements [108].  
CPCs are resorbable, osteoconductive, noncytotoxic, create chemical bonds to the 
host bones, restore contour and have both the chemical composition and X-ray 
diffraction patterns similar to those of bone [48, 108-110]. The major advantages 
of the CPCs include a fast setting time, excellent mouldability, outstanding 
biocompatibility, and easy manipulation [110, 111]; therefore, the cements are 
more versatile in handling characteristics than prefabricated CaP granules or 
blocks. Besides, like any other bioceramics, CPCs provide the opportunity for 
bone grafting using alloplastic materials, which are unlimited in quantity and 
provide no risk of infectious diseases [108].  
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There are a number of CPCs products available in the market that is summarized 
in Table 1.3. 
Table 1.3: Marketed calcium phosphate cements formulations [37, 106, 112] 
Company Product Composition End product Resorbable 
ETEX α-BSM ACP, DCPD PHA yes 
Mitsubishi 
Materials 
Biopex α-TCP, TTCP, DCPD PHA no 
BoneSourceTM TTCP, DCP PHA yes 
Stryker  
HydroSetTM 
DCPD, TTCP, 
Trisodium citrate 
   PHA    n.d. 
Calcibon α-TCP, DCP, CC, PHA CAP n.d.*
Biomet 
Biocement D α-TCP, DCP, CC, PHA PHA yes 
Norian SRS
Norian CRS
α-TCP, CC, MCPM CAP yes 
Synthes 
ChronOS Inject α-TCP, MCPM DCPD yes 
Lorenz Surgical Mimix 
α-TCP, TTCP, HA, 
citric acid 
PHA n.d.* 
Teknimed Cementek TTCP, α-TCP, MCPM PHA n.d.* 
*n.d. = no data 
Chemical reactions that take place during the setting of CPCs depend on their 
chemical composition. Nevertheless, it can be stated that only two major chemical 
types of the setting reaction are possible. The first type is an acid-base reaction 
that depends on the hydration rates of the acid and basic salts, followed by the 
neutralization of the by-products. Examples can be:  
                     
                       264104244 )()(2)(2 OHPOCaCaHPOOPOCa →+                                (1) 
or 
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                     OHCaHPOOHOHPOHCaPOCa 2422242243 2.47)()( →++−β             (2) 
From equation (1), the basic TTCP reacts with the acidic DCPA/DCPD resulting in 
the formation of HA with a neutral pH. A steady state in terms of ion concentration 
in the solution is kept as long as the rate of dissolution of DCPA/DCPD and TTCP 
exceeds the rate of HA formation [113, 114]. Finally, the hardening of the cement 
results from the interlocking of HA crystals [109]. Several deviations from the 
chemical equation (1) have been studied in details [115]. 
The second type of the setting reaction might be defined as hydrolysis of a 
metastable CaP in aqueous media, e.g. when the initial and final CaPs have the 
same Ca/P molar ratio. Examples are cements made of α-TCP, β-TCP, ACP, 
TTCP plus aqueous solution, where they re-crystallize to CDHA upon contact with 
water. An example is expressed by the equation (3):
                               OHPOHPOCaOHPOCa 54492243 ))(()(3 →+−α                      (3) 
Experimental details on the above mentioned hydrolysis reactions are available 
elsewhere [116, 117]. 
CPCs hydration process is a slow exothermic reaction (thus preventing the 
attainment of high curing temperatures), during which the cement does not shrink.  
Previous results showed that the temperature rise arrived at the highest value of 
37ºC 3 h later [118]. 
The liquid phases involved in the setting reaction of CPCs are aqueous solutions. 
As aforementioned, the systems of brushite cements, as TTCP + DCPD, harden in 
water, whereas other systems usually require the use of sodium phosphate 
solution (approximately 0.25 mol L-1) as the liquid [119]. For applications requiring 
longer working times, glycerine or polyethylene glycol can be used [120]. 
As CDHA is similar to the chemical composition of bone, AP cements have been 
more extensively investigated and produced by several companies (Table 1.3). 
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Nonetheless, brushite cements have raised interest because they are resorbed in 
vivo much faster than AP cements. Although AP cements showed higher 
mechanical strength, they have slow in vivo resorption rates that interfere with the 
bone regeneration process [39, 121]. Moreover, brushite is metastable in 
physiological conditions and brushite based cements possess faster setting 
reactions [105, 122-124].
Brushite cements were introduced in 1987 by Mirtchi and Lemaitre, where DCPD 
is the major end product of the setting reaction (equation (2)). Other formulations 
have been already proposed, such as, β-TCP + H3PO4 and TTCP + MCPM + 
CaO. It is important to notice that β-TCP + H3PO4 formulations have several 
advantages over β-TCP + MCPM formulations, namely: (i) easier and faster 
preparation, (ii) a better control of the chemical composition and reactivity, and (iii) 
improved physico-chemical properties, such as longer setting times and larger 
tensile strengths due to a higher homogeneity. However, the use of H3PO4 might 
weaken the biocompatibility of the cement formulation, owing to low pH values 
during setting [125]. 
Brushite cements are acidic during setting, since DCPD can only precipitate from 
solutions at pH values below 6; hence the reaction is very rapid corresponding to 
the setting stage. Despite this initial high reactivity, the hardening stage of brushite 
cements typically lasts one day until completion, due to the increasing of the paste 
pH at the end of the setting reaction. In order to control the start of the setting 
reaction, inhibitors of crystal nucleation and growth, and less soluble reagents (for 
example, HA instead of β-TCP) can be used. Moreover, the use of monodisperse 
and fine powder particles is vital to provide an overall setting reaction. 
Brushite cements are biocompatible and bioresorbable. In contrast to AP cements, 
they are faster resorbed in vivo and bear a rapid decrease in strength (even 
though strength of the healing bone increases as bone ingrowth occurs). 
Conversely, low mechanical strength, short setting times and the consequent rapid 
increase in viscosity to enable injection through hypodermic needles, prevent 
brushite cements from a broader clinical application. Use of chondroitin 4-sulfate 
[126] and glycolic acid [124] as setting retardants is an option to get more 
workable and less viscous pastes of brushite cements. 
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Brushite cements have a fast and linear degradation rate of 0.25 mm/week [127], 
which might lead to formation of an immature bone. Adding b-TCP granules to the 
cement paste could solve this problem because they act as bone anchors and 
encourage formation of a mature bone [127, 128]. 
1.3.4 Calcium phosphate cement properties
From the clinical point of view, the desirable relevant properties of CPCs are 
adequate flow properties, short setting times, easy injectability, mechanical 
properties that are comparable to those of trabecular bone and a resorption rate 
that is neither too fast nor too slow. 
1.3.4.1 Dynamics of flow 
Rheological properties have not been the subject of extensive investigations in the 
past. These properties are crucial in gaining understanding of the fundamentals of 
the dynamics of flow of an injectable CPC through the delivery system (cannula) 
and its subsequent interdigitation into the cancellous bone. This knowledge can 
also help in optimizing the design of the cannula, establishing the optimum time for 
injection and the optimum viscosity at the time of injection, and minimizing the risk 
for cement extravasations [108]. Besides, the first initial setting period, where the 
cements lose gradually their plasticity, can be accessed by rheological 
measurements as well.  
The rheological behaviour of a system depends on many intrinsic factors such as 
the concentration of solid particles in a suspension, particle size and particle size 
distribution, particle shape, the pH value of the suspending media, type and 
amount of dispersing agents of other processing additives (binders, plasticizers, 
lubricants), stabilization mechanism; or on the concentration of polymer molecules 
in a solution, their molecular weight and molecular weight distribution; as well as 
on outside influences such as the ambient pressure the strength of a magnetic or 
an electric field, and other testing conditions including the type of load, the degree 
the duration of load, the temperature, etc. 
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The rheological behaviours can be classified as Newtonian and non-Newtonian. 
The shear viscosity, η, of a Newtonian fluid is independent of the intensity of the 
shear load. Examples of ideal viscous materials include: low molecular liquids 
such as water, solvents, mineral oils (without polymer additives), standard oils, 
pure and clean bitumen (without associative superstructures, i.e. at sufficiently 
high temperatures) and blood plasma. Non-Newtonian systems the evolution of 
viscosity as a function of shear rate, γɺ , might show a decreasing (shear-thinning 
flow behaviour) or an increasing trend (shear-thickening flow behaviour). The 
overall relation between the shear stress, τ, and shear rate for systems without an 
(apparent) yield point can be expressed by: 
nγτ ɺ=
For samples displaying Newtonian flow behaviour (n=1), the shear viscosity is 
independent on the degree of shear and the plots τ versus γɺ  are straight lines 
passing through the origin [Fig. 1.4 (a)], while the plots η versus γɺ  are straight 
horizontal lines [Fig. 1.4 (b)]. Fig. 1.4 (a) and (b), also show typical plots of shear-
thinning (n <1), and shear-thickening (n>1) flow behaviours. In Fig. 1.4 (a), the 
diagram is represented with linear scale, while in Fig. 1.4 (b) a logarithmic scale 
was used. These last scales are recommended when the course of the curves 
should be visible at very low τ and γɺ  values. 
Fig. 1.4: Comparison of the flow (a) and viscosity (b) curves 
Shear-thickening 
Shear-thinning 
Bingham 
Shear-thickening 
n > 1
Newtonian  
n = 1 
o
Shear-thinning 
n < 1
np
(b) 
lg η
lg γɺ
τy
Bingham 
Newtonian 
(a) 
τ
γɺ
22 
Examples of shear-thickening materials include dispersions with a high 
concentration of solids or polymers such as ceramic suspensions, starch 
dispersions, etc.. The flow curve shows an increasing curve slope (Fig. 1.4 (a), i.e. 
η increases with increasing. 
Plastic systems exhibit a yield point and “plastic flow” is the deformation process 
which can only occur above the yield point; below this point no or only elastic 
deformation occurs. The simplest or ideal plastic behaviour is the proposed by 
Eugen C. Bingham. At the yield point the loaded sample starts to be deformed and 
the rate of deformation increases linearly with the shear rate. 
Inhomogeneous plastic behaviour cannot be described unequivocally using 
mathematics. It can only be represented using the results of empirical tests. 
The terms plastic, ideal plastic, viscoplastic or elastoplastic are often used to mean 
different things. It is useful to understand what these terms might mean, but their 
use should be avoided when performing scientific rheological tests. In most cases, 
samples can be characterized as viscoelastic in a limited deformation range. 
However, when a material cannot be sheared homogeneously it is necessary to 
use special relative measuring systems. In this case, it is better to work with the 
measured raw data values (i.e. the torque, speed and deflection angle) instead of 
the rheological parameters (i.e. the shear stress, shear rate, deformation, viscosity 
and shear modulus). 
Bone cements in general are considered viscoelastic materials as they change 
from having primarily liquid-like properties immediately after mixing to having 
primarily solid-like properties once cured. In general, the storage modulus (G’) 
corresponds to the elastic behaviour of the material and determines its inherent 
rigidity, thus it depends on the ability of the material to store mechanical energy. 
Conversely, the loss modulus (G”) corresponds to the viscous behaviour of the 
material and has a strong influence on its toughness and is dependent on the 
material’s ability to absorb and dissipate mechanical energy. 
One of the first studies related to CaP paste rheology, by Bujake [129], 
investigated the viscosity of toothpaste-like suspensions containing DCPD, 
glycerine and water. These authors observed an increase of the viscosity with a 
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decrease of the particle size. Similar results were obtained in other studies [130-
133]. Rao and Kannan [132] examined the yield stress and viscosity of HA 
suspensions. They observed a yield stress of 5 Pa, and a shear-thinning followed 
by shear-thickening behaviour. Generally, shear-thickening appears to occur at 
high particle loading [131, 133].  
In a previous report [134], the study of the rheological behaviour of α-TCP slurries 
using a viscosimeter gave the possibility of looking at the effect on cement 
viscosity of various parameters during the initial setting, such as the particle size of 
the α-TCP powder, the LPR and the addition of dispersants. Also, Baroud et al. 
[135] studied the effects of liquid-to-powder ratio (LPR), milling of the powder 
particles and the presence of additives on the rheological properties of a non-
reactive system. The study also demonstrated the importance of determining the 
rheological properties of the pastes in order to fully understand the injectability 
data. In addition, they recommended increasing the viscosity of the mixing liquid, 
to decrease the particle interactions and to decrease the particle size of the 
powder.   
In an attempt to improve rheological properties of CPCs, the influence of several 
additives to the liquid phase, such as, lactic acid, glycerol, chitosan, citric acid or 
soluble polymers, on the injectability of CPCs have been studied by several 
authors [136-138]. These additives increase the viscosity of the liquid phase up to 
several orders of magnitude and make the cement pastes putty-like, since they 
improve the wetability and increase the surface charge of the cement particles due 
to ions adsorption at the particles’ surface [139].
1.3.4.2 Setting time and reaction rate 
The setting of bone cements is a continuous process that involves: (1) dissolution 
of reactants, (2) nucleation of new crystals, and (3) growth of crystals. After these 
processes, newly crystals entangle and the cement loses its viscofluid properties 
and transforms into a solid body [140]. Commonly, CPC should set slowly to 
provide enough time to a surgeon to perform implantation, by moulding or 
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injection, and harden fast to prevent delaying the operation, allowing the surgeon 
to close the defects shortly after cement placement. 
The setting and hardening process of CPCs have been determined with two 
standardized methods, namely, Vicat needle method (ASTM C191-92) and 
Gilmore needles method (ASTM C266-89). Basically, both methods consist in the 
visual inspection of CPCs surfaces, when the test specimen bears the needles 
without leaving any mark on the surface. Whereas Vicat method only uses a 
needle to determine the final setting time (FST), Gilmore method uses two 
different needles to measure the initial (IST) and FST setting times of CPCs. IST is 
measured with a light and thick needle (113 ± 0.5 g, Ø = 2.12 ± 0.05 mm giving a 
static pressure of 0.3 MPa), while FST is measured with a heavy and thin needle 
(453.6 ± 0.5 g, Ø = 1.06 ± 0.05 mm giving a static pressure of 5 MPa) [141]. IST 
indicates the time during which the material must not be manipulated to avoid 
serious damage to the cement structure, whereas FST defines the time when the 
material has hardened, but maximum strength for some materials has not been 
achieved.  
As far as clinical applications are concerned, the cement should be implanted 
before IST and the desired range of the setting times (in minutes) may be:  
3≤IST<8 
FST≤15 
These parameters are represented schematically in Fig. 1.5. In order to the 
surgeon has at least 1 min to apply and to mould the paste, cohesion time (CT), 
also called swelling time, must be at least 1 min before IST. As the mixing in a 
mortar is about 1 min, the shortest CT that can be allowed is about 2 min [138]. 
However, still have not consensus on what the ideal values of IST and FST should 
be. Ginebra et al. [142] have suggested that IST should be between 4 and 8 min, 
while FST should be between 10 and 15 min. On the other hand, Driessens et al. 
[143] have suggested that the cement should be injected before IST, while the 
wound should be closed after FST, making sure that the cement is not deformed 
between IST and FST otherwise cracks could be induced in it. In contrast, Sarda 
et al. [144] have suggested that the cement probably reaches a sufficient strength 
to withstand the pressure during wound closing well before FST. 
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Fig. 1.5: Diagram of the setting parameters relevant for CPC. CT: cohesion time; IST: 
initial setting time; FST: final setting time (adapted from [143]). 
Vicat and Gilmore methods have been used since the discovery of CPCs. 
However, these methods have not avoided criticism because of their inherent 
subjectivity. For this reason, some studies have been performed to record the 
setting process in a continuous manner and in real time by non-destructive 
methods, such as, isothermal calorimetry [122, 145, 146], pulse-echo ultrasound 
technique [147, 148] and AC impedance spectroscopy [149]. In the isothermal 
calorimetry method, the thermal reactions occurring during CPC setting reactions 
were followed as a function of time and composition. In addition, other methods 
have been proposed. For example, Hofmann et al. [123] followed the setting 
kinetics with Fourier-transform infrared (FTIR), while Grover et al. [150] used X-ray 
diffraction (XRD).  
Accelerators and retarders are usually used to control the setting times and 
rheological properties, as detailed discussed in section 1.3.5.  
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1.3.4.3 Injectability 
The viscous and cohesive properties are of major interest in the case of injectable 
cements. Injectability and cohesion are required for applications with limited 
accessibility and narrow cavities, and when there is a need for precise placement 
of the paste to conform to a defect area, such as periodontal bone repair and tooth 
root canal fillings.  
As there are no standard procedures to assess injectability property, indigenous 
test methods were developed for the purpose [151-153], as shown in Fig. 1.6.  
Fig. 1.6: Schematic representation of the experimental setup used to measure the 
injectability of CPCs. 
Therefore, injectability is reported as the percentage by weight of the cement 
paste that could be extruded without demixing from a standard syringe, through a 
small hole of a long needle (usually, Ø = 2 mm and 10 cm length), pressing the 
Applied 
force 
Syringe 
Cement 
paste 
Injected 
cement 
Needle 
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plunger manually or by applying an equivalent external force (~ 100 N) [151] (for a 
more detailed description, see Materials and Methods in section II.2). 
Frequently, CPCs pastes show liquid-phase separation (so-called filter-pressing 
effect) provoked by the pressure applied to the cement paste after a certain 
injection pressure or after a certain injection time [75, 154]. In the case of 
demixing, the exact composition of the extruded part of the paste becomes 
unknown. For example, in 4.5 mL Norian SRS cement paste, only ~ 3 mL of 
paste is injectable, while up to 1.5 mL of the cement remains in the syringe [143]. 
A good cohesion of the cement pastes during mixing is essential to avoid the 
possible occurrence of inflammatory reactions. Cohesion was reached when no 
disintegration of the cement paste was observed in the fluid, which can be 
obtained by keeping a high viscosity or using cohesion promoters (e.g., 1% 
aqueous solution of sodium alginate) and other chemicals [44, 112, 155]. 
Due to the setting process, the rheological properties of CPCs are transient and 
constantly changing. Combined with this is the complication that the injection 
process may destroy the evolving structure and thereby affect the measurements.  
There are different ways to improve injectability and cohesion, such as, the 
injection device, LPR, particle size and particle size distribution, the plastic limit 
and the use of additives in the mixing liquids [151]. For example, shorter cannulas 
with a larger diameter favour injectability. Moreover, setting retarders, such as 
gelling agents, can improve injectability as well, with the presence of gelling 
agents and the increase of LPR increasing the setting times. Although injectability 
of cements is enhanced with increasing LPR [138], this approach often has a 
detrimental effect on the mechanical properties [156].  In addtition, α-BSM is well 
injectable due to the small particle size of the powder. However, a small particle 
size requires a larger amount of mixing liquid, which decreases cohesion and 
mechanical strength [48, 145]. An indirect approach to improve injectability is to 
add CaP particles that act as spacers between other particles, as for the case 
when DCPA is added to Biocement D [48]. Another approach to improve 
injectability, is adding polymers to increase the viscosity and prevent filter-pressing 
[137, 139, 157]. Sarda et al. [157] found that the injectability of α-TCP water 
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mixtures was increased by 50-100% with the addition of citrate ions. Similar 
results were obtained for brushite and AP cements [139, 158]. 
The influence of all the abovementioned factors is discussed in details below in 
section 1.3.5. 
1.3.4.4 Mechanical behaviour 
As bone cements are meant to be used as bone substitutes, and because one of 
bone’s first functions is to support the body weight, the mechanical behaviour of 
the cements is of a paramount importance. The mechanical strength required for 
cements must be at least as high as that of trabecular bone, which is close to 10 
MPa.  
There are two mechanical tests particularly important for implanted CPCs; 
compression strength (CS) (Fig. 1.7 A) that requires sample dimensions of 6.0mm 
diameter x 12.0mm height, whereas in the diametral compression strength (Fig. 
1.7 B) cylindrical samples with dimensions of 6.0mm diameter x 3.0mm height are 
used. 
Fig. 1.7: Schematic representation of the experimental setups used to measure the (A) 
compression and (B) diametral compression strengths. 
Diametral compression strength (frequently denominated by several authors, as 
diametral tensile strength, DTS), also named the Brazilian test or indirect tension 
Applied 
force Applied force 
A B 
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test, is routinely used for brittle materials as ceramics [159]. Direct tensile tests are 
rarely applied to brittle materials, since they do not deform until rupture, 
misalignment of the specimens may induce a tangential stress component that 
may lower the measured strength of the materials. Therefore, DTS test allows 
measurement of materials tensile strength by applying a compressive load in an 
experimental setup similar to the one used for axial compression, to keep simple 
sample shape, and to avoid the problem of mounting specimens on the universal 
testing machine. The advantage of this type of test is that fracture starts within the 
specimen and the measured value is not depending on the surface state.  
CPCs are strong enough at compression which values are in the range 10-100 
MPa, whereas they possess a low tensile strength (1-10 MPa) [160]. The poor 
mechanical properties noticeably restrict a wider clinical application of CPCs; 
however after 12 weeks of implantation, CS values higher than that of normal 
bone (60-70 MPa) have been reported [161].  
Varying the crystallinity or the particle size of the materials used in the solid phase 
may alter the CS. Since CPC are relatively insoluble at neutral and alkaline pHs, 
their porosity is related to the ratios of powder to liquid used in the starting mixture. 
Obviously, high porosity cement would be expected to exhibit low CS.  
These mechanical properties may also vary with implantation time, and animal 
studies have shown that mechanical properties of AP cements tend to increase 
continually, in contrast to those of brushite cements, which initially decrease and 
then increase when bone grows [161, 162]. This is the result of different porosity 
and bioresorption between AP and brushite cements. 
To improve the mechanical properties of CPCs, incorporation of water-soluble 
polymers into the pastes has been attempted [163, 164]. It was observed that the 
strength increased mainly due to the polymers capacity to entangle. A research 
group reported similar results using sodium alginate and sodium polyacrylate 
[165]. Studies show that composites of α-BSM with polycations (polyethylenimine 
and polyallylamine hydrochloride) exhibited compressive strengths up to 6 times 
higher than that of pure α-BSM material [166].  
Mechanical properties of CPCs were found to decrease exponentially with the 
porosity increase, since the presence of pores lead to cracks in the hardened 
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cement.  Pressure can be applied to reduce the porosity of CPCs [156, 159, 167].  
Another way to control the mechanical strength is by varying LPR in the hardening 
mixture. Elevated CS would be applicable in cranioplasty for regions requiring 
significant soft-tissue support. For smaller bone defects, such as root canal fillings, 
low CS cements must be used [107]. An empirical relationship between strength 
and porosity is reported in the literature [168]. 
As porosity is mainly due to an excess of water used in CPCs formulations, efforts 
to reduce the amount of water were made. Also, a decrease in water content leads 
to a strong increase in viscosity of the CPC pastes. As CPCs set at an almost 
constant volume, the final porosity can be predicted from the initial composition 
[48, 169].  
Other factors affecting strength are the reagents used in the solid phase, particle 
sizes, incorporation of fillers into the solid phase and various liquid phases [170]. 
1.3.4.5 Biocompatibility and bioresorbability 
Biocompatibility, osteoconductivity, and bioresorbability are all features of CPCs 
that make them attractive bone substitute candidates.  
Biocompatibility expresses the biomaterial ability to perform with appropriate 
reactions in applications planned for a particular objective. Biocompatibility and 
bone-bonding ability of a material have been evaluated by in vitro and in vivo tests. 
In vitro biocompatibility assays are usually preceeded by mineralization tests in 
simulated body fluid (SBF) with ion concentrations nearly equal to those of human 
blood plasma [1, 171, 172] with the formation of apatite onto the materials surface. 
The biocompatibility screening tests include cell cultures [173] available on the 
market. The bone-bonding ability of a material is often evaluated. Moreover, there 
is a wide range of repeatable and reproducible methods, which are regulated by 
national and international standards for commercial use and for the scientific 
development of new materials and products. Detailed analysis of the surface 
apatite formed in SBF, by means of thin film X-ray diffraction, Fourier transform 
infrared spectroscopy (FTIR), scanning electron microscopy (SEM) and 
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transmission electron microscopy (TEM), showed that it was similar to bone 
mineral in its composition and structure [174]. As a result, it was speculated that 
osteoblasts might preferentially proliferate and differentiate to produce apatite and 
collagen on its surface. Thus formed apatite might bond to the surface apatite as 
well as to the surrounding bone. Consequently, a tight chemical bond is formed 
between the material and the living bone through the apatite layer. An example is 
β-TCP either in SBF [175, 176] or in vivo [177-179] environments bonding to living 
bone due to its high resorbability. 
In vivo assessment of the biomaterials biocompatibility is a critical step in their 
development and implementation. While in vitro studies yield important 
fundamental interactions with biomaterials, they cannot replace in vivo evaluation. 
An animal model is an appropriate way to identify a material with in vivo bone 
bioactivity, with special attention being paid to the similarities and differences in 
the trabecular bone composition and architecture of human being. In this regard, 
pigs and sheep are suitable models because their bone structure is comparable to 
those from humans. CPC revealed extensive bone formation immediately after 
implantation without any inflammatory tissue response [158]. Bone colonization 
occurred much earlier and faster in CPC than in CaP ceramics [152]. Polymers 
[136], gelatin [33], and collagen [155] can be added to improve the biocompatibility 
of CPCs. Adding chitosan and citric acid improved the biocompatibility and 
decreased the initial inflammatory responses of self-curing CPCs [112]. Addition of 
20% citric acid decreased the initial inflammatory response and enabled good 
bone bonding to be established.  
One of the most appealing characteristics of CPCs is their resorbability in vivo. 
Upon implantation, these materials act as osteoconductive scaffolds but, in time, 
degrade and are replaced by bone during the remodelling process [180, 181]. The 
products of the cements’ degradation are Ca
+2 
and PO4
3-
 ions, which are easily 
excreted or recycled by the body. CPCs degradation occurs by the combination of 
two processes: (i) in vivo dissolution, which is strictly related to their composition 
and particle size [182], and (ii) cell-mediated resorption mainly by osteoclasts. 
Cell-mediated resorption is advantageous since it mimics the natural process of 
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bone turn-over, in which osteoclasts resorb bone and osteoblasts subsequently 
secrete bone matrix [183, 184]. The bioresorption process of bone substitutes 
obviously depends on their chemical nature, being closely related with CaPs 
solubility in aqueous solutions (see section 1.3.1).  
A variety of characteristics may influence resorption rate. Among them are the 
age, sex, and general metabolic health of the host. Taking these variables into 
consideration, the complete resorption of CPCs may take from 3 to 36 months. 
Additional studies are needed in order to describe the degradability of these 
materials in clinical models [185].  
Brushite and AP cements have an excellent bioresorbability and ability to form 
new bone; but AP is less bioresorbable than brushite [122]. Moreover, when the 
crystal size increases or the porosity decreases, the bioresorption will be longer. 
Norian® SRS and α-BSM® are therefore, expected to bioresorb faster than 
BoneSource®, Biopex and Cementek.  Norian SRS was evaluated in canine tibial 
and femoral metaphyseal defects. 
1.3.5 Influence of factors on calcium phosphate cement properties 
The properties of CaP bone cements are influenced by a wide spectrum of factors, 
such as, the presence of additives, the powder particle size, the liquid-to-powder 
ratio (LPR) and the method used to mix the powder and liquid constituents of 
CPCs.
1.3.5.1 Additives 
Additives that have been studied are fluidificants, gelling agents, reinforcing 
agents and antibiotics [186]. Further, radiopacifiers might be used [187]. The main 
requirements for additives are non-toxicity as well as the absence of inhibition of 
the cement setting reaction. 
Fluidificants added to the liquid are aimed at enhancing the flowability of the 
cement pastes. An example is citric acid, which decreases the CS during initial 
33 
setting of the cement but increases its CS at saturation [157]. Moreover, citric acid 
also acts as setting stimulator and improves the mechanical properties of the 
hardened cements [188]. For several cements, mixing with sodium citrate or citric 
acid has resulted in some effects on the IST [139, 157], while for other cements 
the effect was insignificant [158]. 
The main role of gelling agents is to improve the workability of the pastes. These 
kinds of agents significantly increase the injectability, as well as the setting times. 
Two examples of workability-improvement agents are polysaccharides and gelatin, 
which lead to a reduction in total porosity and achievement of a more compact 
microstructure. Hidroxylpropylmethylcellulose (HPMC) is another gelling agent 
capable of improving the pastes cohesiveness, since HPMC is a polysaccharide 
able to hydrogen bond to water and form a viscous solution [189, 190]. 
Reinforcing agents can be added to enhance the mechanical properties of CPCs. 
Bohner et al. [191] used citrate, pyrophosphate and sulphate to modify the 
properties of CPCs. Moreover, in order to decrease CPCs brittleness, reinforcing 
fibres and polymers were added to cements’ matrix as a part of a periodontal 
disease model, yielding promising results [192].  
Studies have reported on the influence of additives in final CPCs properties.  
Wang et al. [193] showed that the addition of disodium phosphate, 
polyethyleneglycol (PEG 200), glycerin and citric acid influenced the injectability 
and the setting time of an ACP + DCPD bone substitute material. The study 
suggested that injectability and the setting time could be balanced and the cement 
could be prepared by optimizing the additives and their concentrations according 
to different clinical requirements. Leroux et al. [137] found that glycerol greatly 
improved the injectability and increased the setting time, but decreased the 
mechanical properties. Lactic acid reduced the setting time, increased the material 
toughness, but limited the dissolution rate. After injection, the cement did not 
present any disintegration. The effects of lactic acid were correlated with the 
formation of calcium complexes. Chitosan alone improved the injectability, 
increased the setting time, and limited the evolution of the cement by maintaining 
the CPC phase. 
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The main role of an antibiotic is to reduce infections in the body [194, 195]. 
However, its presence affects cement properties, as the addition of flomoxef 
sodium, for instance, leads to an increase in cement consistency, a decrease in 
DTS and an increase in the set mass porosity [196]. Both setting time and CS of a 
brushite CPC increased when gentamicin sulfate was added either as a powder or 
as an aqueous solution. 
1.3.5.2 Powder particle characteristics 
Powder particle characteristics include the average particle size, the particle size 
distribution and the specific surface area. Particle size distribution and surface 
area are interdependent characteristics which influence the behaviour of bone 
substitutes.  
A reduction in particle size produces a significant decrease in both initial and final 
setting times, an acceleration of the rate of hardening but an unclear trend with 
regards to mechanical properties [111]. In a study described by Liu et al. [113], a 
steeper increase in pH and accelerating the dissolution of DCPA by reducing the 
particle size of TTCP, was observed. For instance, the commercial reagent DCPA 
presents a median particle size of about 1 µm, while Chow et al. [197] reported 
that TTCP should be ground to a median particle size of approximately 15 µm.  
1.3.5.3 Liquid-to-powder ratio 
The properties of CPCs are influenced by LPR, as the higher amount of mixing 
liquid markedly increased both IST and FST, and decreased mechanical 
properties [75, 151]. A decrease in LPR and the adding of reinforcing fibres, on the 
other hand, would decrease the cements’ porosity and increase their mechanical 
properties [75], while injectability was found not to be affected for a LPR within the 
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range of 0.22 – 0.26 mL g-1, but drops by nearly 100% between LPR = 0.2 and 
0.22 ml g-1 [139].   
In a study reported by Baroud et al. [135], it was found that changing LPR and the 
milling time significantly affected the rheological properties. 
1.3.5.4 Mixing procedure 
Bone cement mixing methods are categorized as manual (or hand) mixing, 
centrifugation, vacuum mixing, and combined mechanical mixing.  
In manual mixing, the powder component is added to the liquid (which may or may 
not have been chilled to a temperature that is usually between 15ºC and 16ºC) in a 
polymeric (usually polypropylene or polyethylene) bowl. Then, these components 
are stirred with a, polypropylene or polyethylene, spatula with a speed of 1 or 2 Hz 
for 45–120 s. To be injected, the cement paste must be then transferred into a 
syringe. Two commercial products, Norian SRS and α-BSM, are sold with a 
reactant pack containing the powder and the mixing liquid, and require the use of a 
mixing machine and an injection gun [48]. The electrically powered mixing 
machine of Norian SRS mixes the cement paste within 70-80 s, and enables a fast 
and consistent filling of the application syringe. In spite of this kind of mixing 
system being very simple, it has some drawbacks. As the mixing procedure 
depends on the user and as the setting time of the cement is temperature 
dependent, the setting time varies from user to user. 
In centrifugation mixing, the hand-mixed dough is immediately poured into a 
syringe (from which the nozzle is detached) that is then promptly placed in a 
centrifuge and spun with a speed of 2300–4000 rpm for 30–180 s [33, 198].  
Applying vacuum to self-setting acrylic cements was first described in dentistry, 
but Lidgren et al. [199] studied vacuum-mixed cements as bone cements in 1984. 
They analyzed the mechanical strength of high- and low-viscosity gentamicin-
containing cements by using three different mixing procedures: hand, vibration, 
and vacuum stirring. They reported that vacuum mixing improved the flexural and 
compression strength especially for high-viscosity cement. In another study of 
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Lidgren et al. [200] in 1987 it was shown that vacuum mixing improved fracture 
strength, maximal deflection, modulus of elasticity, and hardness when compared 
with hand mixing. The fatigue life was ten times longer after vacuum mixing. 
Vacuum mixing delayed the setting time by 1 min, and also decreased the peak 
temperature. Radiographic analysis showed that vacuum mixing mainly reduced 
not only the microporosity, but also the macroporosity. The mechanical properties 
deteriorated slightly after 2 months in Ringer’s solution, but the differences 
between the mixing procedures remained unchanged [201]. 
1.3.6 Clinical application of CPCs 
CPCs are non toxic and resorbable materials with osteoconduction, excellent 
biocompatibility, low exothermicity of setting reactions, but their mechanical 
properties are not ideal, limiting their clinical use. The main purpose of CPCs is to 
fill small bone defects or to increase bone volume in metaphyseal bone, thus 
reducing the need for bone graft. The combination of a self-setting nature, 
mouldability, biocompatibility and a great potential for being replaced by bone, 
make these materials to be used by bone remodelling cells for reconstruction of 
damaged parts of bones [180, 181, 202]. Besides, some formulations were found 
to possess an antimicrobial activity, as well as promote osteoblast cell adhesion 
and gene expression in vitro [117, 203]. 
CPCs have successfully been used for treatment of the distal radius fracture. 
Moreover, other successful attempts have been made to use these materials for 
calcaneal fractures, hip fractures, augmentation of osteoporotic vertebral bodies, 
tibial plateau fractures, restoration of pedicle screw fixation, reinforcement of both 
thoracolumbar burst fractures, cancellous bone screws, in wrist arthrodesis and for 
fixation of titanium implants [204, 205]. They can also be applied to reinforce 
osteoporotic vertebral bodies [169, 206]. Stankewich et al. [207] and Goodman et 
al. [208] showed augmentation of femoral neck fracture with CPC, which improved 
the initial stability and failure strength of the fractures. 
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The use of CPCs for craniofacial and maxillofacial applications has been another 
valuable request. TTCP + DCPA cement that showed to be efficacious in animal 
studies was evaluated in several medical centres for cranial defect repair as part 
of a US FDA-approved study in human subjects [209]. Sliindo et al. [210] reported 
that BoneSourceTM was employed to increase the supraorbital ridge in dogs, as 
well as in a variety of skull base defects. It was also used in 24 patients to 
increase or obliterate the frontal and ethmoid sinus regions and mastoid cavities. 
Cranial base reconstruction with CPCs has been successful for translabyrinthine, 
middle cranial fossa, and suboccipital craniectomy defects, as well as for 
extensive temporal bone fractures [211].  
CPCs have been employed for dental applications too. These materials were tried 
as root canal fillers and for pulp capping [212, 213]. A previous study showed that 
a hydraulic CPC was injected as a bone filler for gaps around oral implants placed 
on the medial femoral condyles of 6 goats and found excellent bone formation 
around the graft material. However, the degradation rate of the cement appeared 
to be very slow and no resorption was observed [214]. In another study, 
researchers used a CPC for direct pulp capping and found its capability of 
producing a secondary dentin after 24 weeks [215]. 
Due to their outstanding properties (injectability, biodegradation, setting at room 
temperature, large surface area, and near neutral pHs [109, 110]), CPCs are very 
attractive candidates to be  used as a delivery system for therapeutic peptides, 
antibiotics, anticancer drugs, anti-inflammatory drugs and bone morphogenetic 
protein. These drugs might be slowly released through set cement pores, after 
their incorporation into a liquid and a powder phase of the cements. However, it 
ought to be taken into account that the drugs incorporation in the cements should 
not affect the final CPCs properties, such as, the setting and hardening processes, 
rheological behaviour and injectability. Thus, the clinical performance of the drug-
delivery system must be evaluated through in vivo tests, before application [109, 
110]. 
38 
The abovementioned possibility offers an attractive and efficient solution for the 
treatment of bone diseases such as tumours, osteoporosis or osteomyelitis [216]. 
In a previous study growth-factor cement (GFC) was reported [217]. A combination 
of bone morphogenetic protein-2, transforming growth factor β, platelet-derived 
growth factor, and a basic fibroblast growth factor used in a CPC for treatment of 
peri-implant defects in a dog model [217]. Results indicated a significant effect of 
GFC on increased bone-to-implant contact and amount of bone per surface area. 
Further examples of CPCs application as drug-delivery systems are given in the 
literature [109, 110, 143]. 
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2 Preparation and characterization of brushite-forming 
calcium phosphate cements doped with Mg and Sr 
Implanted bone tissues take benefits from the initial setting characteristics of the 
cements that give, in an acceptable clinical time, a suitable mechanical strength 
for a shorter tissue functional recovery. The major advantages of the cements 
include a fast setting time, excellent mouldability, injectability, and strength 
comparable to that of trabecular bone. The incorporation of different ions, such as 
magnesium (Mg) and strontium (Sr) into the structure of CPCs improves their 
biological responses upon implantation and might also favourably affect other 
properties.  
Partial substitution of calcium (Ca) by Sr on β-TCP powders by an aqueous 
precipitation was achieved and reported in paper 2.1. The successful incorporation 
of Sr was proved by the observed increase of the lattice volume via XRD analysis 
the powders.  
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The main aim of the paper presented in section 2.2. was to study the influence of 
the setting liquid and the liquid-to-powder ratio on rheological and mechanical 
properties of a new Mg-substituted CPC, where the powder was obtained through 
aqueous precipitation. 
In the paper of section 2.3, the setting behaviour of brushite-forming Sr-substituted 
α-TCP cements by in situ XRD and isothermal calorimetry techniques, is 
presented. The bioactivity through SBF tests was also studied and presented. SBF 
is a relatively easy method to simulate the environment in the human body, which 
has nearly the same chemical composition as blood plasma. 
Combining the excellent properties of novel brushite-forming Mg- and Sr-
substituted α-TCP cements (section 2.2 and 2.3) with the need of injectability to fill 
bone lesions and cracks to strengthen the bone, the paper in section 2.4. is 
focused on the study of the injectability properties of these substituted bone 
cements. 
55 
2.1 Formation of Strontium-Stabilized β-Tricalcium 
Phosphate from Calcium-Deficient Apatite 
S. Kannan, S. Pina, and J. M. F. Ferreira 
Dept. of Ceramics and Glass Engineering, University of Aveiro, 
CICECO, 3810-193 Aveiro, Portugal. 
J Amer Ceram Soc (2006) 89: 3277–3280 
Abstract 
A series of strontium-stabilized β-tricalcium phosphate (β-TCP) was prepared via 
the aqueous precipitation method, and characterized by X-ray diffraction and 
infrared Fourier spectrometer techniques. The general principle of preparing 
calcium-deficient apatite and thereby heat-treating the resultant apatite above 
700ºC to form single-phase β-TCP was attempted to create strontium substituted 
β-TCP. The results have proved that single phase β-TCP could be formed with the 
substituted strontium with only an influence on the increase in lattice constants 
with an increase in the concentration of strontium. Further, it is also stated from 
the present findings that strontium has a specific role in the crystallinity of the 
resultant β-TCP. 
Keywords: Ca-deficient apatite, Strontium, β-TCP, Aqueous precipitation 
56 
1. Introduction 
Beta-tricalcium phosphate [β-TCP, β-Ca3(PO4)2], which possesses stoichiometry 
similar to amorphous biologic precursors to bone mineral, exhibits a Ca/P molar 
ratio of 1.5. β-TCP has been shown to be resorbed in vivo [1], with new bone 
growth replacing the resorbed implanted β-TCP. This property represents a 
significant advantage of β-TCP compared with other biomedical materials that are 
not resorbed and replaced by natural bone. Recent years have witnessed the 
incorporation of strontium (Sr) into the apatite structure due to its presence in 
calcified bone. The essential characteristics and the role of strontium in bone 
mineral are: (i) it has a specific role in osteoporosis [2–4]; (ii) it has an equal share 
with ionic calcium in the physiological pathway [5]; and (iii) it can be deposited into 
the mineral structure of bone, especially into regions of high metabolic turnover [6]. 
As a matter of fact, the beneficial effect of low doses of stable strontium in the 
treatment of osteoporosis, characterized by low bone mass, fracture risk, and 
enhanced bone fragility, was discovered almost half a century ago [7]. 
Research reports have proved that strontium can be substituted in the 
hydroxyapatite (HA) structure prepared via different synthetic routes [8–10]. 
However, the research regarding the formation of single-phase strontium-
substituted β-TCP has witnessed scarce documentation. A recent work reported 
by Bigi et al. [11] has elucidated on the formation of Sr-stabilized β-TCP through a 
solid-state reaction by heating β-TCP and α-Sr3(PO4)2 for 15 h at 1000ºC. In 
general, a β-TCP ceramic can be prepared by a number of different routes [12–
14]. The most common method is a ‘‘Wet-chemical’’ synthesis, which results in the 
formation of a Ca-deficient apatite (or non-stoichiometric apatite). Upon heating 
(calcining) to 700º – 800ºC, the Ca-deficient apatite will transform into a low-
temperature polymorph of β-TCP, with the loss of water as described by Eq. (1). 
                             Ca9(HPO4)(PO4)5(OH) → 3Ca3(PO4)2 + H2O                       (1) 
This methodology was adapted to prepare strontium-stabilized β-TCP by 
introducing a precursor of strontium into the reaction system. A series of 
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compositions was prepared, and the influence of Sr content on the crystallinity of 
β-TCP was evaluated in the present study. 
2. Experimental Procedure 
2.1 Powder Preparation 
Reagent grade Calcium nitrate tetrahydrate [(Ca(NO3)2.4H2O, Vaz Pereira-
Portugal], Strontium nitrate [Sr(NO3)2, Riedel-de-Haen] and diammonium hydrogen 
phosphate [(NH4)2HPO4, Vaz Pereira-Portugal] were used as starting chemical 
precursors respectively for calcium, strontium and phosphorus. For the preparation 
of Ca-deficient apatites, a predetermined Ca/P molar ratios (concentrations of the 
precursors are depicted in Table 1) were set by the slow addition of (NH4)2HPO4 
solution to the continuously stirred (1000 rpm) solution of Ca(NO3)2.4H2O. A 
predetermined concentration of Sr(NO3)2 was added slowly to the above solution 
containing calcium and phosphorus ions. The pH of the mixed solution / 
suspension was increased to 7.4 and maintained at this value by adding the 
required amounts of 8 M ammonium hydroxide (NH4OH) solution. After the 
completion of addition, the reaction was performed at 90°C for 2 hours under 
constant stirring conditions (1000 rpm). A Ca-deficient apatite of Ca/P molar ratio 
of 1.5, simultaneously without added strontium was prepared under the same 
conditions to compare the results. The precipitated suspension was poured out 
from the reactor and precipitates were separated through vacuum filtration and 
dried at 80°C overnight. The dried cakes were groun d to fine powders, sieved 
through a mesh size of 200 µm and used for characterization studies. 
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Table 1: Molar concentrations of the precursors Ca, P and Mg used in the synthesis. 
Phosphorus precursors are same at a constant value of 0.6 M for all the reactions. 
(Ca+Sr)/P molar ratio of 1.5 are same for all reaction conditions 
Molar concentrations of the 
precursors 
Sample 
code 
Ca Sr Ca/P ratio 
Wt.% of 
incorporated 
Sr 
Tcp 0.900 0.000 1.50 - 
Sr-tcp1 0.882 0.018 1.47 1.54 
Sr-tcp2 0.864 0.036 1.44 3.17 
Sr-tcp3 0.846 0.054 1.41 4.76 
Sr-tcp4 0.828 0.072 1.38 6.34 
Sr-tcp5 0.810 0.090 1.35 7.83 
Sr-tcp6 0.780 0.120 1.30 10.48 
Sr-tcp7 0.720 0.180 1.20 15.72 
Sr-tcp8 0.600 0.300 1.00 26.26 
2.2 Powder Characterization 
The as-prepared powders were calcined at different temperatures ranging from 
600º to 1100ºC in a Thermolab furnace (Pt30%Rh/ Pt6%Rh-thermocouple 
Águeda, Portugal) at a heating rate of 5ºC/min to achieve a predetermined 
temperature range and a dwelling time for 2 h, and again cooled to room 
temperature at the rate of 5ºC/min. Phase identification of the powders before and 
after calcination was determined by X-ray diffraction (XRD, using a high-resolution 
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Rigaku Geigerflex D/Mac, C Series diffractometer, Tokyo, Japan). CuKα radiation 
(λ = 1.5406 nm) produced at 30 kV and 25 mA scanned the diffraction angles (2θ) 
between 20º and 50º with a step size of 0.02º 2θ per second. Crystallographic 
identification of the phases of synthesized powders was accomplished by 
comparing the experimental XRD patterns with standards compiled by the Joint 
Committee on Powder Diffraction Standards (JCPDS), which were card # 09-0169 
for β-TCP. Lattice constants for β-TCP phase composition were determined by 
least square refinements from the well-determined positions of the most intense 
reflections. The reflections of the planes (1010), (214), (300), (0210), (220) and 
(4010) were used for calculation.  The volume V of the rhombohedral unit cell was 
determined for each β-TCP formulation from the relation V = 0.8660 × a2 × c. The 
average crystallite size of the final β-TCP composition was calculated using the 
Scherrer formula. The peak width of the (0 2 10) reflection of β-TCP samples were 
used in the calculations. Infrared spectra of the as prepared powders and powders 
calcined at different temperatures were obtained using an Infrared Fourier 
Spectrometer (FT-IR, model Mattson Galaxy S-7000, 32 scans and resolution 4 
cm-1). For this purpose each powder was mixed with KBr in the proportion of 1/150 
(by weight) for 15 min and pressed into a pellet using a hand press. Elemental 
analyses for the presence of Ca, Sr and P were made using X-ray fluorescence 
spectroscopy (Philips PW2400 X-Ray Fluorescence Spectrometer). The vacuum 
of the chamber was lower than two Pascal. The error associated to each chemical 
element could be determined as ± 1 of the last digit of the measured values. 
3.1 Results and Discussion 
3.1 Formation of Sr-stabilized β-TCP 
The XRD patterns of the Sr-tcp1 powder calcined at different temperatures are 
presented in Fig. 1. In fact all the other Sr substituted calcium deficient apatite 
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powders have indicated similar type of XRD and FT-IR patterns irrespective of the 
added strontium during the reaction.  
20 25 30 35 40 45 50
2θ (deg)
In
te
n
sit
y 
(a.
u
)
as-dried
400ºC
600ºC
700ºC
800ºC
 β-TCP
Fig. 1: Powder X-ray diffraction pattern for Sr-tcp1 powder heat treated at different 
temperatures. All diffraction planes at 800ºC correspond to pure β-TCP phase. Unmarked 
peaks at temperatures other than 800ºC corresponds to HAP phase 
The as prepared powder has indicated the formation of poorly crystalline apatite 
phase characterized by the broad diffraction bands. It is obvious that substitution 
of Sr did not found to affect the diffraction pattern of as prepared powders. This 
results are in accordance with the previously reported results that the XRD pattern 
of an as-precipitated apatite powder can resemble that of HAP even though the 
Ca/P ratio is greater or less than the stoichiometric molar ratio of 1.67 for HAP 
[15,16]. The infrared spectra for the Sr-tcp1 powder heat treated at different 
temperatures are presented in Fig. 2.  
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Fig. 2:  FT-IR spectra for Sr-tcp1 powder heat treated at different temperatures 
The spectra obtained in an as-dried condition have also confirmed the apatite 
phase formation with the observed fundamental vibrational modes of PO4 group at 
475, 574, 609, 966 and 1020-1120 cm-1. The weak bands respective of OH group 
of HAP phase could also be witnessed in the infra red spectra at the region around 
630 and 3570 cm-1 in the as-dried powder. The presence of adsorbed water (in the 
region around 3300-3600 cm-1), carbonates (at region 1660 cm-1) that is due to the 
adsorbed species remaining from the aqueous precipitation [17] and nitrates 
(1320-1480 cm-1) can be confirmed in the FT-IR spectra of as-dried powders. The 
presence of nitrates in the as synthesized powders tends to agree with 
observations made in a previous study [18]. However, no sufficient information 
could be gained regarding the influence of Sr in the as prepared powder since the 
observed phases exhibit a low crystallinity leading to a lower peak definition in the 
XRD pattern. 
 Upon heat treatment, the gradual loss of adsorbed water, nitrates and carbonates 
from the as-dried powders are evidenced by the corresponding decrease in the 
FT-IR peaks resolution in the region around 1320-1480 cm-1, 1660 cm-1 and 3400-
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3600 cm-1 (Fig. 2) of the spectra obtained at 400ºC.  The presence of both 
hydrogenophosphate ions (HPO42-) at 870 cm-1 and OH groups [3570 cm-1
(stretching mode) and 630 cm-1 (bending mode)] has been witnessed in the infra 
red spectra recorded at 400ºC. XRD pattern obtained at 400ºC have also strong 
coincidence with FT-IR spectra. These results confirm the formation of Sr 
substituted calcium deficient apatite as defined by the expression (2) given below: 
                               xxxx OHPOHPOCaSr −−− 264410 )()()()(                                     (2)       
Heat treatment at 800ºC has witnessed the formation of single phase β-TCP as 
confirmed by the XRD pattern presented in Fig. 1. FT-IR patterns presented in Fig. 
2 also confirm the disappearance of peaks for OH groups at 630 cm-1 (vibrational 
mode) and at 3570 cm-1 (stretching frequency). The vibrational modes of PO4
tetrahedra of β-TCP phase and the dissappearence of CO3 bands are evident from 
the FT-IR spectra after calcination above 800ºC. This fact is in good agreement 
with the findings of Gibson et al [19], who have reported the occurrence of a 
similar transformation at this temperature range for a powder prepared via 
aqueous precipitation method.  
3.2 Influence of Strontium 
Fig. 3 presents the XRD pattern of the different concentrations of Sr substituted β-
TCP after heat treatment at 1100ºC. The influence of Sr can be confirmed by the 
observed sharp shift in the 2θ and the d-spacing values of various compositions in 
comparison to pure β-TCP. Data of elemental analysis reported in Table 1 also 
confirm the presence of Sr in all the powders. It should be noted that for all the 
compositions, the precursors (Ca+Sr)/P molar ratio during the course of synthesis 
was adjusted to 1.5 to ensure the incorporation of Sr into β-TCP.  
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Fig. 3: XRD patterns for the different Sr substituted β-TCP powder after heat treatment at 
1100ºC 
Hence the role of Sr in stabilizing the β-TCP phase can be represented by 
equation (3) given below: 
             OHPOSrCaOHPOHPOSrCa xxxx 224
33
35449
))((3)())(( +→
−
−
   (3) 
The graphical representation of lattice constants with the influence of Sr 
concentration in the β-TCP phase presented in Figs. 4 and 5 confirms the 
formation of rhombohedral β-TCP space group for all the compositions. From Fig. 
4 it is clear that the incorporation of Sr in β-TCP has led to the significant 
expansion in both a- and c- axis with the increase in concentration of Sr in β-TCP. 
The reason is due to the greater ionic radius of strontium ion (1.13 Å) towards Ca2+
(0.96 Å) that has led to the expansion of unit cell. Regarding the substitution of 
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elements, it has been previously described that β-TCP could be stabilized by the 
inclusion of small cations without significant alteration in its rhombohedral structure 
[20,21]. In fact, Bigi et al. [11] has proved that β-TCP can host up to 80 atom % of 
strontium with a linear enlargement of the lattice constants, which suggests that 
strontium incorporation does not provoke a remarkable rearrangement of the unit 
cell. This fact is proved by the present results. It is also clear from the present 
results that substitution of Sr2+ ion in β-TCP structure have greater influence on 
the crystallinity. The small crystallite size values (Fig. 5) with the corresponding 
increase in the strontium concentration in the β-TCP structure is supported by this 
fact. 
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Fig. 4: Influence of lattice a- and c- axis parameters with respect to the different content of 
Sr in β-TCP structure. Lattice parameters for pure β-TCP (JCPDS file card no. # 09-169) 
(a=10.429, c= 37.38). 
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Fig. 5:  Influence of unit cell volumes and crystallite sizes with respect to the                 
different content of Sr in β-TCP structure. Cell volume for pure β-TCP (V = 3533.70).  
4. Conclusion 
The present study proves that a simple aqueous precipitation technique can be 
employed to form single phase strontium stabilized β-TCP by heating Ca-deficient 
apatite. The transformation mechanism that occurred at 800ºC to form single 
phase β-TCP with substituted Sr is similar to that of Ca-deficient apatite of Ca/P 
molar ratio=1.5 to form pure β-TCP without any substituted elements. The present 
study also confirms a linear increase in the lattice constant values (a-axis, c-axis 
and volume) with the increase in the concentration of strontium that is 
accommodated in the β-TCP structure. Additionally, the substitution of strontium 
has also greater influence in the crystallinity of β-TCP phase.  
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Abstract 
The influence of four variables on various properties of a Mg-substituted calcium 
phosphate cement (CPC) was investigated. The variables were the heat treatment 
temperature of the precipitated powders, the composition of the setting liquid, the 
liquid-to-powder ratio (LPR), and the time over which hardened specimens were 
cured in air. The properties analysed were the phase composition of the starting 
powder, the initial setting time, the evolution of the storage shear modulus (G’) and 
the loss shear  modulus (G’’) with the cement paste curing time (t), and the 
compressive strength. The presence of α-TCP in CPC facilitated the setting and 
hardening properties due to its progressive dissolution and the formation of 
brushite crystals. As far as the liquid composition is concerned, in cases where 
citric acid was used, adding a rheology modifier (10 wt.% polyethylene glycol or 
0.5 wt.% hydroxyl propylmethylcellulose) to the acid led to an increase in the initial 
setting time, while an increase in the acid concentration led to a decrease in the 
initial setting time. The initial setting time showed to be very sensitive towards the 
LPR. The evolution of G’ and G’’ with curing time reflected the internal structural 
changes of cement pastes during the setting process. The compressive strength of 
the wet hardened cement specimens with and without Mg increased with curing 
time increasing, being slightly higher in the case of Mg-substituted CPC.  The 
results suggest that Mg-substituted CPC holds a promise for uses in orthopaedic 
and trauma surgery such as for filling bone defects.  
Keywords: Magnesium; Calcium phosphate; Cement; Rheology, Setting time.  
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1. Introduction 
Calcium phosphate (CaP) ceramics have gained clinical acceptance for bone 
substitution and augmentation due to their similarities with the mineral bone 
composition [1-3]. Among CaPs, tricalcium phosphate (TCP, Ca3(PO4)2), a 
resorbable material, and hydroxyapatite (HA, Ca10(PO4)6(OH)2), a bioactive 
ceramic that induces bone formation on its surface, have received particular 
attention [4,5]. HA-based materials have excellent osteoconductivity and bone 
replacement capability and do not produce toxic inflammation or foreign body 
responses in vivo [6,7]. The bioactive properties of CaP and the ability of certain 
compositions to undergo hydraulic reactions when mixed with a suitable liquid, 
such as maleic acid or citric acid, make them suitable for use as pastes that can 
be moulded or injected into alveolar bone defects and remain in place until tissue 
ingrowth occurs [8]. The predominance of HA or brushite in the hardened cements 
has been used as a criterion to classify the cements. The number of studies 
dedicated to apatite cements that set under near neutral pH region is much higher 
than those devoted to brushite cements [9,10]. One reason is that HA based 
cements exhibit better mechanical properties. However brushite cements are of 
special interest due to their good biocompatibility and faster resorption rate in vivo. 
Moreover, brushite is metastable in physiological conditions and brushite based 
calcium phosphate cements (CPCs) possess faster setting reactions. 
Recent developments have focused on injectable CPCs for various applications in 
orthopaedics and trauma surgery, such as treating vertebral compression 
fractures, fractures of the femoral neck and distal radius, and filling of bone defects 
that have limited accessibility or narrow cavities [5]. Recently, the substitution of 
ions, such as Mg ions, into the structure of CaPs has been investigated [6,11-14]. 
Although present in low levels in natural bone (0.55 wt.%) or tooth enamel (0.44 
wt.%), Mg plays an essential role in the biological process due to its significant 
impact on the mineralization process and also its influence on HA crystal formation 
and growth [6,11-14]. Furthermore, a deficiency of Mg in bone has been 
suggested as a possible risk factor for osteoporosis in humans [11,15,16]. 
Therefore, Mg-substituted CaPs are expected to produce enhanced biological and 
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chemical responses in the body. To date, many reports on the properties of Mg-
substituted CPCs have appeared [17, and references therein]. Lilley et al. [17] 
have shown that the presence of magnesium had a strong effect on cement 
composition and strength, namely by increasing the proportion of brushite and 
decreasing the compressive strength. According to these authors [17], Mg could 
be used to adjust the composition and rate of hydration of the cement. Mg has 
been also reported to have a stabilising role of non-crystalline CaPs, preventing 
crystallisation into other more stable CaP phases [18], in good agreement with an 
observed decrease of the hydrolysis extent of brushite [17]. However, none of the 
previously reported studies have shown the effects of Mg-substitution on the 
structural evolution of CPCs upon hydration using rheological measurements. 
Therefore, the present work aims at studying the effect of Mg-substitution on the 
setting behaviour, as accessed by rheological and other complementary 
measurements, and mechanical properties of CPCs. Furthermore, the effects of 
four main variables on the room-temperature phase composition of the starting 
powder, the initial setting time of the cement paste, the evolution of the storage 
modulus and loss shear modulus with cement paste curing time, and the 
compressive strength of a Mg-substituted CPC were investigated. The variables 
studied were: (i) the heat treatment temperature of the precipitated powder; (ii) the 
composition of the liquid used to prepare the cement (setting agents used, and the 
presence or absence of rheology modifiers); (iii) the liquid-to-powder ratio (LPR); 
and (iv) the time over which hardened specimens were cured in air.  
From the perspective of the clinical uses, the initial setting time of a CPC cement 
paste and the flow properties are of paramount importance in many applications 
like in situ fracture fixation in orthopaedics, filling root canals and sealing furcation 
in endodontics and vertebroplasty. CPC should not harden too fast to allow 
moulding or injection and not harden too slowly to allow the surgeon to close the 
defect shortly after cement placement. Therefore, the CPC must have an optimal 
setting time in order to lead to an acceptable mechanical strength after hardening 
and to prevent migration of cement to undesirable sites. 
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2. Materials and Methods 
The synthesis of the Mg-substituted cement powder was carried out according to a 
method that has been described in detail in a previous report [6]. Briefly, the 
powder was obtained by aqueous precipitation from calcium nitrate tetrahydrate 
[Ca(NO3).4H2O, Vaz Pereira-Portugal, Sintra, Portugal], diammonium hydrogen 
phosphate [(NH4)2HPO4, Vaz Pereira-Portugal, Sintra, Portugal] and magnesium 
nitrate hexahydrate [Mg(NO3)2.6H2O, Merck, Darmstadt, Germany] as the starting 
chemical precursors, respectively for calcium, phosphorus and magnesium. The 
precipitate was vacuum filtrated, dried at 110ºC and then heat treated for 2 h at 
800ºC, 1100ºC and 1500ºC to study the evolution of the crystalline phase.   
The calcined powders were ground under dry conditions in a planetary mill, using 
an agate jar of 250 mL with agate balls of 10 mm and 20 mm diameter, and a 
weight ratio of balls to powder = 3:1, and then passed through a sieve with a mesh 
size of 36 µm. The powders calcined at 800ºC and 1100ºC were ground for 1 h 
and 2 h, respectively, while the powder calcined at 1500ºC was ground for 4 h. 
The separated fine fractions of the α-TCP and Mg-TCP powders calcined at 
1500ºC having average volume particle sizes of 19.2 µm and 14.8 µm, 
respectively, were used to prepare cement pastes with liquid-to-powder ratios 
(LPR) varying between 0.25 and 0.50 mL g-1. Different concentrations of setting 
agents [disodium hydrogenophosphate (Na2HPO4) (2.5, 5.0 and 10.0 wt.%), citric 
acid (5.0, 10.0 wt.%, 15.0 wt.% and 20.0 wt.%) were used. The effects of adding 
10.0 wt.% poly(ethylene glycol) (PEG) (200, Sigma) or 0.5 wt.% hydroxyl propyl 
methylcellulose (HPMC) (3.5-5.6 mPa s at 2% by mass in water, Sigma) to the 
citric acid solutions as rheology modifiers were tested. The selection of these 
setting agents and rheology modifiers as setting liquids was due to the non-toxic 
nature of these additives, which are commonly used in various foods, drinks and 
make-up products. Citrate exists in bone mineral and is believed to play an 
important role in the formation and/or dissolution of bone apatite. PEG was 
selected due to its non-toxicity and due to the fact that it is used as plasticizer in 
drugs. HPMC was selected for its ability to form viscous solutions thus improving 
the washout resistance of the CPC. The concentration of HPMC was limited to 0.5 
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wt.% because preliminary studies have shown that higher concentrations retarded 
the CPC conversion into HA [7]. 
The initial setting time of the cement pastes was determined using Vicat needle 
technique according to the ASTM C 187-98. One minute after placing the pastes 
into a glass plate stored at 37ºC in 100% humidity box, the indenter (100 g in 
mass, 1 mm diameter of the needle) was lowered vertically onto the surface of the 
cement. The indentation was repeated at intervals of 30 s until no more 
penetration was possible. The time at this point was taken as the initial setting 
time. 
The setting behaviour of the cement pastes was monitored through the 
measurement of the viscoelastic properties (storage shear modulus, G’, and loss 
shear modulus, G’’)  under oscillatory shear conditions using a controlled-stress 
rheometer (Bohlin C-VOR 150, Bohlin Ltd., Gloucestershire, UK) equipped with a 
4º / 40 mm cone-and-plate sensor system. Stress-sweep tests were performed in 
the range between 1 and 1000 Pa to determine the upper limit of the linear 
viscoelastic response (LVR) and the shear stress range of the structural 
breakdown of the pastes. The mechanical spectra of the investigated pastes under 
the conditions of LVR were measured in the frequency range from 0.1 to 100 Hz at 
a fixed shear stress of 20 Pa. For each test, 2 g of powder was mixed with the 
setting liquid at the pre-determined LPR, for 1 min to form a homogeneous 
suspension at room temperature. The rheological measurement started 1 minute 
after mixing in order to assure the same rheological history during the preparation 
of all the cement pastes and ended when setting was complete. 
The X-ray diffraction (XRD) technique was used to identify the crystalline phases 
formed upon calcining the starting powder at different temperatures and after 
hardening of the cement pastes. For this purpose, a high-resolution Rigaku 
Geigerflex D/Mac, C Series diffractometer was used with Cu Kα radiation (λ= 
1.5406 Å) produced at 30 kV and 25 mA scanned the diffraction angles (2θ) 
between 20º and 50º with a step size of 0.02º 2θ per second. The phase 
composition of the hardened cements was calculated by Rietveld analysis using 
TOPAS 3.0 software (Bruker AXS, Germany). The microstructures of the 
hardened cements after storage at 37ºC in a 100% humidity box for 24 h were 
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obtained using a scanning electron microscope (SEM) (Hitachi S4100, Tokyo, 
Japan).  
For the compressive strength tests, the cement pastes were cast into PTFE-
moulds (6 mm diameter and 12 mm height) and stored in a 37ºC, 100% humidity 
box for 24 h. The cement specimens were then removed from the moulds and 
immersed in PBS solution at 37ºC for further 12 h, 24 h and 48 h. The specimens 
were loaded to failure at a crosshead displacement rate of 1 mm/min using a 
universal materials testing machine (Instron Series IX 4301, Instron, High 
Wycombe, England).   
Results of initial setting time and compressive strength are expressed as the mean 
± standard error of the mean of triplicate determinations. Statistical analysis was 
performed using the SPSS 16.0 software. Comparative studies of means were 
performed using one-way ANOVA followed by a post hoc test (Fisher projected 
least-significant difference) with a statistical confidence coefficient of 0.95; 
therefore, p values < 0.05 were considered significant. 
3. Results and Discussion 
The evolution of crystalline phases with the heat treatment temperature was 
studied in order to select the most suitable temperature that leads to the formation 
of the desired α-TCP phase that exhibits hydraulic power. Fig. 1 shows the XRD 
patterns of the Mg-substituted (MgTCP) powder calcined at 800ºC, 1100ºC and 
1500ºC. It can be seen that a low crystalline phase of β-TCP was obtained after 
calcination of the starting powder at 800ºC. The intensity of the XRD peaks of this 
phase increased considerably, with increasing the heat treatment temperature. 
Calcination at 1500ºC led to the formation of mostly α-TCP phase. The presence 
of Mg was found preferentially incorporated into the β-TCP phase [6]. However, 
the peaks corresponding  to Mg-substituted β-TCP did not show exact matches 
with those of JCPDS PDF  # 09-169, which, in fact have indicated considerable 
shift in the 2θ and d-spacing values of maximum intensity plane (0210) towards 
JCPDS PDF # 1-70-0682 of phase Ca2.81Mg0.19(PO4)2 [6]. This is confirmed in the 
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present work. Although it is well documented that Mg enhances the thermal 
stability of β−TCP phase [19,20], the present results show that practically all the β-
TCP existing at lower temperatures has been transformed into the high 
temperature polymorph.  
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Fig. 1: XRD patterns of the Mg-substituted (MgTCP) powder heat treated at 800ºC, 
1100ºC and 1500ºC. β-TCP (β-Ca3(PO4)2, JCPDS PDF File # 1-70-682 and α-TCP (α-
Ca3(PO4)2, JCPDS PDF File # 29-359), full scale intensity = 12,000 cps. 
The presence of α-TCP in bone cements facilitates the setting and hardening 
properties due to its progressive dissolution and the formation of an entangled 
network of calcium deficient HA (CDHA) crystals [6,21-25]. On the other hand, β-
TCP does not cure but helps the handling time in which experiments can be 
conducted [24]. For this reason, it was decided to use the powder calcined at 
1500ºC containing mostly the α-TCP phase. The values of the initial setting time 
using this powder, for various combinations of setting liquids and LPRs, are given 
in Table 1. Literature studies [7,25-28] on the influence of LPR on CPC properties 
have used a relatively wide range of LPR values (0.25-0.87 mL g-1). As mentioned 
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in the experimental section, the values of LPR were firstly varied in the range of 
0.25-0.50 mL g-1. It was noted that for LPR values below 0.30 mL g-1 the cement 
paste could not be injected through a needle gauge 12 (2.2 mm inner diameter) 
due to its high viscosity, while good flowability was verified for LPR ≥ 0.35 mL g-1. 
However, considering that the initial setting time of the paste was > 30 min for LPR 
≥ 0.35 mL g-1, the LPR range of 0.30-0.34 mL g-1 was selected to prepare cement 
pastes to proceed with further experiments.  
Table 1: Influence of additives and LPRs on the setting time of the pastes.
Initial Setting times (min)
Additives (wt. %) L/P = 0.3 mLg-1
L/P = 0.32 
mLg-1 L/P = 0.34 mLg
-1
2.5 % Na2HPO4 
5 %  Na2HPO4
10% Na2HPO4
>>30 
>>30 
>>30 
>>30 
>>30 
>>30 
>>30 
>>30 
>>30 
5 wt% Citric acid 
10 wt% Citric acid 
15 wt% Citric acid   
4.0±0.1 
3.0±0.1 
3.0±0.4  
8.0± 0.2 
5.0±0.5 
2.0±0.8 
6.0±0.1 
4.0±0.3 
2.0±0.1 
10 % PEG + 5  % Citric acid 
10 % PEG +10 % Citric acid 
10% PEG + 20 % Citric acid
6.0±0.1 
4.0±0.6 
3.0±0.3 
9.0±0.2 
8.0±0.5 
6.0±0.1 
10.0±0.2 
6.0±0.3 
3.0±0.2
0.5% HPMC+ 5% Citric acid 
0.5%HPMC+10% Citric acid 
0.5%HPMC+20% Citric acid 
13.0±0.2 
12.0±0.1 
11.0±0.1 
16.0±0.5 
15.0±0.4 
9.0±0.8 
18.0±0.1 
16.0±0.2 
11.0±0.5 
It is seen that both liquid solutions (based on Na2HPO4 or in citric acid) enabled 
workable cement pastes to be formed with the lowest LPR used (0.30 mL g-1). As 
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expected, the initial setting time increased with increasing LPR values (p < 0.05). 
Rapid hardening of the cement paste was observed for low LPR values, resulting 
in short working time frame which, effectively, makes these materials unsuitable 
for injection. Therefore, a LPR of 0.34 mL g-1 was used in subsequent tests. The 
evolution with time of G’and G’’ of the cement pastes prepared with different 
concentrations of Na2HPO4 and citric acid for the selected LPR of 0.34 mL g-1 is 
shown in Fig. 2 and 3, respectively. 
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Fig. 2: Time-sweep curves of Mg-substituted (MgTCP) cement pastes prepared with 
different added amounts of Na2HPO4, (LPR = 0.34 mL g-1). 
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Fig. 3: Time-sweep curves of Mg-substituted (MgTCP) cement pastes prepared with 
different added amounts of citric acid, (LPR = 0.34 mL g-1). 
All the curves presented in Fig. 2 show a decreasing trend of the rheological 
parameters along the whole plotted time frame. Moreover, the G’’ curves appear 
always above the G’ curves, confirming the predominance of the viscous character 
of the pastes containing Na2HPO4. An opposite situation was observed with the 
cement pastes prepared with citric acid (Fig. 3). Both G’ and G’’ increase with time 
increasing, but the G’ curves appear always above those of G’’, confirming the 
predominance of the solid-like characteristics of the pastes. This means that the 
hydration reactions and the setting process are faster in the presence of citric acid. 
As can be seen, the main changes in the slope of the G’ and G’’ curves occur for 
shorter times as the citric acid concentration increases, resulting in a decreasing 
trend in the initial setting time, in close agreement with the data presented in Table 
1. Both G’ and G’’ increased with increasing concentrations of the citric acid from 5 
to 10 wt.%, followed by an opposite trend when the amount of citric acid was 
increased to 15 wt.% (p = 0.002). Increasing amounts of citric acid result in an 
79 
increase of the viscosity of the liquid and of the paste and accelerates the setting 
time of the cement. However, when citric acid is present in excess it appears to 
weaken the hardened cement structure. 
While the addition of citric acid resulted in pastes that were workable within a few 
minutes, those made with Na2HPO4 remained liquid for more than 30 min for all 
the LPRs tested. A literature survey [28,29] about the role of Na2HPO4 solutions as 
setting liquids for CPC suggests that it can not be easily described. Using α-TCP 
and α-TCP + dicalcium phosphate dihydrate (DCPD) based cements systems, 
Khairoun et al. [28] found decreasing setting times with increasing concentrations 
of Na2HPO4. It was argued that the addition of Na2HPO4 increased the degree of 
supersaturation of Ca2+ and PO43- ions in the solution during hydration, thus 
improving the impetus of the reaction. On the other hand, the study by Wang et al. 
[29], who investigated a cement based on highly reactive amorphous calcium 
phosphate (ACP) and brushite, reports a small delaying effect compared with 
water. From these reported results and those found in the present work, it seems 
clear that the effect of Na2HPO4 on the cement hardening kinetics strongly 
depends on the chemical and phase compositions of the CPC and eventually on 
the characteristics of the starting powders derived from the preparation method, or 
even specific powders/ liquid interactions.  
In order to better understand the role of Mg in the Mg-substituted (MgTCP) cement 
pastes, a baseline cement based on pure α-TCP, denominated as TCP cement, 
was also prepared and ground under the same conditions. The aim was to include 
a critical comparison of the values for the properties (initial setting time, 
compressive strength, microstructural features) for this baseline cement to the 
corresponding values for the appropriate Mg-substituted cement. The magnesium 
content of the cement is believed to inhibit setting to calcium deficient HA [13]. To 
evaluate if the long setting times with sodium phosphate in the present study could 
be due to the presence of magnesium, cement pastes made of Mg-free α-TCP 
(TCP) and Mg-substituted (MgTCP) were prepared with 5 wt.% Na2HPO4 solution. 
For both cases, the results presented in Figure 4 show a first similar decreasing 
trend of G’ and G’’, with the G’’ curves appearing always above the G’ curves, 
confirming the predominance of the viscous character, like observed in Fig. 2. The 
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curves of the Mg-free cement paste start increasing a bit sooner (after about 11 
min, in comparison to about 14 min) and appear above those of the Mg-substituted 
cement paste. However, the differences in setting behaviour between Mg-free and 
Mg-substituted cement pastes are not so remarkable. These results suggest that 
Na2HPO4 solutions are unsuitable as setting liquids for both TCP and MgTCP 
cement pastes. The different effectiveness of Na2HPO4 solutions and citric acid 
solutions as setting liquids might be due to their different pH values and dissolution 
capabilities of the CPC powders. The pH values for Na2HPO4 and citric acid 
solutions were around 5 and 1.5, respectively. 
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Fig. 4: Time-sweep curves of Mg-substituted (MgTCP) and Mg-free (TCP) cement pastes 
prepared with 5 wt.% Na2HPO4 (LPR = 0.34 mL g-1).
The addition of rheology modifiers to the citric acid made the initial setting times to 
increase in comparison to the systems in which rheology modifiers are absent 
(Table 1). In other words, the presence of rheology modifiers enhances the flow 
ability and, hence, the injectability, of the cement. The delay of the setting process 
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is less pronounced in the case of PEG (initial setting times in the range of 6-10 
min.), in comparison to HPMC. In fact, an added amount of HPMC that is 20 times 
less that of PEG resulted in longer initial setting times (9-18 min.). PEG and HPMC 
are hydrophilic polymers that form a network structure with water molecules, which 
become less free to spontaneously react with inorganic CaPs. Consequently, the 
formed network may integrate the polymer structure. This phenomenon is more 
emphasized when the polymer presents high molecular weight as in the case of 
HPMC, which could explain the decrease of setting time in the presence of this 
additive in comparison to the systems with added PEG. These results are 
important from the perspective of the clinical uses giving room to adjust the 
optimal setting time, since CPC should not harden too fast to allow moulding or 
injection and not harden too slowly to allow the surgeon to close the defect shortly 
after cement placement.  
The evolution with cement paste curing time of G’ and G’’ of the cement pastes 
prepared with different concentrations of citric acid and fixed added amounts of the 
rheology modifiers, 10 wt.% PEG, or 0.5 wt.% HPMC, is shown in Fig. 5 and 6, 
respectively. The results in Fig. 5 show that the increase of citric acid 
concentration from 5 wt.% to 10 wt.% resulted initially in a faster setting of the 
pastes, but a further increment of citric acid to 20 wt.% revealed again an opposite 
effect, similar to the trend shown in Fig. 3 in absence of PEG. In contrast, the 
presence of 0.5 wt.% of HPMC inhibited the setting process for citric acid 
concentrations lower than 10 wt.% (Fig. 6). In this case, the setting process only 
took place with added 20 wt.% of citric acid after about 12 min.  
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Fig. 5: Time-sweep curves of Mg-substituted (MgTCP) cement pastes prepared with 10 
wt.% PEG and different added amounts of citric acid (LPR = 0.34 mL g-1). 
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Fig. 6: Time-sweep curves of Mg-substituted (MgTCP) cement pastes prepared with 0.5 wt.% 
HPMC and different added amounts of citric acid (LPR = 0.34 mL g-1). 
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Based on the results shown in Fig. 5 and 6, and considering that bone cement 
must be placed in the implantation site in about 6-8 min [9], the setting liquid with a 
composition of 10 wt.% PEG + 20 wt.% citric acid was selected for preparing CPC 
samples for mechanical tests. The setting behaviour of Mg-free and Mg-
substituted cement pastes prepared under these conditions were also compared. 
Fig. 7 presents the evolution of G’ and G’’ with the curing time of the TCP and 
MgTCP cement pastes. The results show that TCP presents a faster setting and 
higher storage modulus along the whole hydration period in comparison to 
MgTCP. The results of Vicat test (not presented) for the TCP cement paste 
prepared with 20 wt.% of citric acid + 10 wt.% of PEG gave initial setting times in 
the range of 2-3 min, in close agreement with rheological tests shown in Figure 7, 
being shorter than those presented in Table 1 for MgTCP cement pastes. These 
results show that Mg incorporation delays the initial setting time. This feature can 
be usefully exploited in combination with the setting liquid composition to optimise 
the setting behaviour of Mg-containing cements and make their clinical application 
successful. 
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Fig. 7: Time-sweep curves of Mg-substituted (MgTCP) and Mg-free (TCP) cement pastes 
prepared with 10 wt.% PEG + 20 wt.% citric acid (LPR = 0.34 mL g-1). 
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Fig. 8 compares the XRD patterns of the cements prepared using 10 wt.% PEG + 
20 wt.% citric acid as setting liquid after curing for 24 h. It can be seen that the 
hardened cements consist of three crystalline phases. The TCP cement is 
constituted by 76% of α-TCP and 24% brushite, while the MgTCP cement consists 
of 62% α-TCP, 23% brushite and 15% β-TCP. However, the degree of crystalinity 
of the MgTCP cement is apparently lower in comparison to TCP cement. This can 
be understood considering Mg exerts a stabilising effect of the β-TCP phase [6, 
11, 12] and tends to prevent the crystallisation of the most stable CaP phases 
upon hydration [18]. These findings are consistent with the morphological features 
observed in the SEM micrographs of fractures surfaces of the hardened cements 
after 24 h of setting at 37ºC shown in Fig. 9. Larger and better developed crystals 
are seen in the TCP cement. The crystals are irregular in shape and size in the 
case of Mg-containing cement.  
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Fig. 8: XRD patterns of MgTCP and TPC cements hardened for 24 h. The pastes were 
prepared with 10 wt.% PEG + 20 wt.% citric acid (LPR = 0.34 mL g-1). Brushite JCPDS PDF 
File # 9-0077); α-TCP (Ca3(PO4)2, JCPDS PDF File # 29-359) and β-TCP (β-Ca3(PO4)2, 
JCPDS PDF File # 1-70-682), full scale intensity = 4,000 cps. 
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Fig. 9: Scanning electron micrographs of the MgTCP and TCP cements hardened for 24 
h. The pastes were prepared with 10 wt.% PEG + 20 wt.% citric acid (LPR = 0.34 mL g-1). 
The compressive strength values of TCP and MgTCP cements hardened for 24 h 
and kept under wet conditions for further 12 h, 24 h and 48 h, before performing 
the measurements, are shown in Fig. 10. The decrease of the compressive 
strength of the hardened cement specimens after 24 h of immersion in PBS 
solution can be attributed to a gradual structural degradation process (p ≅ 0.004). 
The measured values of the wet compressive strength after 48 h are somewhat 
around the lower limit of the range for cancellous bone (10-30 MPa) [30], 
achieving average values of about 12.4 and 9.2 MPa for the MgTCP and TCP 
cements, respectively. The results show that Mg-containing cement specimens 
exhibit slightly higher compressive strength values in comparison to cements with 
no Mg substitution (p<0.05), probably due to the different phase compositions 
(TCP cement is richer in α-TCP and brushite, while MgTCP cement also contains
β-TCP). 
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Fig. 10: Compressive strength values measured for the MgTCP and TCP cements 
hardened for 24 h and kept under wet conditions for further 12 h, 24 h and 48 h. The 
pastes were prepared with 10 wt.% PEG + 20 wt.% citric acid (LPR = 0.34 mL g-1). 
The overall results obtained in the present study enable to state that Mg-
substituted CPC pastes prepared with a setting solution comprising citric acid and 
PEG have a good potential for being use in orthopaedic and trauma surgery (for 
example, to fill bone defects) and therefore should be considered for further 
experimentation aiming at exploiting other recognized beneficial effects of Mg on 
the biological and mineralization process.  
4. Conclusions 
The results presented and discussed along this work proved the usefulness of 
rheological measurements under oscillatory mode to access the structural 
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evolution of the cement pastes upon the hydration process in situ before setting. 
This is of significance concerning the moulding ability and injectability of cement 
pastes intended for applications in poorly accessible fracture sites such as is the 
case in vertebroplasty and kyphoplasty.  It was demonstrated that for obtaining 
reactive CPC, the precipitated powders must be heat treated at a temperature of 
1500ºC to favour the formation of α-TCP as the predominant phase.  
The use of aqueous solutions of Na2HPO4 revealed to be unsuitable as setting 
liquids for both TCP and MgTCP cements prepared in the frame of the present 
work. Contrarily, aqueous citric acid solutions exhibited high reactivity towards the 
cement powders, firstly accelerating the setting process with increasing acid 
concentrations, followed by a decreasing trend in the presence of excess citric 
acid. The initial setting times tended to decrease in the presence of rheology 
modifiers (10 wt.% PEG or 0.5 wt.% HPMC) enabling to tailor the setting 
behaviour, the flow ability, and the workability of the cement pastes according to 
the surgical needs. The setting process tends to be slower in the case of MgTCP 
in comparison to TCP cements, a giving further room to adjust the relevant paste 
properties. Workable cement pastes were obtained for LPR in the range of 0.30-
0.34 mL g-1. The flowing ability and the initial setting times are enhanced with 
increasing LPR. The compressive strength of the hardened cement specimens 
tended to decrease for curing times longer than 24 h due to a gradual degradation 
effect experienced upon immersion in PBS solution. Mg-containing cement 
specimens appeared to be slightly stronger in comparison to Mg-free cements, 
probably due to a more favourable crystalline phase composition.  
Acknowledgments 
Thanks are due to CICECO for the support and to the Portuguese Foundation for 
Science and Technology for the fellowship grants of S. Pina 
(SFRH/BD/21761/2005) and S.M. Olhero (SFRD/BPD/27013/2006). 
88 
References 
[1]   Takagi, S. and Chow, L. C. Formation of macropores in calcium-
phosphate cement implants. J Dent Res 1995; 74:559-559. 
[2]   Generosi, A., Smirnov, V. V., Rau, J. V., Albertini, Y. R., Ferro, D., and 
Barinov, S. M. Phase development in the hardening process of two 
calcium phosphate bone cements: an energy dispersive X-ray diffraction 
study. Mater Res Bull 2007;in press 
[3]   Bohner, M. Calcium orthophosphates in medicine: from ceramics to 
calcium phosphate cements. Injury-Inter J Care Injured 2000; 31:37-47. 
[4]   Bohner, M., Merkle, H. P., Landuyt, P. V., Trophardy, G., and Lemaitre, J. 
Effect of several additives and their admixtures on the physico-chemical 
properties of a calcium phosphate cement. J Mater Sc: Mater Med 1999; 
11:111-116. 
[5]   Liu, C. S., Shao, H. F., Chen, F. Y., and Zheng, H. Y. Rheological 
properties of concentrated aqueous injectable calcium phosphate cement 
slurry. Biomaterials 2006; 27:5003-5013. 
[6]   Kannan, S., Lemos, I. A. F., Rocha, J. H. G., and Ferreira, J. M. F. 
Synthesis and characterization of magnesium substituted biphasic 
mixtures of controlled hydroxyapatite/beta-tricalcium phosphate ratios. J 
Sol St Chem 2005; 178:3190-3196. 
[7]   Xu, H. H. K., Carey, L. E., Simon, C. G., Takagi, S., and Chow, L. C. 
Premixed calcium phosphate cements: Synthesis, physical properties, 
and cell cytotoxicity. Dent Mater 2007; 23:433-441.
[8]   LeGeros, R. Z. Calcium Phosphates in Oral Biology and Medicine. Basel, 
Karger 1991; 
[9]  Bohner, M. and Gbureck, U. Thermal reactions of brushite cements. J 
Biomed Mater Res Part B: Appl Biomater 2008; 84B:375-385. 
[10] Bohner, M. Reactivity of calcium phosphate cements. J Mater Chem 
2007; 17:3980-3986. 
[11]   Kannan, S., Lemos, A. F., Rocha, J. H. G., and Ferreira, J. M. F. 
Characterization and mechanical performance of the Mg-stabilized β-
Ca3(PO4)2 prepared from Mg-substituted Ca-deficient apatite. J Am Cer 
Soc 2006; 89:2757-2761. 
[12]  Kannan, S., Rocha, J. H. G., and Ferreira, J. M. F. Synthesis and thermal 
stability of sodium, magnesium co-substituted hydroxyapatites. J Mater 
Chem 2006; 16:286-291. 
[13]  Suchanek, W. L., Byrappa, K., Shuk, P., Riman, R. E., Janas, V. F., and 
TenHuisen, K. S. Preparation of magnesium-substituted hydroxyapatite 
powders by the mechanochemical-hydrothermal method. Biomaterials 
2004; 25:4647-4657. 
89 
[14]  Fadeev, I. V., Shvorneva, L. I., Barinov, S. M., and Orlovskii, V. P. 
Synthesis and structure of magnesium-substituted hydroxyapatite. Inorg 
Mater 2003; 39:947-950. 
[15]  Kannan, S. and Ferreira, J. M. F. Synthesis and thermal stability of 
hydroxyapatite-beta-tricalcium phosphate composites with cosubstituted 
sodium, magnesium, and fluorine. Chem Mater 2006;18:198-203. 
[16]  Suchanek, W., Byrappa, K., Shuk, P., Riman, R, Janas, V., and 
TenHuisen, K. S. Mechanochemical-hydrothermal synthesis of calcium 
phosphate powders with coupled magnesium and carbonate substitution. 
J Sol St Chem 2004; 177:793-799. 
[17]   Lilley, K.J., Gbureck, U., Farrar, D.F., Ansell, C. and Barralet, J.E. Cement 
from magnesium substituted hydroxyapatite. J Mater Sc: Mater Med 2005; 
16: 455-460. 
[18]   TenHuisen, K.S. and Brown, P.W. Effects of magnesium on the formation 
of calcium-deficient hydroxyapatite from CaHPO4.2H2O and Ca4(PO4)2O. 
J Biomed Mater Res 1997; 36: 306-314. 
[19]  Mortier, A., Lemaitre, J., and Rouxhet, P. G. Temperature-Programmed 
Characterization of Synthetic Calcium-Deficient Phosphate Apatites. 
Thermochim Acta 1989; 143:265-282. 
[20]  Enderle R, Goetz-Neunhoeffer F Gobbels M Muller FA Greil P. Influence 
of magnesium doping on the phase transformation temperature of α-TCP 
ceramics examined by Rietveld refinement. Biomaterials 2005; 26:3379-
3384. 
[21]  Fernandez, E., Gil, F. J., Ginebra, M. P., Driessens, F. C. M., Planell, J. 
A., and Best, S. M. Calcium phosphate bone cements for clinical 
applications - Part II: Precipitate formation during setting reactions. J 
Mater Sc: Mater Med 1999; 10:177-183. 
[22]  Fernandez, E., Gil, F. J., Ginebra, M. P., Driessens, F. C. M., Planell, J. 
A., and Best, S. M. Calcium phosphate bone cements for clinical 
applications - Part I: Solution chemistry. J Mater Sc: Mater Med 1999; 
10:169-176. 
[23]  Nilsson, M. Injectable calcium sulphate and calcium phosphate bone 
substitutes. Thesis, Lund University, Faculty of Medicine, Lund, Sweden, 
2003; 
[24]  Baroud, G., Cayer, E., and Bohner, M. Rheological characterization of 
concentrated aqueous -tricalcium phosphate suspensions: The effect of 
liquid-to-powder ratio, milling time, and additives. Acta Biomater 2005; 
1:357-363. 
[25]  Sarda, S., Fernandez, E., Llorens, J., Martinez, S., Nilsson, M., and 
Planell, J. A. Rheological properties of an apatitic bone cement during 
initial setting. J Mater Sc: Mater Med 2001; 12:905-909. 
90 
[26]   Burguera, E. F., Xu, H. K. and Sun, L. Injectable calcium phosphate 
cement: effects of powder-to-liquid ratio and needle size. J Biomed Mater 
Res Part B: Appl Biomater 2008, 84B:493-502. 
[27]   Alves, H. L. R., Santos, L. A. and Bergmann, C. P. Injectability evaluation 
of tricalcium phosphate bone cement. J Mater Sci: Mater Med 2008, 
19:2241-2246. 
[28]  Khairoun, I., Boltong, M. G., Driessens, F. C. M., and Planell, J. A. Some 
factors controlling the injectability of calcium phosphate bone cements. J 
Mater Sc: Mater Med 1998; 9:425-428. 
[29]  Wang, X. P., Ye, J. D., and Wang, H. Effects of additives on the 
rheological properties and injectability of a calcium phosphate bone 
substitute material. J  Biomed Mater Res Part B: Appl Biomater 2006; 
78B:259-264. 
[30]      Duck, F.A. Physical properties of tissue: a comprehensive reference 
book. Academic, London 1990. 
91 
2.3 Newly developed Sr-substituted α-TCP bone cements 
S. Pina1, P.M.C. Torres1, F. Goetz-Neunhoeffer2, J. Neubauer2 and J.M.F. Ferreira1 
1University of Aveiro, Department of Ceramics and Glass Engineering, CICECO, 3810-193 Aveiro, 
Portugal. 
2Mineralogy, University of Erlangen-Nuremberg, 91054 Erlangen, Germany 
Acta Biomaterialia (2009), doi: 10.1016/j.actbio.2009.09.001
Abstract 
New bone cements made of Sr-substituted brushite-forming α-TCP were prepared 
and characterised in the present work. The quantitative phase analysis and 
structural refinement of the starting powders and of hardened cements were 
performed by X-ray powder diffraction and Rietveld refinement technique. 
Isothermal calorimetry along with setting time analysis allowed a precise tracing of 
the setting process of the pastes. The pastes showed exothermic reactions within 
the first 10-15 minutes after mixing and further release of heat after about 1 hour.  
An apatitic phase formed upon immersion of the hardened cements in simulated 
body fluid for 15 and 30 days due to the conversion of brushite into apatite 
confirming their in vitro mineralization capability. The compressive strength of the 
wet cement specimens decreased with increasing curing time, being higher in the 
case of Sr-substituted CPC.   
The results suggest that the newly developed Sr-substituted brushite-forming α-
TCP cements hold an interesting promise for uses in orthopaedic and trauma 
surgery such as for filling bone defects.  
Keywords: strontium; brushite; bone cement; XRD, Rietveld refinement; 
calorimetry; in vitro tests. 
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1. Introduction 
Calcium phosphate (CaP) ceramics have gained clinical acceptance for bone 
substitution and augmentation due to their similarities with the mineral bone 
composition [1-3]. At present, there are two types of calcium phosphate cements 
(CPCs) depending on the end-product of the reaction: apatite (AP) cements and 
dicalcium phosphate dihydrate (DCPD or brushite) cements [4, 5]. Apatite is 
formed above pH 4.2, while brushite is preferentially formed in calcium phosphate 
cements when pH value of the paste is < 4.2 [6], although it may grow even up to 
pH 6.5 [6]. AP cements showed higher mechanical strength but have slow in vivo
resorption rates that interfere with the bone regeneration process. Brushite 
cements have raised interest because they are resorbed in vivo much faster than 
AP cements [7,8]. Moreover, brushite is metastable in physiological conditions and 
brushite based cements possess faster setting reactions [6]. 
Recent years have witnessed the incorporation of strontium (Sr) into the CaP 
structure due to its presence in calcified bone. The essential characteristics and 
the role of Sr in bone mineral are: (i) its specific role in osteoporosis; (ii) its equal 
share with ionic calcium in the physiological pathway and (iii) it can be deposited 
into the mineral structure of bone, especially in regions of high metabolic turnover 
[9-11]. In addition, Sr increases osteoclast apoptosis and enhances 
preosteoblastic cell proliferation and collagen synthesis. Consequently, Sr ions 
depress bone resorption and maintain bone formation. Therefore, Sr-substituted 
CaPs are expected to produce enhanced biological and chemical responses in the 
body. The substitution of Ca by Sr has been studied in various CaP, namely 
brushite-forming cements [12,13]. Saint-Jean et al. [14] reported that the 
bioactivity of the set strontium-containing apatite cements was comparable to the 
bioactivity of pure calcium deficient hydroxyapatite (CDHA). 
Isothermal calorimetry has proved to be a powerful tool to study the setting 
kinetics of CPCs, in which the thermal reactions of the cement pastes are followed 
at constant temperature over time [4, 15-17]. Over the years, isothermal 
calorimetry has been used to characterize the setting properties of many 
materials, such as acrylic bone cement [18-20], apatite cements [16, 21-23] and 
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brushite based cements [4, 5, 17]. Nevertheless, none of the previously reported 
studies have shown the effects of the presence of Sr in a brushite-forming α-TCP 
cement upon hydration using isothermal calorimeter measurements. Therefore, 
one of the aims of the present work is studying the setting of Sr-substituted 
brushite-forming α-TCP cements by the evolution of the heat release rate 
accompanied by in situ XRD analysis. The second goal of the present study aims 
at evaluating the bioactivity of the hardened cements through in vitro tests and 
their wet mechanical properties.  
In vitro tests may not represent the real situation of an implant, since the greater is 
the systems complexicity, the greater is its variability. However, they can provide 
fast results regarding the materials interactions in biological mediums, thus helping 
to minimize testing on animals. In vitro tests have been used to evaluate the 
biocompatibility of materials for over two decades and they are widely used today 
owing to the easy availability of cell strains on the market. The in vitro studies on 
the (Ca, Sr) HA powders revealed a greater apatite deposition with Sr-containing 
HA, while the in vivo (Ca, Sr) HA cement study revealed an increase in the 
thickness of the bone layer formed at the interface bone-cement and a better 
osteointegration [15, 24, 25].  
2. Materials and Methods 
2.1. Preparation of powders and cement pastes 
The synthesis of the Sr-substituted cement powder was carried out according to a 
method that has been described in detail in previous report [26]. Briefly, the 
powder was obtained by aqueous precipitation from calcium nitrate tetrahydrate 
[Ca(NO3).4H2O, Vaz Pereira-Portugal, Sintra, Portugal], diammonium hydrogen 
phosphate [(NH4)2HPO4, Vaz Pereira-Portugal, Sintra, Portugal] and strontium 
nitrate [Sr(NO3), Riedel-de-Haen, Seelze, Germany] as the starting chemical 
precursors, respectively for calcium, phosphorus and strontium. The molar ratio 
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(Ca + Sr)/P used was (1.32+0.18)/1, thus performing the stoichiometric ratio of 1.5 
for β-TCP.  
The formation of Sr-substituted β-TCP can be described by Equation (1) [26]: 
OHPOSrCaOHPOHPOSrCa xxxx 224
33
35449
))((3)())(( +→
−
−
  (1)
The precipitate was vacuum filtrated, dried at 110ºC and then heat treated for 2 h 
at 1500ºC, in order to obtain the formation of the desired α-TCP phase that 
exhibits hydraulic power. This powder will be hereafter designated as SrCPC. The 
calcined powder was ground under dry conditions in a planetary mill, using an 
agate jar of 250 mL with agate balls of 10 mm and 20 mm diameter, and a weight 
ratio of balls to powder = 3:1, and then passed through a sieve with a mesh size of 
36 µm. The separated fine fraction of the SrCPC powder had an average particle 
size of 13.4 µm measured using a light scattering instrument (Coulter LS 230, UK, 
Fraunhofer optical model). For comparison purposes, and a better understanding 
of the role of Sr in the Sr-substituted cement pastes, reference cement made of 
pure α-TCP, denominated as aCPC cement, was also prepared and ground under 
the same conditions described above. The aim was to include a critical 
comparison of the values for the properties (initial setting time, compressive 
strength, microstructural features) for the reference cement to the corresponding 
values for the appropriate Sr-substituted cement. The measured average particle 
size of aCPC powder was 17.32 µm. 
From the SrCPC and aCPC powders, cement pastes were prepared using liquid-
to-powder ratio (LPR) of 0.34 mL g-1, which has been considered in a previous 
work of the same authors [27], to give a good balance between the rheological and 
setting behaviours. Two different mixing liquids were used: (i) 10 wt.% 
poly(ethylene glycol) (PEG) (200, Sigma) + 20 wt.% citric acid solution (called as 
Liquid P) and (ii) 0.5 wt.% hydroxyl propyl methylcellulose (HPMC) (3.5-5.6 mPa*s 
at 2% by mass in water, Sigma) + 10 wt.% PEG + 20 wt.% citric acid solution 
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(called as Liquid H). Citric acid was selected as setting liquid because its non-
toxicity [28]. Citrate exists in bone mineral and is believed to play an important role 
in the formation and/or dissolution of bone apatite. PEG was also selected for its 
non-toxicity and its non-immunogenicity [29]. HPMC was selected for its ability to 
form viscous solutions thus improving the washout resistance of the CPC. The 
concentration of HPMC was limited to 0.5 wt.% because preliminary studies have 
shown that higher concentrations retarded the CPC conversion into HA [30].  
Specific surface areas (SSA) of the starting powders and of some similarly milled 
hydrated cements were obtained according to the BET method using a 
Micromeritics Gemini 2370 V5.00 (Norcross, USA) through the gas adsorption 
measurements, after degassing the powders in a Micromeritics Flow prep 060 
(Norcross, USA).  
2.2. X-ray diffraction and structural analysis by the Rietveld refinement 
method  
For refinement studies, the XRD of the powders was performed with a SIEMENS 
D5000 equipped with a diffracted beam graphite monochromator and the in situ
XRD of the hardening cements was recorded with a SIEMENS D5000 with SolX 
detector. Data sets were collected from 2θ = 10-50º with a step size of 0.02º, with 
CuKα radiation. XRD measurements for all the investigated compositions were 
repeated three times in three independent samples. 
The phase composition of the samples was calculated on the basis of XRD 
patterns by means of Rietveld analysis with TOPAS 3.0 software (Bruker AXS, 
Germany). Rietveld refinement was performed using the structural models (ICSD 
Database) of all phases listed in Table 1. Refined parameters were scale factor, 
sample displacement, background as Chebyshev polynomial of fifth order, 
crystallite size and lattice parameters. All parameters were refined simultaneously.  
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2.3. Isothermal calorimetry 
The heat flow evolved during hydration of the cements was monitored using an 
isothermal calorimeter (TAM Air, Sweden), containing eight separated measuring 
cells, at 23ºC. The cements (4.0 g of powder) were separately mixed with two 
different liquids H and P, with LPR of 0.34 mL g-1. The pastes were placed in 
closed HDPE ampoules and left in the calorimeter chamber for 20 h. At least two 
measurements were made for each composition. After 5 days of hydration, dried 
and milled powder cements were used for XRD analyses. 
2.4. Setting time
The initial setting time of the cement pastes was determined using Vicat needle 
technique according to the ASTM C 187-98. One minute after placing the pastes 
into a glass plate stored at 37ºC in 100% humidity box, the indenter (100 g in 
mass, 1 mm diameter of the needle) was lowered vertically onto the surface of the 
cement. The indentation was repeated at intervals of 30 s until no more 
penetration was possible. The time at this point was taken as the initial setting 
time. 
2.5. Chemical analysis 
The chemical analysis of the starting SrCPC powder and of cylindrical (6 mm 
diameter, and 3 mm height) SrCPC (P) and SrCPC (H) cement samples 
(hardened for 5 days) after immersing for 2 days into 5 mL distilled water at 37ºC 
under constant stirring (75 rpm), as well as the Sr2+ and Ca2+ concentrations 
leached out from SrCPC (P) and SrCPC (H) cement samples were determined by 
ICP spectroscopy (Model 70 Plus, Jobin Yvon, France). 
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2.6. In vitro tests 
In order to evaluate the mineralisation behaviour of the cements in vitro, the set 
cements were placed into polystyrene flasks containing simulated body fluid (SBF) 
with ion concentrations (Na+ 142.0, K+ 5.0, Ca2+ 2.5, Mg2+ 1.5, Cl- 148.8, HPO4- 
1.0, HCO32- 4.2, SO42- 0.5 mM L-1) nearly equivalent to those of human blood 
plasma, as discussed by C. Tas [31], for 15 and 30 days. The samples were left 
setting in PTFE-moulds (Φ 6 × 12 mm3) in a 37ºC, 100% humidity box, for 24 h. 
The set samples were then immersed into SBF solution and continuously shaken 
at a rate of 75 r min-1, at 37ºC. The liquid was refreshed after every 2 days. After 
the above mentioned immersion periods in SBF, the samples were washed with 
distilled water and allowed to dry at 37ºC for 1 day and analysed by means of 
Scanning Electron Microscopy (SEM) (Hitachi S4100, Tokyo, Japan) and ATR-
FTIR spectrometry (FT-IR model Mattson Galaxy S-7000, 32 scans and resolution 
4 cm-1). 
2.7. Compressive strength  
For the compressive strength measurements, the cement pastes were cast into 
PTFE-moulds (Φ 6 × 12 mm3) and stored in a 37ºC, 100% humidity box for 24 h.
The cement specimens were then removed from the moulds and immersed in PBS 
solution (1.37 M NaCl, 27 mM KCl, 80.6 mM Na2HPO4, 19.4 mM KH2PO4) at 37ºC 
for further 6 h, 24 h and 48 h. The specimens were loaded to failure at a 
crosshead displacement rate of 1 mm min-1 using a universal materials testing 
machine (Shimadzu Autograph, Trapezium 2, Japan). Results of compressive 
strength are expressed as the mean ± standard error of the mean of triplicate 
determinations. 
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2.8. Statistical analysis 
Statistical analysis was performed using the SPSS 16.0 software. Comparative 
studies of means were performed using one-way ANOVA followed by a post hoc 
test (Fisher projected least-significant difference) with a statistical confidence 
coefficient of 0.95; therefore, p values < 0.05 were considered significant. 
3. Results 
The chemical composition of the starting of SrCPC powder and of the hardened 
cement as determined by ICP spectroscopy indicated the following concentrations: 
11.74 mol.% Sr2+ and 88.26 mol.% Ca2+ for the starting of SrCPC powder,  which 
are close to the planned ones of 12 mol.% and 88 mol.%, respectively.  
The evolution of crystalline phases of the starting powders without and with Sr 
incorporation, as well as of the respective cements hydrated for 5 days at 23ºC 
with the liquids P and H is shown in Figure 1 and Figure 2, respectively. It can be 
seen that α-TCP was the single phase identified in the starting powders. Hydration 
led to some consumption of α-TCP and to the formation of brushite, as a minor 
crystalline phase.  
The quantitative Rietveld analysis of XRD patterns confirmed that the starting 
powders consist of 100% of α-TCP phase, whereas both hydrated cements 
contained predominantly α-TCP and a fraction of brushite. The cements hydrated 
with liquid P contained around 77.5 ± 1.0 % of α-TCP and 22.5 ± 1.0 % of 
brushite, whereas in the case of the cements prepared with liquid H, brushite 
formation was favoured, reaching values about 25.7 ± 1.0 %.  
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Fig. 1: XRD patterns of the starting powder aCPC, and of the cements prepared from 
pastes with (i) 10 wt.% PEG + 20 wt.% citric acid (Liquid P (P)) and (ii) 0.5 wt.% HPMC + 
10.0 wt.% PEG + 20.0 wt.% citric acid (Liquid H (H)) after 5 days of hydration. Brushite 
(JCPDS PDF File # 9-0077) and α-TCP (Ca3(PO4)2, JCPDS PDF File # 29-359), full scale 
intensity = 6,000 cps. 
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Fig. 2: XRD patterns of the starting powder doped with Sr, SrCPC, and of the cements 
prepared from pastes with (i) 10 wt.% PEG + 20 wt.% citric acid (Liquid P (P)) and (ii) 0.5 
wt.% HPMC + 10.0 wt.% PEG + 20.0 wt.% citric acid (Liquid H (H)) after 5 days of 
hydration. Brushite (JCPDS PDF File # 9-0077) and α-TCP (Ca3(PO4)2, JCPDS PDF File 
# 29-359), full scale intensity = 6,000 cps. 
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Table 2 shows the lattice parameters of the α-TCP and brushite phases 
determined in the cements aCPC and SrCPC after 5 days of hydration. The 
SrCPC presented increased lattice parameters compared to α-TCP powder, 
proving that Sr has been incorporated in the SrCPC crystal structure. Table 2 also 
shows that the lattice parameters of brushite crystals remained similar for both 
hydrated cements. 
Table 2: Lattice parameters of α-TCP and brushite phases of aCPC and SrCPC, after 5
days of hydration. 
 Lattice parameters (Å) (±0.002) 
α-TCP Brushite 
Samples a b c β a b c β 
         
aCPC 12.885 27.285 15.221 126.2 5.807 15.189 6.237 116.4
        
         
SrCPC 12.936 27.521 15.287 126.5 5.807 15.183 6.256 116.3
        
For a better perspective concerning the phase’s evolution with hydration time, in 
situ XRD measurements were done. Figure 3 shows the in situ XRD patterns for 
SrCPC upon hydration for a period of 12 h using 10 wt.% PEG + 20 wt.% citric 
acid. In view of the fact that both mixing liquids enabled similar behaviour during 
hydration, it was decided to present simply for one case (liquid P). It can be seen 
that the brushite phase started its formation after approximately 1 h of hydration 
and the intensity of these diffraction lines increase very intensively from 1 to 5 h of 
hydration. Concomitantly, the diffraction lines corresponding to α-TCP phase 
decreased with increasing hydration times. The in-situ XRD experiments with 
cements pastes started immediately after 2 min of mixing. We must assume that 
part of the α-TCP has been already dissolved after mixing with the liquid 
containing 10 wt.% PEG + 20 wt.% citric acid.
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Fig. 3: In situ XRD patterns performed within the first 12 h of hydration of cement pastes 
of SrCPC prepared with 10 wt.% PEG + 20 wt.% citric acid. 
Isothermal calorimetry measurements showing the heat flow and the cumulated 
heat of hydration released from the exothermic setting reaction as a function of 
reaction time for the powders aCPC and SrCPC, mixed with two different liquids, 
are presented in Figures 4a and 4b, respectively. For both starting powders and 
setting liquids, the heat flow profiles display first and main exothermic peaks with 
maxima centred at approximately 4 min, and the end of this main exothermic 
reaction occurs after 10-15 min (Fig. 4a). A second and much smaller exothermic 
effect appears centred at hydration times close to 1 h.  These two steps of 
hydration are consistent with the gradual decreasing intensity of XRD lines of α-
TCP and the appearance of XRD lines of brushite phase after about 1 h of 
hydration, as shown in Fig. 3. Such consecutive events suggest the occurrence of 
dissolution-precipitation and phase transformation processes.  
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Fig. 4: (a) Heat flow, and (b) Cumulated released heat of hydration profiles as measured 
by isothermal calorimetry for two hardening cements prepared with (i) 10 wt.% PEG + 20 
wt.% citric acid (Liquid P (P)) and (ii) 0.5 wt.% HPMC + 10.0 wt.% PEG + 20.0 wt.% citric 
acid (Liquid H (H)). 
The first initial heat flow can be correlated to the dissolution of α-TCP directly after 
mixing and a possible precipitation of amorphous material, but not to the formation 
of any crystalline phase. After 1 h brushite, the stable phase at pH below 5, starts 
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to form, probably from precipitated amorphous material. This relatively slow 
transformation process stops after about 5 h since only little heat is produced from 
the reaction of the paste after that time.  
The reactions are more intensive in the case of Sr-substituted cement pastes. The 
heat flow intensity of SrCPC cement pastes achieves values of ~88 mW g-1 and 
~103 mW g-1, for liquid P and liquid H, respectively, which compare respectively 
with about 43 mW g-1 and 68 mW g-1 for aCPC cement pastes (Figure 4a). The 
same information can be drawn from Figure 4b: within 15 h the SrCPC cement 
pastes released cumulated heat of hydration of ~69 J g-1 and ~77 J g-1, for liquid P 
and liquid H, respectively, which compare respectively with about ~42 J g-1 and 
~50 J g-1 for aCPC cement pastes. These observations are consistent with the 
measured average particle diameters, D50, of the 17.32 µm and 10.78 µm, for 
aCPC and SrCPC powders, respectively and with their specific surface areas 
(Table 3). The results presented in Figure 4 clearly show that the thermal effects 
are stronger for the cement pastes prepared with liquid H.  
The initial setting times of the cement pastes were measured using Vicat needle 
technique. The obtained results were 2 ± 0.5 min for aCPC and 3 ± 0.5 min for 
SrCPC the cements prepared with liquid P; and 5 ± 0.5 min for aCPC and 7 ± 0.5 
min for SrCPC, when cement pastes were made with liquid H (p<0.05), in line with 
thermal results.  
The BET specific surface areas of the starting powders and of the similarly milled 
cements aCPC and SrCPC after 5 days of hydration in the two different mixing 
liquids are reported in Table 3. It can be seen that, in comparison to the starting 
powders, the SSA of set cements is significantly higher (26-38 times for the aCPC 
cements and 67-71 times for the SrCPC). This suggests that the hydration product 
in the hardened cements might consist of intermingle brushite crystals or 
amorphous material (calcium citrate, amorphous calcium phosphate) with a fine 
porous structure. 
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Table 3: Comparison of the BET specific surface areas measured for the starting powders 
and for the similarly milled hardened cements aCPC and SrCPC prepared with liquid P 
and liquid H after 5 days of hydration. 
Specific surface area  
(m2/g)
Milled hardened cements 
Starting powders 
Set in Liquid P Set in Liquid H 
aCPC 0.62 ± 0.01  16.36 ± 0.14 23.41 ± 0.17 
SrCPC 0.78 ± 0.01 55.11 ± 0.5 52.15 ± 0.5 
In order to predict the mineralization behaviour of the cements after implantation, 
the ATR-FTIR spectra of the SrCPC cement hardened for 24 h and prepared from 
the Sr-substituted α-TCP powder mixed with 10.0 wt.% PEG + 20.0 wt.% citric 
acid, taken before and after 30 days of immersion in SBF is shown in Fig. 5. 
Before immersion, SrCPC presents two sharp PO4 peaks at 1060 and 540 cm-1
and a broad peak centred at 3330 cm-1 due to adsorbed H2O. The peaks at 1590 
and 1420 cm-1 might belong to calcium citrate. According to Hofmann et al. [5], 
FTIR-monitoring of a fast setting brushite bone cement revealed sharp peaks in 
close proximity at 1555 and 1410 cm-1.  
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Fig. 5: ATR-FTIR spectra of the SrCPC cements prepared with (i) 10 wt.% PEG + 20 
wt.% citric acid (Liquid P (P)) and (ii) 0.5 wt.% HPMC + 10.0 wt.% PEG + 20.0 wt.% citric 
(Liquid H (H)), before and after 30 days of  immersion in SBF solution. 
These peaks were consistent with the most intense peaks in the calcium citrate 
spectra and related with DCP formation (either DCPD or DCPA) upon hydration in 
the presence of citric acid solution. They were attributed to the CO2- symmetric 
and asymmetric stretching vibrations of calcium citrate intermediates in the 
hardened cements before immersion in SBF [5]. The immersion of the cements in 
SBF resulted in a sharpening of PO4 peaks at 1060 and 540 cm-1 and a significant 
decreased intensity of the band relative to adsorbed water and of the Ca citrate 
peaks. The differences observed in the ATR-FTIR spectra support the dissolution 
of brushite and precipitation of apatite.  
Figure 6 shows the morphological features of fractured surface of hardened 
SrCPC cements before and after immersion in SBF for 15 and 30 days. The 
hardened cement shows well developed dense crystals, probably belonging to the 
remaining α-TCP phase, and porous aggregates of the hydration product 
consisting of smaller crystals with irregular morphologies. These observations 
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support the measured SSA values reported in Table 3. After 15 days of immersion, 
the surface appears partially covered with a fine apatite layer. Prolonging the 
immersion period for further 15 days just gives rise to a more extensive deposition 
of the apatite layer.  
The chemical composition of the cements hardened for 5 days after the leaching 
experiments in distilled at 37ºC for two days indicated Sr2+ concentrations of 11.32 
mol.% and 11.15 mol.% for the SrCPC (P) and SrCPC (H), respectively, which are 
slightly lower in comparison to the planned concentration of 12 mol.% and 88 
mol.%, respectively. On the other hand, the Sr2+ concentrations in the leaching 
liquids were 13.5 mol.% and 14.4 mol.% for the SrCPC (P) and SrCPC (H), 
respectively. These results suggest a somewhat preferential release of Sr2+ in 
water in comparison to Ca2+ ions.  
Fig. 6: Scanning electron micrographs of the SrCPC cement before (0 d), and after 
immersion in SBF solution for 15 days and 30 days. The pastes were prepared with 10 
wt.% PEG + 20 wt.% citric acid (LPR = 0.34 mL g-1). Bar 60 µm. 
0 d 15 d
30 d
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The compressive strength values of aCPC and SrCPC cements hardened for 24 h 
and kept under wet conditions for further 6 h, 24 h and 48 h, before performing the 
measurements, are shown in Figure 7. The compressive strength dropped with an 
increase of immersion time in PBS solution, which can be attributed to a gradual 
structural degradation process (p ≅ 0.008). The measured values of the wet 
compressive strength after 48 h achieved average values of about 13.7 MPa and 
9.2 MPa for the SrCPC and aCPC cements, respectively. The results show that 
Sr-containing cement specimens exhibit higher compressive strength values in 
comparison to Sr-free cements (p<0.05). 
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Fig. 7:  Compressive strength values measured for the aCPC and SrCPC cements 
hardened for 24 h and kept under wet conditions for further 6 h, 24 h and 48 h. The pastes 
were prepared with 10 wt.% PEG + 20 wt.% citric acid (LPR = 0.34 mL g-1). 
4. Discussion 
The results presented in this study put into evidence several beneficial effects 
derived from the presence of strontium in brushite-containing α-TCP cements.  
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The observed decrease in the intensity of the α-TCP peaks and to the formation of 
brushite upon the hydration reactions between the single phase α-TCP starting 
powders and setting liquids can be attributed to the partial dissolution of the 
starting powders and the precipitation of brushite as new phase. This is consistent 
with the isothermal calorimetry measurements. The first strong exothermic peaks 
with maxima centred at approximately 4 min are due to dissolution reactions.  
Brushite appears in the in-situ XRD pattern after 1 h of reaction whereas the first 
heat flow maximum is reached after a few minutes, which might be the result of 
the higher solubility of the brushite compared to the dissolving phase α-TCP and to 
a possible precipitation of amorphous material (calcium citrate, amorphous 
calcium phosphate). The first range of in-situ XRD data is completed after 15 
minutes of hydration and we have to take into account that some α-TCP was 
already dissolved immediately after mixing with the liquid. The second maximum 
of heat flow at 50 minutes (SrCPC) and 60 minutes (aCPC) can be correlated to a 
transformation of amorphous material to brushite phase. But a mass balance 
based on the quantitative Rietveld phase analysis of cements hydrated with e.g. 
liquid P (77.5 ± 1.0 % of α-TCP and 22.5 ± 1.0 % of brushite) and on the LPR =
0.34 mL g-1 used in the present experiments strongly suggest the occurrence of 
this event. As a matter of fact, neglecting the amorphous material, the mass 
balance could be described by Equation 2: 
(Ca,Sr)3(PO4)2 + 0.11 C6H8O7 + H2O → 0.11 (Ca,Sr)3(C6H5O7)2 + 0.775 
(Ca,Sr)3(PO4)2 + 0.225 CaHPO4.2H2O                                                 (2) 
However, reactants and reaction products are not balanced in terms of Ca2+ and 
Sr2+ cations, since we start from 3 mol of (Ca,Sr) and end up with only 2.885 mol 
in all reaction products. These results strongly support the hypothesis that 
amorphous calcium phosphate has been also formed, witch has a Ca/P ratio 
ranging from 1.2-2.2 [32]. The formation of amorphous calcium phosphate could 
not be seen in the XRD pattern because of its non-crystalline nature, but the 
formation of amorphous calcium citrate is also supported by the observed sharp 
ATR-FTIR peaks at 1590 and 1420 cm-1 (Figure 5). 
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The higher exothermicity of the cement pastes prepared with Sr-substituted 
powder is related to a several factors: (i) The lattice strains associated to the 
expansion of the lattice parameters with the incorporation of a larger ionic radius of 
Sr (1.21 Å) compared to Ca (1.07 Å) [33] causes the lattice to expand in both the a
and c axis directions [34] are expected to favour particle size reduction during 
milling, as has been observed; (ii) The same lattice strains might also facilitate a 
faster kinetics and favourable thermodynamics of the dissolution process due to 
changes of the pH value in the cement pastes. M. H. Alkhraisat et al. [12] 
investigated the effectiveness of using  Sr-substituted β-TCP as cement reactant 
and verified that, after mixing, the cement pH started to increase rapidly until it 
reached a first plateau and that lower pH values are maintained for a longer period 
of time by higher Sr-content in β-TCP. This interpretation is consistent with the 
higher values of SSA and lower average particle diameters measured for the 
SrCPC cements in comparison to Sr-free cements for both liquid solutions. As a 
matter of fact, a faster dissolution process implies a higher degree of 
supersaturation to be achieved, leading to higher rates of nucleation and product 
formation [17]. Therefore, a less ordered hydrated structure is expected to be 
precipitated. 
The somewhat more intense heat flow and heat of hydration from the setting 
reaction of cements prepared with liquid H (Figure 4) suggests that the presence 
of HPMC is playing some role. The difference between two liquids can solely be 
attributed to the heat of adsorption of HPMC, probably onto the surface of the 
newly formed brushite nuclei. The ability of cellulose derived molecules such as 
CMC and HPMC to be readily adsorbed onto the surface mineral particles, 
including apatite-like minerals is well documented in literature [35]. The extent of 
adsorption increases with increasing ionic strength of the liquid, a situation that 
occurs in a reacting system involving dissolution [35]. It has also been reported 
[36] that these kinds of polymeric additives tend to adsorb onto the surface of the 
calcium phosphate powders, acting sometimes as dispersing agent, improving the 
flowability of cement pastes by keeping the particles separated from each other. 
The specific adsorption of the polymeric species is certainly thermodynamically 
driven, so that some heat of adsorption is expected to be released [36]. This would 
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explain the small heat flow differences observed in Figure 4 between cement 
pastes prepared from the two setting liquids tested. 
On the other hand, the newly formed brushite nuclei and the amorphous material 
(calcium citrate, amorphous calcium phosphate) are expected to exhibit a high 
surface area. Adsorbing HPMC molecules onto the surface of these newly formed 
brushite and amorphous calcium phosphate nuclei species would delay the growth 
of brushite crystals and create favourable conditions for a continual dissolution of 
α-TCP phase. This is consistent with the delayed initial setting times of cement 
formulations prepared with liquid H (3 ± 0.5 min and 7 ± 0.5 min for aCPC and for 
SrCPC, respectively) in comparison to liquid P (2 ± 0.5 min and 5 ± 0.5 min, for the 
corresponding aCPC and for SrCPC). This would explain why the content of 
brushite is slightly higher in the hardened cements prepared with liquid H. As a 
matter of fact, the second exothermic effect centred at hydration times close to 1 h 
is also smaller for liquid P in comparison to liquid H. This exothermic effect can 
indubitably be attributed to the formation of brushite and further dissolution of α-
TCP, which diffraction lines start to appear after approximately 1 h of hydration, as 
seen in Figure 3. As expected, the increasing intensity of the brushite diffraction 
lines with hydration time increasing is accompanied by a decreasing of the α-TCP 
phase.  
It was reported [4] that the exothermic precipitation of brushite occurs rapidly 
compared to the formation of HA. Furthermore, the heat released in the presence 
of Sr was considerably higher towards Sr-free cements, reflecting the high 
reactivity of SrCPC cement in contrast to aCPC cement. These findings and the 
present results are in apparent contradiction with other results reported elsewhere 
[14] showing a decrease in the reactivity with increasing Sr content, but this could 
be different at neutral pH for apatite-forming α-TCP cements. However, this last 
study [14] used 2.5 wt.% Na2HPO4 as the setting liquid and a LPR = 1. 
Considering these differences and the fact that in the present work a fixed content 
of Sr has been used, a direct comparison of the results can not be made. 
Rietveld refinement analyses performed on the starting powders and on the 
hardened cements confirmed the considerable increase in the lattice parameters 
of Sr-substituted α-TCP in both the a and c axis directions (Table 2) [33, 34]. Table 
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2 further shows that the lattice parameters for brushite crystals present in aCPC 
and SrCPC cements are similar meaning the absence of Sr in this phase.  
From the perspective of the clinical uses, the setting time of a CPC cement paste 
is of paramount importance since it should not harden too fast to allow moulding or 
injection and not harden too slowly to allow the surgeon to close the defect shortly 
after cement placement. Therefore, the CPC must have an optimal setting time in 
order to lead to an acceptable mechanical strength after hardening and to prevent 
migration of cement to undesirable sites. To authors’ knowledge there are only 
three calorimetry studies devoted to brushite cements suggesting that 
thermograms are related to the setting time [4, 17, 37]. Hoffmann et al. [17] 
observed that the initial and final setting time of various brushite formulations were 
correlated to the extent of the largest exothermic peak occurring during setting 
reaction, while Pittet [37] determined the change of brushite CPC temperature 
during setting using a thermocouple. Moreover, Bohner et al. [4] upon measuring 
the setting times of different pastes prepared from β-TCP + MCPM powders also 
suggested a linkage between setting time and first exothermic peak. These 
findings support the present results that also point out to a link between setting 
time and main exothermic peak since the first exothermic peak occurred within the 
same time interval as the initial setting times obtained via indentation.  
The immersion tests intended to approach an in vivo environment upon 
implantation of the cement in a clinical application provide conditions for a 
continuous hydration of cements and to promote in situ deposition of apatite 
around the residual pores [38]. The results shown in Figures 5 and 6 confirm that 
an apatitic layer has been formed at the surface the Sr-substituted cements 
immersed in SBF, indicating its mineralization capability. ATR-FTIR spectroscopy 
(Figure 5) was found useful to detect the presence of brushite and apatitic groups. 
Several in vitro and in vivo studies [14] showed that at low doses of Sr 
administration, the Sr uptake in bone might increase the bone volume by 
increasing the extent of bone formation sites and reducing bone resorption, 
without however affecting the rate of bone formation, neither altering the bone 
mineralization. This was attributed to the role of Sr on bone cells, inducing 
osteoblast activity and inhibiting osteoclast activity. Additionally, the resorption in 
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vivo was found to be inhibited by the stabilization of the bone apatite crystals upon 
Sr incorporation.  
The wet compressive strength values of SrCPC cement are in the range of 1-24 
MPa for compressive strengths reported in literature for brushite-forming cements 
[1] as well as in the range for cancellous bone (10-30 MPa) [39]. The results show 
that Sr-containing cement specimens exhibit higher compressive strength values 
in comparison to Sr-free cements, probably due to the lower content of brushite 
phase present in SrCPC cement (pure brushite cements are characterized by their 
low mechanical strength). It is thought possible that citric acid might have slowly 
diffused out of the cement during soaking in PBS, thus leading to a weaker 
structure. This helps explaining the decrease of compressive strength with 
immersion time.  
5. Conclusions 
The incorporation of Sr in the α-TCP crystal structure was proved by increased 
lattice parameters of the starting SrCPC powder in comparison to the Sr-free 
aCPC. The lattice strains due to Sr-substitution favoured the milling process and 
made the starting SrCPC powder more reactive. The isothermal calorimetry, used 
for the first time in Sr-substitutedbrushite-forming α-TCP cements, enabled a good 
traceability of the hydration reactions pointing out to a two-step hardening process: 
(i) the dissolution of the starting powders and nuclei formation of intermediate 
amorphous phases (calcium citrate, amorphous calcium phosphate) within the first 
10-15 min after mixing; and (ii) the nucleation and growth of brushite after about 1 
h. The results confirmed a close linkage between initial setting time and main 
exothermic peak. The precipitation of amorphous (Ca, Sr)-citrate, amorphous (Ca, 
Sr)-phosphate) needs to be considered in an overall mass balance of hydration 
reactions. After a certain time the amorphous (Ca, Sr)-phosphate is transformed 
into brushite. From our results we conclude that the amount of remaining α-TCP in 
the hydrated pastes is dependent of the amount of added citric acid. The initial 
setting time of the newly developed Sr-substituted brushite-forming α-TCP 
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cements can be extended and optimised, in comparison to Sr-free α-TCP 
cements, to allow the surgeon to close the defect shortly after cement placement 
in a better controlled manner. The presence of Sr did not hinder the conversion of 
brushite into apatite. The wet compressive strength of SrCPC cements are in the 
range of values (10-30 MPa) reported for cancellous bone even after immersion in 
PBS solution for 48 h. These characteristics, allied to the specific roles of Sr in 
osteoporosis and physiological pathway, and in the regulation of bone apposition 
and resorption, confer them an interesting promise for uses in orthopaedic and 
trauma surgery such as for filling bone defects. Such characteristics qualify the 
SrCPC cements for further studies in vivo.  
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Abstract 
The influence of Magnesium- and Strontium-substitutions on injectability and 
mechanical performance of brushite-forming α-TCP cements has been evaluated 
in the present work. The effects of Mg- and Sr-substitutions on crystalline phase 
composition and lattice parameters were determined through quantitative X-ray 
phase analysis and structural Rietveld refinement of the starting calcium 
phosphate powders and of the hardened cements. A noticeable dependence of 
injectability on the liquid-to-powder ratio (LPR), smooth plots of extrusion force 
versus syringe plunger displacement and the absence of filter pressing effects 
were observed. For LPR values up to 0.36 mL g-1, the percentage of injectability 
was always higher for Mg-containing cements and lower for Sr-containing 
cements, respectively, while all the pastes could be fully injected for LPR > 0.36 
mL g-1. The hardened cements exhibited relatively high wet compressive strength 
values (~17-25 MPa) being the Sr- and Mg-containing cements the strongest and 
the weakest, respectively, holding an interesting promise for uses in trauma 
surgery such as for filling bone defects and in minimally invasive techniques such 
as percutaneous vertebroplasty to fill lesions and strengthen the osteoporotic 
bone. 
Keywords:  magnesium; strontium; brushite; bone cement; injectability; 
mechanical strength 
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1. Introduction 
The continued increase in the age of the population and the concomitant 
increasing incidence of bone diseases such as osteoporosis (a disease that 
results in a loss of normal bone density, mass and strength, leading to a condition 
in which bones are increasingly porous or full of small holes and vulnerable to 
breaking), osteomyelitis, malignant tumors, or traumatic accidents, has generated 
higher demands for bone grafting [1,2]. Vertebroplasty and kyphoplasty are 
minimally invasive procedures for vertebral compression fractures (VCF) usually 
caused by osteoporosis, which are fractures in vertebra, the irregular bones that 
make up the spinal column.  
The orthopedic cements used in vertebroplasty and kyphoplasty are based on 
polymethylmethacrylate (PMMA) for their mechanical properties. However, this 
kind of cements might cause extensive necrosis due to noticeable exothermal 
effects upon curing [2-5]. Besides, PMMA cements have several other drawbacks, 
including no biologic potential to remodel or integrate into the surrounding bone, 
no direct bone apposition, excessive inherent stiffness, high polymerization 
temperature, and potential monomer toxicity. PMMA is also commonly used as 
bone void filler in surgery requiring the removal of bone as in bone tumours [6,7]. 
Calcium phosphate cements (CPC) have been in clinical use for the last 10 years. 
They are prepared from a powder and a liquid, forming a viscous and easy 
mouldable paste that after being implanted sets and hardens within the body as 
either a non-stoichiometric calcium deficient hydroxyapatite (CDHA) or brushite, 
sometimes blended with unreacted particles and other phases. They are 
commonly used as bone filling defects and in trauma surgeries as mouldable 
paste-like bone substitute materials. Their most salient features include good 
biocompatibility, excellent bioactivity, self-setting characteristic, low setting 
temperature, adequate stiffness, and easy shaping to any complicated geometry 
[8-16]. Nearly perfect adaptation to tissue surfaces in bone defects, a gradual 
bioresorption followed by new bone formation and the lack of any by-products are 
other distinctive advantages of CPC [6,7]. 
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Recently, the development of injectable CPC is seen with alacrity due to their 
importance for minimally invasive surgical techniques such as percutaneous 
vertebroplasty to fill bone lesions and cracks to strengthen the bone [15,17-22]. 
Injectable osteoconductive CPC can fit bone defects perfectly and be used as an 
adjunct to internal fixation for treating selected fractures, as filling voids in 
metaphyseal bone, thereby reducing the need for bone graft, and improving the 
holding strength around metal devices in osteoporotic bone. They can easily be 
used by bone remodeling cells for reconstruction of damaged parts of bones 
[11,15]. Injectability is also important for applications with limited accessibility and 
narrow cavities, and when there is a need for precise placement of the paste to 
conform to a defect area, such as periodontal bone repair and tooth root canal 
fillings. However, liquid-phase separation (the so-called filter-pressing effect) 
provoked by the extrusion pressure applied to the cement paste after a certain 
injection time has often been observed in commercial formulations [4,23]. This 
problem has been the focus of several previous studies [4,11,15,21-26]. Habib et 
al. [23] concluded that high extrusion velocity, small syringe size, short cannula 
and high liquid-to-powder ratio (LPR) favoured injectability. Sarda et al. [21] found 
enhanced injectability of α-TCP-water mixtures with the addition of citrate ions. 
Barralet et al. [24] made similar observations for brushite and apatite cements and 
found improved injectability with increasing LPR. Leroux et al. [26] used sodium 
glycerophosphate, latic acid, glycerol and chitosan to improve injectability and 
measured lower extrusion forces in the presence of all these additives. However, 
commercial formulations still suffer from several shortcomings related to 
unsatisfactory levels of some properties: (i) low mechanical strength; (ii) poor 
injectability; (iii) ionic mismatches towards the bone composition, which includes 
(but is not limited to) the following cations: Na+, K+, Mg2+, Ca2+, H+ and anions: 
PO43-, HPO42-, H2PO4-, CO32-, HCO3-, SO42-, HSO4-, Cl-, F-, SiO44- [4,7,11,15]. 
Insufficient mechanical strength and the poor injectability are interdependent 
properties, both affected by a number of experimental factors, such as particle size 
and particle size distribution of the powder, the degree of crystallinity (amorphous 
calcium phosphates tend to give more viscous and reactive mixtures), the 
presence of rheological modifiers and/or other additives with specific roles. 
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Usually, injectability of a cement paste varies inversely with its viscosity and with 
the time after starting the mixing of liquid and powder [4,7,23,26]. Enhancing the 
injectability of a cement paste by increasing LPR degrades the mechanical 
properties and cohesion of hardened cements and markedly elongates the initial 
and final setting times [7]. 
Substitution of trace elements, such as Mg and Sr ions in the apatite structure has 
been the subject of widespread investigation, because of their impending role in 
the biological process, as observed during implantation studies [27-35]. Mg is 
undoubtedly one of the most important bivalent ions associated with the biological 
apatite; Sr increases osteoclast apoptosis and enhances preosteoblastic cell 
proliferation and collagen synthesis [35]. However, none of the above mentioned 
literature reports have been focused on studying the injectability of brushite-
forming Mg- and Sr-substituted α-TCP cements. Therefore, the main goal of the 
present study is to investigate the influence of single Mg- and Sr-substitutions on 
the injectability of brushite-forming α-TCP cements. 
2. Materials and Methods 
2.1. Preparation of powders and cement pastes 
The Mg- and Sr-substituted cements with molar ratio (Ca + x)/P = (1.35 + 0.15)/1 = 
1.5 (x denoting the molar content of Sr or Mg), thus performing the stoichiometric 
ratio of β-TCP, were used in the present study. The starting Mg- and Sr-
substituted powders were prepared by aqueous precipitation as described 
elsewhere [36]. Briefly, calcium nitrate tetrahydrate [Ca(NO3).4H2O, Vaz Pereira-
Portugal, Sintra, Portugal], diammonium hydrogen phosphate [(NH4)2HPO4, Vaz 
Pereira-Portugal, Sintra, Portugal], magnesium nitrate hexahydrate 
[Mg(NO3)2.6H2O, Merck, Darmstadt, Germany] and strontium nitrate [Sr(NO3), 
Riedel-de-Haen, Seelze, Germany] were used as starting chemical precursors, 
respectively for calcium, phosphorus, magnesium and strontium. The precipitates 
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were filtrated, dried at 110ºC and then heat treated at 1500ºC to convert them 
mostly into α-TCP. 
The calcined cakes were milled and passed through a 36 µm sieve and then used 
as starting CPC powders. Particle size distributions of the powders were 
determined using a light scattering instrument (Coulter LS 230, UK, Fraunhofer 
optical model). The particle morphology of the powders was obtained using a 
scanning electron microscope (SEM) (Hitachi S4100, Tokyo, Japan).  
Cement pastes were prepared by mixing different proportions of the starting CPC 
powders with an aqueous solution consisting of 20 wt.% citric acid (Sigma) + 10 
wt.% poly(ethylene glycol) (PEG) (200, Sigma) + 0.5 wt.% hydroxyl propyl 
methylcellulose (HPMC) (3.5-5.6 mPa s at 2% by mass in water, Sigma) in order 
to get liquid-to-powder ratios (LPR) of 0.34, 0.35, 0.36 and 0.38 mL g-1.  
These cements will be hereafter designated as Mg-BC and Sr-BC, respectively for 
Mg- and Sr-substituted cements. For comparison purposes and a better 
understanding of the effects of Mg and Sr on injectability of substituted cement 
pastes, pure α-TCP cement was also prepared and used as reference (Ref-BC). 
2.2. X-ray diffraction and structural analysis by the Rietveld refinement 
method 
Identification of the crystalline phases formed upon hydration of cement pastes 
was performed by X-ray diffraction (XRD) using a high-resolution SIEMENS 
D5000 with SolX detector. Data sets were collected from 2θ = 10-50º with a step 
size of 0.02º, with CuKα radiation. The phase composition of the samples was 
calculated on the basis of XRD patterns by means of Rietveld analysis with 
TOPAS 3.0 software (Bruker AXS, Germany). Rietveld refinement was performed 
using the structural models (ICSD Database) of all phases listed in Table 1. 
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Table 1: ICSD-Data used for Rietveld refinement and phase quantification 
 Structural model 
Phase ICSD code Authors 
α-TCP (tricalcium phosphate) 
β-TCP 
923 
97500 
Mathew et al. [37] 
Yashima et al. [38] 
Brushite (DCPD) 16132 Curry et al. [39] 
2.3. Rheological measurements 
Rheological measurements of the cement pastes were carried out with a rotational 
controlled-stress rheometer (Bohlin C-VOR 150, Bohlin Ltd., Gloucestershire, UK) 
equipped with a 4º / 40 mm cone-and-plate sensor system. Viscosity 
measurements were performed in the shear rates range of about 0.1 - 100 s-1. For 
each test, 2 g of powder was mixed with the setting liquid at LPR = 0.35 mL g-1, for 
1 min to form a homogeneous paste at room temperature. The rheological 
measurement started 1 minute after mixing in order to assure the same rheological 
history during the preparation of all the cement pastes.  
2.4. Setting times 
The initial setting time of the cement pastes was determined using Vicat needle 
technique according to the ASTM C 187-98. One minute after placing the pastes 
into a glass plate stored at 37ºC in 100% humidity box, the indenter (100 g in 
mass, 1 mm diameter of the needle) was lowered vertically onto the surface of the 
cement. The indentation was repeated at intervals of 30 s until no more 
penetration was possible. The time at this point was taken as the initial setting 
time. 
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2.5. Injectability testing 
The injectability tests were carried out with a 10 mL syringe (15 mm diameter and 
80 mm in length) fitted with a cannula of 2.2 mm inner diameter and 91 mm in 
length, according to a procedure described in previous studies [9,14,40]. The 
paste (5 g of powder + the required amount of liquid) was hand-mixed for 1 min 
and then placed into the syringe. The syringe was placed between the 
compression plates of a testing machine (Shimadzu Autograph, Trapezium 2, 
Japan) using a home made apparatus fixture. The cement pastes were extruded 
at a crosshead speed of 15 mm min-1 up to a maximum load of 100 N. The 
evolution of the extrusion force was recorded against the extruding time and the 
percentage of extruded paste was determined as the mass of the paste that could 
be expelled from the syringe divided by the original mass of the paste inside the 
syringe [14,40]. For each experimental set of conditions, injectability 
measurements were repeated three times and the average values calculated.  
In order to evaluate the eventual occurrence of filter-pressing effects whenever the 
pastes could not be totally extruded, both the extruded pastes and the pastes 
remaining in the syringe were examined for the LPR. For that, the weights of the 
pastes before and after complete drying at 120ºC for 24 h were measured. 
2.6. Mechanical testing  
Cement pastes were cast into PTFE-moulds (Φ 6 × 12 mm deep) and stored for 24 
h in a 100% humidity box at 37ºC. The cement specimens were then removed 
from the moulds and immersed in PBS solution at 37ºC for additional 6 h, 24 h and 
48 h. The compressive strength measurements were done using a universal 
materials testing machine (Shimadzu Autograph, Trapezium 2, Japan) at a 
crosshead displacement rate of 1 mm min-1. Results of compressive strength are 
expressed as the mean ± standard error of the mean of triplicate determinations.  
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2.7 Statistical analysis  
Statistical analysis of injectability and mechanical strength data was performed 
using the SPSS 16.0 software. Comparative studies of means were performed 
using one-way ANOVA followed by a post hoc test (Fisher projected least-
significant difference) with a statistical confidence coefficient of 95%; therefore, p
values < 0.05 were considered significant. 
3. Results 
Particle diameter distributions of the starting CPC powders after milling and 
sieving are depicted in Fig. 1. All size distribution curves are essentially 
monomodal with average particle diameters, D50, of 17.32 µm, 10.78 µm, 15.97 
µm, for Ref-BC, Sr-BC and Mg-BC powders, respectively. Minor populations 
centred at about 2 µm are also apparent, being somewhat more intense in the 
case of Sr-BC powder.  
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Fig. 1: Particle size distributions of the starting CPC powders after milling. 
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Fig. 2 presents the XRD diffraction patterns of the powdered hardened undoped 
and Mg- or Sr-substituted cements after 2 days of hydration. All the hydrated 
cements consist mostly of α-TCP, and brushite as a minor crystalline phase. The 
presence of β-TCP is noted only in the case of Mg-substituted cement.  
Quantitative Rietveld XRD analyses of phases on the starting powders and formed 
upon hydration for 2 days are presented in Table 2. The reported data confirm that 
the starting powders are mostly constituted by α-TCP for Ref-BC and Sr-BC 
cements, while for Mg-BC it consists of a mixture of α-TCP as the main phase and 
β-TCP as minor phase. The hydrated cements consist predominantly of α-TCP 
and a fraction of brushite, with an additional β-TCP phase in the case of Mg-BC. 
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Fig. 2:  XRD patterns of cements prepared from a mixing liquid with 0.5 wt.% HPMC + 10 
wt.% PEG + 20 wt.% citric acid, after 2 days of hydration. α-TCP (Ca3(PO4)2, JCPDS PDF 
File # 29-359), Brushite (JCPDS PDF File # 9-0077) and β-TCP (β-Ca3(PO4)2, JCPDS 
PDF File # 1-70-682); full scale intensity = 6,000 cps.  
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Table 2: Rietveld refinement phase analysis of the starting powders and of the cements 
hydrated for 2 days 
Composition (%) 
Ref-BC Sr-BC Mg-BC 
Phases Powder Hydrated Powder Hydrated Powder Hydrated 
α-TCP 100.0 77.5 100.0 77.3 84.6 71.8 
Brushite - 22.5 - 22.7 - 22.8 
β-TCP - - - - 15.4 5.4 
The flow curves of the cement pastes with a LPR = 0.35 are presented in Fig. 3. 
All of them exhibit similar shear-thinning character. Although very close to each 
other, if ordered by decreasing viscosity at given shear rates, the curves appear as 
Sr-BC > Ref-BC > Mg-BC. Accordingly, the initial setting times of the cement 
pastes tended to increase in the same order: 5 ± 0.5 min for Ref-BC, 7 ± 0.5 min 
for Sr-BC and 10.0± 0.5 min for Mg-BC (p<0.05). 
  
Fig. 3: Viscosity versus shear rate curves of the cement pastes prepared with LPR of 0.35 
mL g-1. 
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The forces required for extruding the pastes as a function of syringe plunger 
displacement are shown in Fig. 4 for two different LPR values of 0.34 and 0.38 mL 
g-1. It can be seen that for LPR = 0.34 mL g-1 the extrusion force soon exceeded 
the pre-set maximum force after 4.3-5.1 mm of plunger travel. The higher 
extrusion forces demanded for the lower LPR hindered full injection under the set 
conditions, although higher extrusion forces could be exerted even by hand 
injection. For the LPR = 0.38 mL g-1, the extrusion curves present a relatively long 
plateau followed by a fast increase. All the extrusion curves present similar 
behaviors with the shortest and the longest extrusion plateaux being observed for 
the Sr-, and the Mg-substituted cement pastes, respectively, with the Ref-BC 
cement paste in an intermediate position. The observed trends denote different 
reactivities of the starting cement powders (p<0.05) towards the setting liquid. 
None of the cements presented the filter-pressing effect during extrusion from the 
syringe.  
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Fig. 4: Extrusion force versus syringe plunger displacement for cement pastes prepared 
with LPR of 0.34 mL g-1 (continuous lines) and of 0.38 mL g-1 (dashed lines).  
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Fig. 5 plots the dependence of the injectability of the cement pastes versus LPR in 
the range 0.34-0.38 mL g-1, 1.5 min after starting mixing the powder with the
setting liquid. It can be seen that the injectability increased with increasing LPR, 
due to the concomitant decrease of the viscosity of the pastes. Nearly full 
injectable pastes were obtained for LPR ≥ 0.38 mL g-1. It is also observed that the 
composition of the starting powders influences the injectability. Mg-BC is the 
easiest injectable composition, probably due to the presence of some remaining β-
TCP phase, which has a much longer handling time, and to the specific role of Mg 
in delaying the setting process [36]. 
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Fig. 5: Injectability of the cement pastes as function of LPR, 1.5 min after starting mixing 
the powder with the setting liquid.
The wet compressive strength values of the cements hardened for 24 h and kept 
under wet conditions for further 6 h, 24 h and 48 h, before performing the 
measurements, are shown in Fig. 6. As expected, the compressive strength 
decreased with an increase of immersion time in PBS solution, due to a gradual 
structural degradation process (p < 0.05). It can be observed that Sr-BC cement 
specimens exhibit the highest compressive strength values, followed by Ref-BC 
cements (p ≅ 0.009), and by Mg-BC cements (p ≅ 0.012). This can be probably 
due to the presence of β-TCP phase in Mg-BC.  
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Fig. 6: Compressive strength values measured for the wet cements hydrated for 24 h and 
kept under wet conditions for further 6 h, 24 h and 48 h. The pastes were prepared with 
0.5 wt.% HPMC + 10 wt.% PEG + 20 wt.% citric acid (LPR = 0.38 mLg-1).  
4. Discussion 
Improving the less performing aspects of CPCs requires lowering the LPR values 
while keeping suitable flow properties. These requirements are not easy to 
conciliate, especially in reacting systems as cement pastes are. It has been shown 
that in non-reacting aqueous systems low viscosity suspensions of calcium 
phosphate powders containing unusual high solids loading (60 vol.%) could be 
easily prepared [41]. This solids loading corresponds to a LPR of 0.21 mL g-1, 
much lower than those used in injectable CPC [7]. Therefore, the key to formulate 
strong injectable CPC is to decrease LPR while keeping a relatively low viscosity. 
This strategy to enhance the mechanical properties leads to a decrease of the 
cement porosity, which in turn will reduce the resorption kinetics. But this 
drawback can be coped using brushite-based CPC like the ones proposed in the 
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present work, which have a faster resorption than apatite CPC [4,36,42]. 
Injectability of CPC pastes is strongly dependent on their flow properties, which, in 
turn, depend on a number of factors including particle/agglomerate size and 
particle/agglomerate size distributions, the nature of the phases present 
(amorphous or crystalline), the liquid-to-powder ratio (LPR), and the presence of 
rheological modifiers. Injectability, the ability of the cement pastes to be extruded 
through relatively fine nozzles, requires a shear thinning behaviour. The presence 
of particle agglomerates with an open structure and sweeping large areas when 
the system flows tends to confer a shear thickening behaviour to the cement 
pastes, which, in turn, is the direct cause of the filter-pressing effect often 
observed in CPC pastes. Considering that the time allowed for mixing the starting 
CPC powders and setting liquid is short and that hand mixing is unsuitable for 
destroying particle agglomerates, it is essential that the starting powders have 
been already deagglomerated and possess a relatively wide particle size 
distribution [43]. This was the reason why the powders were milled / 
deagglomerated and passed through a 36 µm sieve before being used to prepare 
the cement pastes. This procedure, and probably the use of HPMC as gelling 
agent, fully prevented the filter-pressing phenomenon during extrusion from the 
syringe for all cement pastes.  
The shear-thinning character revealed in Fig. 3 (LPR = 0.35) was typical of cement 
pastes with other LPR values. This type of rheological behaviour with viscosity 
decreasing as shear rate increases is very suitable for injection through narrow 
nozzles.  
In order to check if the shear rate range adopted could well represent the 
injectability conditions, the maximum shear rate, τw, at the cannula wall was 
estimated based on the Hagen-Poisseuille equation for steady laminar flow [44]. 
The following holds for the maximum shear rate τw at the pipe wall:  
3
4
R
V
w pi
τ
ɺ
=
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Where Vɺ is the volume flow rate [m3 s-1], and R is the inside diameter of the 
capillary [m]. The conditions set for injectability tests correspond to a volume flow 
rate of about 44.2×10-9 m3 s-1 and a maximum shear rate at the inner cannula wall
of about 16.6 s-1. Therefore, the shear rate range used to access the flow 
behaviour covers all the possible values for this inner diameter (2.2 mm) of the 
cannula even if the volume flow rate was increased by 6 times. 
The plots of extrusion force as a function of syringe plunger displacement shown 
in Fig. 4 reveal the dependence of extrusion force on the LPR as shown by several 
previous studies [4,7,21,23,26]. It is worthy noting that all the extrusion curves 
presented in Fig. 4 are smoother that those reported for similar LPR values but 
non-reacting systems. Such roughness was probably due to the presence of 
particles agglomerates, although their destruction would be easier in a non-
reacting system [14]. 
Concerning the effects of ionic substitutions, the sets of extrusion curves 
presented in Fig. 4 show the same order: the Sr-BC is always shortest and the 
Mg-BC is the longest. This means that Sr enhances the reactivity of the cement 
pastes, while Mg tends to delay the setting process of α-TCP based cements. The 
remaining β-TCP phase in the starting powder of this cement, which has a much 
longer handling time, is also expected to improve the injectability. This is according 
to what has been reported earlier for the influence of Sr-substituted and Mg-
substituted cements [35,45]. Lilley et al. [34] showed a strong effect of Mg on 
setting kinetics and on the characteristics of hardened cements namely, a 
decreasing rate of hydration, an increased proportion of brushite formed upon 
setting, and a decrease in compressive strength. Mg has been also reported to 
have a stabilizing role of non-crystalline CaPs, preventing crystallization into other 
more stable CaP phases [46], in good agreement with an observed decrease of 
the hydrolysis extent of brushite [34]. Bone restoration studies made in rats 
showed that using CPC doped with low doses of Sr increased the number of bone 
forming sites and vertebral bone volume, while no adverse effects could be 
observed on mineral profile, bone mineral chemistry or bone matrix mineralization 
[47]. Saint-Jean et al. [48] reported comparable bioactivities for hardened Sr-
containing apatite cements and calcium deficient hydroxyapatite. 
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The injectability results plotted in Fig. 5 are in good agreement with the extrusion 
curves shown in Fig. 4 and with data reported in previous studies [49]. For LPR 
values up to 0.36 mL g-1, the percentage of injectability is always higher for the 
case of Mg-BC and lower for Sr-BC. For LPR > 0.36 mL g-1 all the pastes could be 
fully injected under the relatively low applied forces set in the present work. 
The measured wet compressive strength values (~17-25 MPa) of the cements are 
in the upper limit of range of 1-25 MPa for compressive strengths reported in 
literature for brushite-forming cements [6] as well as in the range for cancellous 
bone (10-30 MPa) [50].  The results show that Sr-containing cement specimens 
exhibit higher compressive strength values in comparison to undoped Ref-BC 
followed by Mg-BC cement, probably due to the lower content of brushite phase 
present in Sr-BC (pure brushite cements are characterized by their low mechanical 
strength). Citric acid has likely diffused out slowly during soaking in PBS, thus 
leading to a weaker structure. This helps explaining the decrease of compressive 
strength with immersion time.  
5. Conclusions
The present study showed that the obtained Mg- and Sr-substituted α-TCP 
cement pastes exhibited general good injectability characteristics even under a 
moderate maximum applied force of 100 N, which revealed to be dependent on 
the cement composition and on the LPR. Practically full injectable cement pastes 
were obtained for LPR ≥ 0.36 mL g-1. The wet compressive strength of the 
hardened cements specimens is fairy high. Even the lower compressive strength 
values corresponding to the higher LPR used in the present work 0.38 mL g-1 are 
comparable to that of trabecular bone. These results shown that the brushite-
forming α-TCP bone cements developed in the present work, especially the Sr-
substituted one, hold an interesting promise for uses in trauma surgery such as for 
filling bone defects and in minimally invasive techniques such as percutaneous 
vertebroplasty to fill the lesions and to strengthen the osteoporotic bone. 
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3 In vitro and in vivo behaviour of brushite-forming 
calcium phosphate cements doped with Sr and Zn 
Biocompatibility, resorption and replacement of bone substitutes are required for 
good fracture repair. Therefore, the evaluation of cytotoxicity, resorption and new 
bone formation of the brushite-forming CPCs in a body environment were studied 
in vitro (using MG63 and MC3T3-E1 cell lines) and in vivo by injecting pastes of 
the cements studied in paper 3.1 and 3.2 into trabecular bone defects in a pig 
model. 
Zn and Sr are essential trace elements with stimulatory effects on bone formation 
having a direct specific proliferative effect on osteoblastic cells in vitro, hence the 
effects of Zn and Sr incorporation into the structure of starting powders on the 
properties with of the CPCs were also evaluated. 
139
3.1 In vitro performance assessment of new brushite-
forming Zn- and ZnSr-substituted β-TCP bone cements 
S. Pina1*, S.I. Vieira2*, P.M.C. Torres1, F. Goetz-Neunhoeffer3, J. Neubauer3, O.A.B. da 
Cruz e Silva2, E.F. da Cruz e Silva4, J.M.F. Ferreira1
1University of Aveiro, Dept. of Ceramics and Glass Engineering, CICECO, 3810-193 Aveiro, 
Portugal 
2University of Aveiro, Health Sciences Dept., Centro de Biologia Celular, 3810-193 Aveiro, Portugal 
3Mineralogy, University of Erlangen-Nuremberg, 91054 Erlangen, Germany 
4University of Aveiro, Dept. of Biology, Centro de Biologia Celular, 3810-193 Aveiro, Portugal 
*Both authors contributed equally to this work 
Submitted to J Biomed Mater Res, Part B: Applied Biomaterials 
Abstract 
The present study investigated the in vitro performance of brushite-forming Zn- 
and ZnSr-substituted β-TCP cements bone cements in terms of wet mechanical 
strength and biological response. Quantitative phase analysis and structural 
refinement of the powdered samples were performed by X-ray powder diffraction 
and Rietveld refinement technique. Initial and final setting times of the cement 
pastes, measured using Gilmore needles technique, showed that ZnSrCPC sets 
faster than ZnCPC. The measured values of the wet strength after 48 h of 
immersion in PBS solution at 37ºC showed that ZnSrCPC cements are stronger 
than ZnCPC cements. Human osteosarcoma derived MG63 cell line proved the 
non-toxicity of the cement powders, using the resazurin metabolic assay.  
Keywords:  Zinc; Strontium; Brushite Cement; Setting time, Mechanical strength, 
Cytotoxicity 
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1. Introduction 
During the last three decades, there has been a growing interest in calcium 
phosphate cements (CPC). CPC are excellent bone substitutes due to their good 
biocompatibility, excellent bioactivity, self-setting characteristics, low setting 
temperature, adequate stiffness, and easy shaping for any complicated geometry 
[1-9].  
According to the end-product of the setting reaction, hydraulic CPCs can be 
classified into apatite (AP) cements and brushite (dicalcium phosphate dihydrate, 
DCPD) cements [10, 11]. Recently, brushite cements have been considered with 
increasing enthusiasm because brushite is metastable in physiological conditions 
and can be resorbed in vivo much faster than AP cements [12, 13].  
The biocompatibility of brushite based cements has been tested in various in vitro
experimental applications and in vivo [12-16]. The results showed that brushite 
cements are generally well tolerated by the bone and soft tissue environment in 
vivo, such that cement resorption was closely followed by new bone formation.  
In recent years, ionic substitutions in calcium phosphate ceramics, such as 
strontium (Sr) and zinc (Zn), have been the subject of massive interest owing to 
the critical roles these ions play in the biological process after implantation [16-23]. 
Zn is an essential trace element with stimulatory effects on bone formation, having 
a direct specific proliferative effect on osteoblastic cells in vitro and thought to 
possess a potent and selective inhibitory effect on osteoclastic bone resorption in 
vivo [16, 22]. The Zn2+ ion is involved in many metallo-enzymes and proteins 
including alkaline phosphatase (ALP). Sr increases osteoclast apoptosis and 
enhances preosteoblastic cell proliferation and collagen synthesis [23]. 
Consequently, Sr ions depress bone resorption and maintain bone formation. 
Therefore, Sr- and/or Zn-substituted CaPs are expected to produce enhanced 
biological and chemical responses in the body.  
Among various calcium phosphate phases, β-TCP is greatly biocompatible and 
resorbable in bone tissue. Furthermore, β-TCP is an adequate Zn carrier with low 
release rate. For example, Ito et al. [24] found that a slow Zn2+ release from a 
biphasic ZnTCP/AP ceramics containing Zn doped β-TCP implanted in rabbit 
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femora stimulated bone formation. Based on a histological and 
histomorphometrical study using femora of rabbits, Kawamura et al. [25] reported 
that 51% of new bone has grown around ZnTCP/AP implants. 
The present study investigated the setting times, compressive and diametral 
tensile strengths, and the cytotoxicity for osteoblast-like cells (MG63 cell line) in in 
vitro culture of new brushite-forming Zn- and ZnSr-substituted β-TCP cements. 
The release of Zn and Sr ions from the cements into distilled water and the in vitro
bioactivity tests through immersion in SBF were also determined. 
2. Materials and Methods 
2.1. Cements preparation 
Brushite cement pastes were produced by mixing 55 wt.% of Zn- or ZnSr-
substituted β-tricalcium phosphate (β-TCP) powder with 45 wt.% of monocalcium 
phosphate monohydrate (MCPM, Sigma-Aldrich, Germany) using liquid-to-powder 
ratio (LPR) of 0.34 mL g-1. According to a previous study of the same authors [26], 
a LPR of 0.34 mL g-1 yielded an optimal balance between the rheological and 
setting behaviors. The mixing liquid used was 10 wt.% poly(ethylene glycol) (PEG) 
(200, Sigma) + 15 wt.% citric acid solution. The cements setting occurs via the 
reaction as follows:  
β-Ca3(PO4)2 + Ca(H2PO4)2.H2O + 7H2O → 4CaHPO4.2H2O 
Zn- and ZnSr-substituted β-TCP powders were synthesized by aqueous 
precipitation as described in detail in previous reports [27-29]. The precipitates 
were vacuum filtrated, dried at 110ºC, heat treated for 2 h at 1100ºC and grounded 
under dry conditions in a planetary mill. The powders containing Zn, or Zn + Sr 
were designated, respectively, as ZnCPC and ZnSrCPC. The milled powders were 
passed through a sieve with a mesh size of 36 µm and the separated fine fractions 
of the ZnCPC and ZnSrCPC powders had an average particle size of 1.37 and 
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1.53 µm, respectively, measured using a light scattering instrument (Coulter LS 
230, UK, Fraunhofer optical model). 
2.2. XRD and Rietveld refinement evaluation  
The incorporation of doping elements into the β-TCP structure was assessed by 
Rietveld refinement studies. The X-ray diffraction (XRD) analysis of the powders 
was performed with a SIEMENS D5000 equipped with a diffracted beam graphite 
monochromator and the XRD of the hardened cements was recorded with a 
SIEMENS D5000 with SolX detector. Data sets were collected from 2θ = 10-70º 
with a step size of 0.02º and counting time of 6 s with CuKα radiation. XRD 
measurements for all the investigated compositions were performed by preparing 
and measuring them three times independently. The phase composition of the 
samples was calculated on the basis of XRD patterns by means of Rietveld 
analysis with TOPAS 3.0 software (Bruker AXS, Germany). Rietveld refinement of 
the starting β-TCP powders and of the hydrated cements was performed using the 
structural models (ICSD Database) of all phases listed in Table 1. Refined 
parameters were scale factor, sample displacement, background as Chebyshev 
polynomial of fifth order, crystallite size and lattice parameters. All parameters 
were refined simultaneously.  
Table 1: ICSD-Data used for Rietveld refinement and quantification 
 Structural model 
Phase ICSD code Authors 
β-TCP (tricalcium phosphate) 97500 Yashima et al. [30] 
Brushite (DCPD) 16132 Curry et al. [31] 
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2.3. Determination of setting times  
The setting times of the cements were assessed using an automated Gilmore 
needle apparatus (imeter, MSB Breitwieser, Augsburg, Germany). To test the 
setting time, a freshly prepared cement paste was automatically lifted against a 
needle weighing 212 g with a diameter of 0.692 mm connected to an analytical 
balance. For each indentation the weight reduction of the needle and the 
corresponding penetration depth was recorded. From these values the so-called 
“imeter-hardness” was calculated from the relation strength per penetration depth 
standardized by the diameter of the used needle [32]. The indentation was 
repeated at intervals of 30 s until the cement was completely set. Applying the 
dimensions and weights of the needles given in ASTM C266 the values for the 
static pressure acting on the specimen at the initial and final setting time were 
calculated. In accordance with the standard the initial and final setting times are 
defined when the light and the heavy needles, respectively, failed to make an 
appreciable indentation. A depth of 0.08 mm of the resulting, barely visible 
indentation, leads to an ‘imeter-hardness’ of 3.94 MPa mm-1 or 63.0 MPa mm-1
matching the criteria for the initial or final setting times. Therefore, initial and final 
setting times were obtained when these characteristic values were reached in the 
course of the measurement. The setting times of the cements were measured at 
37ºC and >60% humidity. Each measurement was performed three times and the 
average value was calculated. 
2.4. Mechanical testing  
The mechanical strengths of the cements were evaluated in terms of compressive 
strength (CS) and of diametral tensile strength (DTS), as illustrated in previous 
reports [33,34]. Therefore, for CS and DTS measurements, the cement pastes 
were cast into PTFE cylindrical moulds (Ø 6 x 12 mm3) and (Ø 6 x 3 mm3), 
respectively, and stored in a 37ºC, 100% humidity box for 24 h. The cement 
specimens were then removed from the moulds and immersed in PBS solution 
(1.37 M NaCl, 27 mM KCl, 80.6 mM Na2HPO4, 19.4 mM KH2PO4) at 37ºC for 
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further 48 h. The specimens were loaded to failure at a crosshead displacement 
rate of 1 mm min-1 and 10 mm min-1, for CS and DTS, respectively, using a 
universal materials testing machine (Shimadzu Autograph, Trapezium 2, Japan). 
For DTS tests, the samples were compressed diametrically and DTS (MPa) was 
calculated by 
ld
FMax
××pi
2
, where =d diameter, =l length and MaxF  is the failure load. 
Results of CS and DTS are expressed as the mean ± standard error of the mean 
of triplicate determinations. 
2.5. Release of ionic species from cements  
The chemical compositions of the starting ZnCPC and ZnSrCPC powders and of 
the cylindrical (Ø 6 x 3 mm3) cement samples (hardened for 5 days) after 
immersing for 1, 3 and 7 days into 5 mL of SBF at 37ºC under constant stirring (75 
rpm), as well as, the amounts of Zn2+, Sr2+ and Ca2+ released from ZnCPC and 
ZnSrCPC cements were determined by ICP spectroscopy (Model 70 Plus, Jobin 
Yvon, France). 
2.6. Mineralization tests in SBF 
The cement samples were left setting in PTFE-moulds (∅ 6 × 12 mm3) in a 37ºC, 
100% humidity box, for 24 h. In order to evaluate the biomineralization activity of 
the cements in vitro before cell cultures, the set cements were immersed for 30 
days into polystyrene flasks containing simulated body fluid (SBF) with ionic 
concentrations (Na+ 142.0, K+ 5.0, Ca2+ 2.5, Mg2+ 1.5, Cl- 148.8, HPO4- 1.0, 
HCO32- 4.2, SO42- 0.5 mM L-1) nearly equivalent to those of human blood plasma 
[35] and continuously shaken at a rate of 75 rpm, at 37ºC. Then, the samples were 
washed with distilled water and allowed to dry at 37ºC for 1 day and analyzed by 
means of Scanning Electron Microscopy (SEM) (Hitachi S4100, Tokyo, Japan) 
and elemental chemical analysis by EDS (Rontec EDS System). 
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2.7. Cytotoxicity assays using MG63 cells 
The powdered cements were sterilized by γ-radiation prior testing them in cell 
cultures. The human osteosarcoma derived MG63 cell line (ATCC CRL-1427) was 
used to determine the cement powders cytotoxicity through the resazurin 
metabolism assay [36]. MG63 cells were maintained at 37ºC in a humidified 
atmosphere of 5% CO2 in air, in Eagle’s Minimum Medium in EBSS (Eagle’s
Balanced Salt Solution) supplemented with 1% NEAA and 2 mM L-Glutamine 
(Gibco BRL, Invitrogen), supplemented with 10% (v/v) fetal bovine serum (FBS, 
Gibco BRL, Invitrogen), 1% (v/v) of a 100 U mL-1 penicillin and 100 mg mL-1
streptomycin solution (Gibco BRL, Invitrogen) and 3.7 g L-1 NaHCO3. First, the 
sensitivity and the range of linearity between resazurin reduction to resorufin and 
the density of MG63 viable cells were determined in a cell curve assay. Cells were 
seeded in 35 mm plates at 1 x 103 cells cm-2.  For 11 days, each 24 h growth 
medium was removed by aspiration and replaced with fresh medium containing 
10% of a resazurin (Sigma Aldrich) solution (0.1 mg mL-1 resazurin in PBS [Pierce, 
Perbio]). Cells were further incubated for 4 h at 37ºC in the dark and resazurin 
reduction was measured spectrophotometrically (Cary 50 BIO, Varian) at 570 and 
600 nm. Cells were subsequently ressuspended with 0.25% trypsin/EDTA (Gibco 
BRL, Invitrogen) and the number of viable cells determined using a 0.4% solution 
of the Trypan blue dye (Sigma Aldrich) and a hemocytometer. For each day, a 
final resazurin value (O.D.F) was calculated as the ratio O.D. 570/O.D. 600 nm 
minus the O.D. 570/O.D. 600 nm ratio of a negative control (resazurin media 
incubated for 4 h in the absence of cells) and the O.D.
 F was plotted against cells 
density. 
To determine cell viability when exposed to the cement powders, cells were 
seeded at 1 x 104 cells cm-2 onto 35 mm plates, and cultured in cell media 
supplemented with 0, 0.01, 0.1 or 1 mg mL-1 of ZnCPC or ZnSrCPC cement 
powders. This range of cement concentrations were chosen as 1 mg mL-1 already 
resulted in a saturated solution. Following 24 h, 48 h and 72 h of incubation at 
37°C in a humidified 5% CO 2 and 95% air atmosphere, growth medium was 
removed by aspiration and replaced with fresh medium containing 10% of the 0.1 
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mg mL-1 resazurin solution. After 4 h incubation as described above, 1 mL of the 
medium was collected and cell viability was determined by measuring O.D. at 570 
and 600 nm. For each time point, the O.D.F levels of cells incubated with 0 mg mL-
1
 cement powder were taken as 100% and cell viability calculated as a percentage 
of these control values. All experiments were carried out in triplicate and 
expressed as the mean ± standard error of the mean.
2.8. Statistical analyses 
Statistical analyses were performed for setting times, CS and DTS measurements 
and cell viability tests using the SPSS 16.0 software. Comparative studies of 
means were performed using one-way ANOVA followed by a post hoc test (Fisher 
projected least-significant difference) with a statistical confidence coefficient of 
0.95; therefore, p values < 0.05 were considered significant.  
3. Results 
The evolution of crystalline phases of the cements hydrated for 2 days with Sr 
and/or Zn incorporation is presented in Fig. 2.  
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Fig. 2: XRD patterns of the ZnTCP and ZnSrTCP cements after 2 days of hydration. 
Brushite (JCPDS PDF File # 9-0077) and β-TCP (Ca3(PO4)2, JCPDS PDF File # 1-70-
682), full scale intensity = 6,000 cps. 
It can be seen that the main product of the setting reaction in both cements is 
brushite, with some remaining β−TCP phase. The quantitative Rietveld analysis of 
XRD patterns confirmed that the starting powders consisted of 100% of β−TCP 
phase, while the cements contained around 90% of brushite and about 10% of 
β−TCP. Table 2 shows the lattice parameters of the β−TCP of the starting powders 
and of the brushite phase determined in the cements after 2 days of hydration. It 
can be seen that the lattice parameters of β−TCP phase decreased with the 
incorporation of Zn and Zn+Sr ions in the crystal structure. The decrease is more 
accentuated in the Zn-substituted β−TCP. Table 2 also shows that the lattice 
parameters of the formed brushite crystals were not noticeably affected by the 
incorporation of Sr or Zn, although an unexpected slightly increasing trend is 
apparent. 
148
Table 2: Lattice parameters of β-TCP in the starting powders and of brushite phase in the 
hardened cements after 2 days of hydration 
Lattice parameters (Å) 
β-TCP (starting 
powder) Brushite (hydrated cement) 
Samples a c a b c β 
Pure phase 10.435 37.409 5.812 15.180 6.239 116.43 
ZnCPC 10.413 37.337 5.816 15.193 6.246 116.38 
ZnSrCPC 10.428 37.372 5.822 15.206 6.252 116.38 
Setting times and wet mechanical, CS and DTS, results are presented in Table 3. 
The presence of Sr in the cement ZnSrCPC led to a faster setting in comparison to 
the ZnCPC cement. 
The measured values of the wet strengths, CS and DTS, after 48 h immersion in 
PBS solution at 37ºC show that the tensile strength is around 5 times lower than 
compressive strength, in good agreement with other findings reported elsewhere 
[34]. Besides, ZnSrCPC cement exhibit higher CS and DTS values, in comparison 
to ZnCPC cements (p<0.05). 
Table 3: Setting time and wet mechanical strengths, after 48 h, of the cements 
Setting time  
(min) 
IST FST 
Compressive 
strength (CS) 
(MPa) 
Diametral tensile 
strength (DTS) 
(MPa) 
ZnCPC 13.2 ± 0.4 23.9 ± 0.3 16.3 ± 0.5 3.4 ± 0.4 
ZnSrCPC 11.1 ± 0.3 20.8 ± 0.2 18.2 ± 0.5 3.7 ± 0.5 
The chemical composition of the starting ZnCPC and ZnSrCPC powders and of 
the hardened cements as determined by ICP spectroscopy indicated the following 
concentrations: 2.43 mol.% Zn2+ and 97.57 mol.% Ca2+ for the starting ZnCPC 
sample, and  2.33 mol.% Zn2+, 2.12 mol.% Sr2+ and 95.55 mol.% Ca2+ for the 
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starting ZnSrCPC  sample, which are close to the planned ones of 2.22 mol% Zn 
and 2.22 mol% Sr respectively. The concentrations of Zn and Sr released from the 
hardened cements after the leaching experiments in distilled water at 37ºC for 1, 3 
and 7 days are plotted in Fig. 2.  
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Fig. 2: Concentration of Zn2+ and Sr2+ released from ZnCPC and ZnSrCPC cements, after 
1, 3 and 7 days of immersion in SBF. 
It can be seen that both cement compositions, ZnCPC and ZnSrCPC show a 
gradual increase of the amounts of Zn2+ and Sr2+ released along the time period of 
immersion in SBF. The results suggest that there seems to be a certain preference 
for the release of Zn2+ in comparison to Sr2+.  
The morphological features of fractured surfaces of hardened ZnCPC and 
ZnSrCPC cements after immersion in SBF for 30 days are shown in Fig. 3. The 
cements show well developed porous spherulites made of intermingling lamellar 
crystals of apatite, as confirmed by EDS (data not shown), due to the conversion 
of brushite into apatite.  
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Fig. 3: Scanning electron micrographs of the ZnCPC and ZnSrCPC cements after 
immersion in SBF solution for 30 days.  
Cell viability of MG63 osteoblastic-like cells cultured on the cement powders and 
under control conditions was evaluated by the non-destructive and non-toxic 
resazurin metabolism assay (Fig. 4). In the resazurin reduction test, viable cells 
reduce this non-toxic blue-colored probe dye to pink resorufin. The usefulness of 
the resazurin assay as a measure of cell proliferation and viability was first tested 
in a MG63 cell proliferation assay (Fig. 4a), and a linear response could be 
observed between 1 and 7 x 104 cells cm-2. Cells were then seeded at 1 x 104 cells 
cm-2 in the presence of different cement powder concentrations and the 
percentage of cell viability determined (Fig. 4b). The levels of resazurin reduction 
by cells seeded with increasing concentrations of both cement powders was 
similar and non-significantly different from control conditions (0 mg mL-1 powder 
cements). Of note, MG63 cell morphology did not show any alterations in the 
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presence of the powders (data not shown). Hence, ZnCPC and ZnSrCPC cements 
were not cytotoxic to MG63 osteoblastic-like cells at the concentrations tested, 
being both viable for further in vivo tests of their physiological properties.   
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Fig. 4: Cell viability assays of MG63 osteoblastic-like cells exposed to ZnTCP and 
ZnSrTCP cement powders: (a) relation between the resazurin assay and MG63 
cellular density, demonstrating a zone of linearity between measured O.D. and cell 
proliferation; and (b) cell viability of cells cultured with increasing concentrations of 
ZnCPC and ZnSrCPC cement powders. 
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4. Discussion 
Bone fractures and diseases such as osteoporosis are common throughout an 
individual’s life and at more advanced ages, and both result in bone breakdown 
and in the need for bone regeneration. Ceramic biomaterials have been shown to 
exhibit osteoconductive properties, and ionic substitution in ceramic biomaterials 
can modify their properties like crystallinity, solubility, and biological performance. 
Among other ions, strontium and zinc are beneficial due to their excellent 
properties on stimulating bone formation, as investigated in the present study after 
their incorporation in a brushite-forming β-TCP. 
Rietveld refinement analyses performed on the cements hydrated for 2 days 
confirmed that no significant changes in the lattice parameters of the newly formed 
brushite phase occurred with the partial replacement of Ca by Zn and Sr (Table 2). 
The incorporation of Sr and Zn ions in the crystal structure of the starting β-TCP 
powders were proved by the resulting changes in the lattice parameters. As a 
matter of fact, the observed variations can be understood considering the ionic 
radii of the relevant elements (Zn = 0.74 Å; Ca = 0.99 Å; Sr= 1.12 Å) [37,38]. 
Therefore, the structure is expected to shrink more when the smaller Zn ion 
replaces Ca. On the other hand, the average size of Zn + Sr [(0.74 Å+1.12 Å)/2 = 
0.93 Å] is somewhat smaller that the size of Ca ion, justifying the smaller decrease 
the lattice parameters. However, the same reasoning does not seem to be 
applicable to the formed brushite phase in which a slightly opposite trend is 
apparent. The different behaviors of these two crystalline phases need to be better 
investigated in the future. 
The setting time of a CPC cement paste is of vital importance since it should not 
harden too fast, to allow molding or injection, nor too slowly, to allow the surgeon 
to close the defect shortly after cement placement. The setting times of brushite 
cements are usually too fast, and for the case of β-TCP + MCPM mixtures, setting 
can occur in a few seconds [39]. The use of additives, such as gelling agents that 
exert a retarding effect, enable to keep the setting reaction under control. 
Accordingly, the obtained initial and final setting times (Table 3) in the present 
study are somewhat higher than the ones reported elsewhere [40], possibly due to 
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the presence of PEG, a gelling agent, that slows down the dissolution of the 
starting powders, and the nucleation and precipitation processes of the resulting 
brushite phase while improving the handling and cohesive properties of the 
cements. Another reason for the longer setting times obtained might be the 
relatively high amount of β-TCP (55%), since β-TCP alone does not cure and 
tends to prevent the crystallization of brushite phase upon hydration. Moreover, 
the presence of Sr in the ZnSrCPC cement led to a faster setting than for the 
ZnCPC cement. This is according to the higher reactivity of brushite-forming 
SrCPC cement in comparison to undoped or Mg-doped β-TCP cements reported 
elsewhere [41]. 
The measured wet mechanical strength values (Table 3) are comprised within the 
ranges reported for brushite (1-24 MPa) [42] and for trabecular bone (10-30 MPa) 
[43]. Besides, the presence of Sr in ZnSrCPC cement led to higher CS and DTS 
values, in comparison to ZnCPC cements (p<0.05). The beneficial effect of Sr on 
the CS has been also reported for brushite forming β-TCP bone cements [44]. 
The observed slow increase of released Zn2+ and Sr2+ along the time of  
immersion in SBF (Fig. 2) of both cement compositions, ZnCPC and ZnSrCPC, is 
not surprising considering that this medium is supersaturated towards HA. The 
present results of in vitro mineralization tests after 30 days of cements immersion 
in SBF showed that Zn ions released from ZnCPC and ZnSrCPC did not inhibit the 
formation and growth of an apatite layer as confirmed by EDS and SEM analysis 
(Fig. 3). It was reported that the release of Zn from Zn-containing TCP was 
partially inhibited by the precipitation of HA on ZnTCP particles during immersion 
in SBF [22]. Therefore, it was suggested that the rates of Zn release in vitro
depend on the solution calcium and phosphate concentrations, meaning that 
ZnTCP is an “intelligent material” with self-release regulating ability [22]. 
Considering that ZnCPC and ZnSrCPC cements were able to release the 
physiological relevant Zn and Sr ions and to transform into apatite under simulated 
physiological conditions, these biomaterials were qualified for in vitro cytotoxicity 
assays using human osteosarcoma derived MG63 cells. The results obtained 
revealed that both ZnCPC and ZnSrCPC cement powders are biocompatible up to 
concentrations reaching saturation in cell media.  
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5. Conclusions 
The results presented and discussed along this work enabled to conclude that Zn 
and Sr elements could effectively replace partially Ca in the structure of starting β-
TCP powders. The observed decreases in the lattice parameters are proportional 
to the size of single or combined substituted ions. The incorporation levels are 
close to the planned ones suggesting the suitability of the method used to prepare 
the powders. The retention of substituted ions in the hardened cements was also 
proved by their slow release in SBF. This feature is promising to grant the 
continuous presence of low concentrations of these ions to play their specific roles 
in osteoporosis and physiological pathways in the regulation of bone apposition 
and resorption in vivo. Further, the presence of zinc and strontium in brushite-
forming cements did not inhibit the convertion into apatite under simulated 
physiological conditions. Moreover, the ZnCPC and ZnSrCPC cements were found 
to be non-toxic to human osteosarcoma-derived MG63 cells. The wet mechanical 
properties of cements are comprised within the ranges reported for brushite and 
for trabecular bone, qualifying them for further in vivo experiments.  
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Abstract 
The core aim of this study was to investigate the in vivo performance of brushite-
forming Zn- and ZnSr-substituted β-TCP cements injected into trabecular bone 
cylindrical defects in pigs.  
In vitro proliferation and differentiation responses of osteoblastic-like cells 
(MC3T3-E1 cell line) to bone cements, at cellular and molecular levels, were also 
studied. Presence of zinc and strontium in brushite-forming cements was found to 
stimulate pre-osteoblastic proliferation, activity and maturation. MC3T3-E1 
osteoblastic-like cells exposed to the powdered cements showed higher 
adhesiveness capacities and higher ALP activity, in comparison with control cells. 
Furthermore, they presented higher Type-I collagen secretion and fiber formation. 
Proliferative and collagen extracellular matrix deposition properties were more 
evident for cells grown in cements doped with Sr. 
 In vivo assays of the ZnCPC and ZnSrCPC osteoconductive properties were 
carried out, using carbonated apatite cement (Norian SRS) as control. There was 
no evidence of adverse foreign body reaction. Histological and histomorphometric 
analyses were performed at 1 and 2 months, after implantation. Results indicate 
that the investigated ZnCPC and ZnSrCPC cements are biocompatible, 
osteoconductive, and good candidate materials to use as bone substitutes. The 
presence of Sr enhanced the rate of new bone formation. The new ZnCPC and 
ZnSrCPC cements revealed better in vivo performance in comparison to the 
control carbonated apatite cement. 
Keywords:  zinc; strontium; brushite cement; proliferation; ALP; cell adhesion; 
Type-I collagen; resorption 
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1. Introduction 
Calcium phosphate cements (CPC) have unique characteristics for bone 
substitution compared with other biomaterials. Their excellence relies on good 
biocompatibility, excellent bioactivity, self-setting characteristic, low setting 
temperature, adequate stiffness, and easy shaping for any complicated geometry 
[1-9]. In addition, CPC have such compositional resemblance to bone mineral that 
they induce a biological response similar to the one generated during bone 
remodelling. Calcium phosphate biomaterials are successfully used in cranio-
maxillofacial, dental, and orthopedic surgery [10-13].  
Among the different biocompatible calcium phosphate (CaP) phases present in 
human bone, brushite (dicalcium phosphate dihydrate, DCPD) has a higher 
solubility than hydroxyapatite (HA) at physiological pH, and an ideal in vivo
resorption rate [14-16]. Brushite based bone cements are generally well tolerated 
by the bone and soft tissue environment in vivo, such that cement resorption is 
closely followed by new bone formation. Furthermore, brushite cements are known 
to be biocompatible, osteoconductive and bioresorbable, having a potential 
interest for bone regeneration procedures. 
From a cellular and molecular perspective, it has been shown that some 
biomaterials are able to directly modify the osteoblastic proliferation rate and some 
of their functions, such as the synthesis of alkaline phosphatase (ALP) [17-19]. 
The ionic composition of such biomaterials is a key factor in their bioactivity, and 
ionic incorporation into TCP structure, such as zinc (Zn) and strontium (Sr) ions, 
have been proved to be traces elements with stimulatory outcomes on bone 
formation, having a direct specific proliferative effect on osteoblastic cells in vitro
and a potent and selective inhibitory effect on osteoclastic bone resorption in vivo
[20, 21]. Moreover, Zn is involved in many metallo-enzymes and proteins, 
including ALP, whereas Sr enhances collagen synthesis and has beneficial effects 
in the treatment of osteoporosis due to the prevention of bone loss by a 
mechanism that depresses bone resorption [22-25]. Osteoblasts are cells found on 
bone surface, being directly responsible for bone formation. As osteoblasts 
differentiate from their precursors they begin to secrete bone matrix proteins, such 
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as Type-I collagen that represents about 90% of the organic matrix. The network 
of Type-I collagen fibres provides the structure on which bone mineral is 
deposited. Type-I collagen and brushite particles are both predominant in fracture 
callus [26, 27], with the main structural framework of a human fracture callus 
consisting of disordered, mineralized collagen fibrils containing CaP crystals. 
Brushite particles are found in the noncollagenous organic matter around 
nonmineralized, ordered collagen fibrils, and it is believed that these particles 
serve as the reservoir of calcium and phosphate ions for subsequent 
mineralization [28].  
There is still little knowledge concerning the in vivo behaviour of brushite-forming 
cements with Zn and Sr co-substituted in β-TCP. The main aim of the present 
study was to examine and compare the in vivo response of two new brushite-
forming Zn and ZnSr-containing CPCs and a commercial apatite CPC, after 
implantation in trabecular bone in pigs. Additionally, the in vitro proliferation and 
differentiation responses of osteoblast-like cells (MC3T3-E1 cell line) to the bone 
cements were studied. Various cellular and molecular responses to the 
biomaterials were assayed, including cell viability determinations by the resazurin 
assay, photometric evaluation of ALP activity after enzymatic cleavage of p-
nitrophenyl phosphate, and time-dependent Type-I collagen production.  
2. Materials and Methods 
2.1. Cement preparation 
Brushite cements were prepared as described in the previous study [29]. Briefly, 
the cement pastes were prepared by mixing 55 wt.% of Zn- or ZnSr-substituted β-
tricalcium phosphate (β-TCP) powder with 45 wt.% of monocalcium phosphate 
monohydrate (MCPM, Sigma-Aldrich, Germany) using liquid-to-powder ratio (LPR) 
of 0.34 mL g-1. The aqueous solution used was 10 wt.% poly(ethylene glycol) 
(PEG) (200, Sigma) + 15 wt.% citric acid solution. 
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Zn- and ZnSr-substituted β-TCP powders were synthesized by aqueous 
precipitation as described in detail in previous reports [30-32]. The precipitates 
were vacuum filtrated, dried at 110ºC, heat treated for 2 h at 1100ºC and grounded 
under dry conditions in a planetary mill, and finally passed through a sieve with a 
mesh size of 36 µm.  
The Zn- and ZnSr-substituted β-TCP cements were designated as ZnCPC and 
ZnSrCPC, respectively.  
2.2. MC3T3-E1 cell culture  
The osteoblastic cell line MC3T3-E1 (ATCC CRL-2593) was maintained at 37ºC in 
a humidified atmosphere of 5% CO2 in air, in 2mM Glutamine-containing Minimum 
Essential α-Medium in EBSS (Eagle’s Balanced Salt Solution) supplemented with 
10% (v/v) fetal bovine serum (FBS), 1% (v/v) of a 100 U mL-1 penicillin and 100 mg 
mL-1 streptomycin solution (Gibco BRL, Invitrogen) and 3.7 g L-1 NaHCO3. Sub-
confluent cultures (80-90% confluency) were splitted 1:5 using a 0.25% 
trypsin/EDTA (Gibco BRL, Invitrogen) solution at 5% CO2, 37ºC.  
2.3. Cytotoxicity and cell proliferation assays in cement blocks and powders 
The resazurin metabolic assay [33] was used to determine the cements 
cytotoxicity/biocompatibility to MC3T3-E1 cells. The sensitivity and the range of 
linearity between resazurin reduction to resorufin and the density of MC3T3-E1 
viable cells were first determined in a cell curve assay, as previously [33]. Briefly, 
cells were seeded in 35 mm plates at 1 x 103 cells cm-2 and, at the indicated time 
points, cells were incubated for 4 h with fresh medium containing 10% of a 
resazurin (Sigma Aldrich) solution (0.1 mg mL-1 resazurin in PBS [Pierce, Perbio]). 
Resazurin reduction was thereafter measured spectrophotometrically (Cary 50 
BIO, Varian) at 570 and 600 nm. The number of viable cells was further counted 
using a 0.4% solution of the Trypan blue dye (Sigma Aldrich) and a 
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hemocytometer. For each day, a final resazurin value (O.D.F) was calculated as 
the ratio O.D. 570/O.D. 600 nm minus the O.D. 570/O.D. 600 nm ratio of a 
negative control (resazurin media incubated for 4 h in the absence of cells), and 
the O.D.
 F was plotted against cells density. 
To determine dose-dependent cell viability and proliferation when exposed to the 
cement powders, 1 x 105 cells were seeded in 35 mm wells (density of 1 x 104
cells cm-2), and cultured in cell media supplemented with 0, 0.01, 0.1 or 1 mg mL-1
of ZnCPC or ZnSrCPC cement powders. This range of cement concentrations 
were chosen as 1 mg mL-1 already resulted in a saturated solution. Following 24 h, 
48 h and 72 h of incubation at 37°C in a humidified  5% CO2 and 95% air 
atmosphere, growth medium was removed by aspiration and replaced with fresh 
medium containing 10% of the 0.1 mg mL-1 resazurin solution. After 4 h of 
incubation, 1 mL of the medium was collected and cell viability was determined by 
measuring O.D. at 570 and 600 nm, as described above. For each time point, the 
O.D.F levels of cells incubated with 0 mg mL-1 cement powder were taken as 100% 
and cell viability calculated as a percentage of these control values. Upon 72 h, 
cells morphology was evaluated by phase contrast (PhC) microscopy in an 
inverted Olympus IX81 epifluorescence microscope, and microphotographs were 
taken at 18ºC with a Digital CCD monochrome camera F-View II (Soft Imaging 
System). 
For the cement blocks assay of cellular viability and proliferation with time in 
culture, ZnCPC and ZnSrCPC blocks (∅ 6 × 3 mm3, set at 37ºC, for 24 h) in 24-
wells were pre-incubated with media for 2 days, after what were washed with 
phosphate buffer saline (PBS) solution. Cells were seeded at 2.5x104 cells cm-2 
onto the surface of the blocks and incubated for 20 days, with media being 
substituted by resazurin-containing media at days 2, 5, 8, 10 and 20. After 4 h of 
incubation, cell viability was determined as described for the powdered samples. 
Cells were re-incubated with fresh media at each experimental day and at day 15 
in culture, between experimental days 10 and 20.  
Prior to cell experiments, cement samples were sterilized by γ-radiation. All 
experiments were carried out in triplicate and expressed as the mean ± standard 
error of the mean.  
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2.4. Determination of alkaline phosphatase (ALP) activity 
MC3T3-E1 cells were seeded at 1 x 104 cells cm-2 in 35 mm wells and cultured on 
1 mg mL-1 ZnCPC and ZnSrCPC powders. At day 3 in culture, achievement of 
cells confluency was visually confirmed. ALP activity of exposed cells was 
evaluated at 0, 1, 3, 6, 14 and 21 days post-confluency (DPC). After removal of 
the culture medium, cells were washed with PBS and harvested in 1 mL universal 
ALP buffer (100 mM citric acid, 100 mM KH2PO4, 100 mM sodium 
tetraborate.10H2O, 100 mM Tris, 100 mM KCl; pH 11) with a disposable cell 
scraper.  
Cells with or without cement were sonicated twice for 20 sec and centrifuged for 5 
min at 2000 rpm at room temperature. The supernatant was used for 
determinating ALP activity following addition of the substrate p-nitrophenyl 
phosphate (Fluka). The production of p-nitrophenol was determined 
spectrophotometrically at 420 nm, after 2 and 5 min of reaction at 37ºC. The ALP 
activity was expressed as the increase in p-nitrophenol aborbance per min per 
microgram of protein (∆OD.min-1.mg-1), upon subtraction of the blank O.D. (1mL 
universal buffer plus substrate). To determine protein mass, parallel samples were 
harvested with 1% SDS, and total protein content measured using a BCA kit 
(Pierce). 
2.5. ZnCPC and ZnSrCPC time-dependent cell adhesion assays 
The altered capacity of cells to adhere to a plastic support was measured upon 
cells exposure to the cement powders for increasing time periods. Post-exposition 
adhesion assays were performed at 0, 3, 14 and 21 days post-confluency (DPC), 
upon cells plating as described above for the ALP assay (day 0 = 3 days post-
seeding). Cells media was changed every other ~3-5 days in culture. At each 
experimental day, cells were washed with PBS, incubated with Trypsin-EDTA 
solution for 5 min at 37ºC, and ressuspended in 3 ml fresh media. Cells were 
counted using the Trypan blue dye, 1x105 cells were seeded into 24-well plates 
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with 1 mL fresh media (final volume), and left to adhere for 1 h in an atmosphere 
of 5% CO2 at 37°C. Quantification of adherent cells was perf ormed indirectly by 
measuring the amount of non-adherent ressuspended cells in the media. For that, 
cells media were homogeneized and collected, ressuspended cells counted using 
the Trypan blue dye, and the percentage of adherent cells was calculated taken 
the seeded 1x105 cells as 100%. Three independent experiments were performed.  
2.6. Type-I collagen time-dependent protein expression and cellular 
localization 
MC3T3-E1 cells were treated as described for the ALP assays and subjected to 
immunoblot analyses to determine the profile of Type-I procollagen and collagen 
protein expression and medium secretion with time of exposition to 1 mg/ml 
cement powders (days in post-confluency, DPC, cultures). Type-I collagen cellular 
distribution was further analyzed by immunocytochemistry procedures at 3 DPC 
(confluency was achieved at 3 days in vitro).   
2.6.1. Antibodies  
Primary antibody used was anti-Collagen Type-I (Novus Biologicals, Germany), 
which recognizes Type-I procollagen (monomeric α1(I) and α2(I) chains, β chains 
corresponding to α/α dimmers, trimeric γ chains) and various collagen forms 
(tropocollagen, the mature trimeric γ chains, microfibrils, fibrils and fibers). 
Secondary antibodies used were FITC-conjugated anti-rabbit IgGs (Calbiochem) 
for immunocytochemistry analyses, and horseradish peroxidase-linked anti-rabbit 
IgGs for enhanced chemiluminescence (ECL) detection (GE Healthcare).  
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2.6.2. Immunoblot analyses of Type-I collagen protein expression and media 
secretion 
At the indicated days in post-confluency (DPC) cultures, cells conditioned media (1 
ml) were collected into 10% SDS-containing microtubes and cells were harvested 
with a 1% SDS boiling solution. Samples were boiled for 10 min and sonicated, 
and total mass content determined using the BCA kit (Pierce). Mass-normalized 
cell lysates and media samples (60 µg) were subjected to reducing 6.5% SDS-
PAGE in Tris-Glycine buffer, and electrophoretically transferred onto nitrocellulose 
membranes. Precision Plus Dual Color (Bio-Rad) were used as protein standards. 
Immunoblotting of the transferred proteins was performed by incubating 
membranes O/N with the anti-Collagen Type-I primary antibody, after blocking 
non-specific binding sites with non-fat dry milk in TBS-T (10 mM Tris-HCl at pH 
8.0, 150 mM NaCl, 0.5% Tween). Detection was achieved using a horseradish 
peroxidase-linked secondary antibody and an ECL kit (GE Healthcare). 
  
2.6.3. Confocal microcopy analyses of Type-I collagen protein distribution 
Cells treated as above (section 2.8.2) were grown on 35 mm plates-containing 
pre-treated coverslips and fixed with a 4% paraformaldehyde PBS solution at 3 
DPC. Cells were methanol-permeabilized, non-specific sites blocked by 1 h 
incubation with  a 3% BSA PBS solution, and coverslips submitted to 
immunocytochemistry procedures using the anti-Collagen Type-I antibody diluted 
in 3% BSA PBS. Upon three washes with PBS, cells were incubated with the 
FITC-conjugated secondary antibody. Coverslips were mounted on microscope 
slides with DAPI-containing Vectashield antifading reagent (Vector). Images were 
acquired in a LSM 510 META confocal microscope (Zeiss) using an Argon laser 
line of 488 nm (FITC channel), and a Diode 405-430 laser (DAPI channel). 
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2.7. Animal model and implantation procedure 
Animal studies were performed at Hospital Santa Maria, Lisbon, Portugal, 
according to European regulations and following permission granted by the Ethical 
Committee. Owing to ethical and economic reasons, only two animals were used 
for implantation procedures. Two mature male pigs weighting between 40 and 50 
kg were used as experimental animals, for observation periods of 1 and 2 months 
for each animal. Injection sites were shaved and cleaned with Betadine (10% 
povidone-iodine). The animals were operated under general anesthesia performed 
with intravenous injection of ketamine (Ketalar, Pfizer, Porto Salvo, Portugal) and 
xylazine hydrochloride (Rompun 2%, Bayer, Germany) under aseptic conditions. 
To implant the cement pastes, a longitudinal incision on the outer surface of the 
foot was made until expose the tarsal bone and three circular holes drilled 
perpendicular to the long axis of the bone with a drill bit of Ø 3.5 mm (Synthes, 
USA) in each animal (see Fig. 1). The CPCs to be implanted were prepared by 
hand mixing for 1 min and then injected in the cavities with a 5 mL syringe. The 
holes were filled, respectively, with ZnSrCPC, ZnCPC and reference apatite 
cement (Norian SRS, Norian Corp., Synthes, USA). In each hole, one marker 
(skin stapler) was placed into the cement paste, during setting, for localization of 
the implant position at the end of the implantation period. Setting time of 11 ± 2 
min after filling the holes was granted for the cements, ZnSrCPC and ZnCPC, 
before closing. Norian SRS was mixed and applied according to the specifications 
of the producer. Subcutaneous tissues were closed using resorbable Dafilon 2/0 
sutures (Braun, Queluz de Baixo, Portugal), whereas skin was closed with a skin 
stapler. Both animals recovered from the operative procedure without incident. 
Postoperative pain killer, Tramadol (Medinfar, Amadora, Portugal) and antibiotic 
cefazolina (Labesfal, Campo de Besteiros, Portugal) were administered for 3 days. 
By the second postoperative day, the pigs began to walk freely with access to food 
and water. At the end of the predetermined period of implantation (1 and 2 
months), the animals where operated according to the same protocol. Removal of 
the implants and some surrounding bone was performed using a hollow drill bit of 
Ø 6.5 mm (Synthes, USA). 
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Fig. 1: Photograph showing the surgical procedure of drilling holes for posterior cement 
pastes implantation. 
2.7.1. Histological and histomorphometric analyses 
The specimens containing the defects with the cements were fixed in 4% 
formaldehyde, decalcified in nitric acid and embedded in paraffin. For histological 
and histomorphometric analysis, cross-sections of 5 µm thicknesses were cut 
(Leica RM 2145 saw microtome). The sections were taken from the middle of the 
specimens and stained with hematoxylin/eosin (H&E), which allows detection of 
newly formed bone. Histological and histomorphometric analyses were performed 
using a laser scanning confocal fluorescence microscope (Zeiss LSM 510 META), 
equipped with a 561 nm DPSS laser. To quantitatively determine the amount of 
newly formed bone, the histological sections were analyzed after both implantation 
time periods (1 month and 2 months). At least twelve H&E stained histological 
sections were randomly chosen for every condition, and each section was 
observed under a confocal laser scanning microscope at Plan-Neofluar 10x/0.3 
magnification (histological and histomorphometrical analyses) and Plan-
Apochromat 100x/1.4 Oil  (histological analyses). The removed cylindrical 
specimen (Ø 6.5 mm) contained old trabecular bone at the periphery (~1.5 mm at 
each side). Hence, images of newly formed bone and matrix were taken at the 
middle and periphery of the removed implant (defect area). A total of 25 
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microphotographs were taken and analyzed for every condition. The Zeiss LSM 
510 4.0 image analysis software was used to determine the areas occupied by 
organic material positive for the protein-staining Hematoxylin dye. The areas 
occupied specifically by newly formed bone, organic matrix and ‘empty spaces’ 
(non-protein) were also determined, with data being presented as mean ± 
standard error of the mean. The intensity of the fluorescent organic material was 
also recorded as a measure of density, as microphotographs were taken with the 
same laser and gain settings. For the ZnSrCPC implants, low magnified (10x) and 
zoomed (4x) or highly magnified images (100x) were taken along the z-axis (z-
stack), projected into one image and used to create a 3D volume image further 
displayed as a video (supplemental figures).   
2.8. Statistical analysis 
Statistical significance analysis was conducted using the SPSS 16.0 software, by 
one way analysis of variance ANOVA, followed by a post hoc test, with the level of 
statistical significance set at p<0.05. Data are expressed as means ± standard 
error of the mean of at least three independent experiments. In order to the low 
number of experimental animals, statistical analyses were not performed for the 
histological and histomorphometric analyses. 
3. Results 
Dose-dependent cell viability and proliferation of MC3T3-E1 osteoblastic-like cells 
cultured on the ZnCPC and ZnSrCPC cements for 24, 48, and 72 h was evaluated 
by the non-destructive and non-toxic resazurin metabolism assay (Fig. 2). The 
usefulness of the resazurin assay as a measure of cell proliferation and viability 
was first tested in a MC3T3-E1 cell proliferation assay (Fig. 2a), and a linear 
response could be observed between 1 and 4 x 104 cells cm-2, being this cell 
density interval used in the following proliferation assays.  
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Cells were seeded at 1 x 104 cells cm-2 in the presence of different cement powder 
concentrations and the percentage of cell viability determined (Fig. 2b and 2c). No 
cytotoxic effects were observed for any of the cement powders doses used, and 
cells O.D. increased with time in culture for all conditions. For ZnCPC (Fig. 3b), 
small increases in cellular proliferation were observed for 0.1 and 1.0 mg mL-1
(fold-increases of 1.10-1.30 over control conditions, 0 mg mL-1 powder cements). 
Exposition to 0.1 and 1.0 mg mL-1 ZnSrCPC (Fig. 2c) induced higher dose-
dependent increases in cellular proliferation, resulting in fold-increases of 1.30-
1.50 (for 1.0 mg mL-1) over control levels. Noteworthy, at day 3 in culture cells 
confluency was achieved, as visually confirmed. The pH range indicator on cells 
media (phenol red) revealed no alterations to the physiological pH 7.4, as 
confirmed by pH media measurements (Basic Meter PB-11, Sartorius).  
Cytotoxicity and proliferation assays in cement blocks (Fig. 3d) revealed that 
MC3T3-E1 cell viability was decreased relatively to control conditions (cells plated 
directly onto the plastic bottom). Results also showed that cell viability increased 
until 8-10 days in culture and slight decreased further on, for all conditions tested. 
Again, cells grown in the presence of ZnSrCPC showed higher levels of 
proliferation for all time points tested than for ZnCPC (p<0.05). Media pH 
acidification was visually detected in the first days of culture in ZnCPC and 
ZnSrCPC blocks. The alteration in media colour corresponded to pH decreases to 
5.5-6.5, but pH in cement blocks-containing wells increased to physiological levels 
of ~7.4 following day 2 in culture.  
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Fig. 2: Cell viability assays of MC3T3-E1 osteoblastic-like cells exposed to ZnCPC and 
ZnSrCPC cement powders: (a) relation between the resazurin assay and MC3T3-E1 
cellular density, demonstrating a zone of linearity between measured O.D. and cell 
proliferation; (b) cell viability of cells cultured with increasing concentrations of 
ZnCPC and (c) ZnSrCPC cement powders for 24, 48 and 72 h; (d) cell viability of 
cells cultured onto ZnCPC and ZnSrCPC blocks. Results presented are the mean ± 
SE of at least three independent experiments.  
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Morphological analyses of MC3T3-E1 cells exposed for 72 h to 1 mg mL-1 of 
ZnCPC and ZnCPC cement powders revealed some observable differences (Fig. 
3). Phase contrast microphotographs reveal that cells in contact with cements 
(arrows) appear to possess a more irregular cell shape, especially for ZnCPC, with 
increased number of plasma membrane protuberances. A decrease in cellular 
volume and nucleus (N) size is especially evident for ZnSrCPC-exposed cells, 
what correlates with its observed higher rate of cellular proliferation (Fig. 2c). Of 
note, the higher cellular densities of ZnSrCPC-exposed cultures can be depicted in 
Fig. 3 microphotographs that show a higher number of cells (and respective 
nuclei) and less intercellular space.   
Fig. 3: Phase contrast microphotographs of MC3T3-E1 cells exposed to 1 mg mL-1 of 
cement powders (ZnCPC and ZnSrCPC) for 72 h. N: cells nuclei. Arrows: visible 
aggregates of cement powders. Bar 10 µm. 
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ALP assays indicated that MC3T3-E1 cells not only maintain their capability to 
express active ALP enzymes on powdered cements, but even increase it with time 
in culture (Fig. 4). For all conditions tested, ALP activity was similarly maintained 
and slightly increased until two weeks in post-confluency culture, after what it 
rapidly increased until the last time point (28th day). From days 21 to 28, a known 
period of cell differentiation, ALP activity of cells incubated with ZnCPC and 
ZnSrCPC cement powders significantly increased over control levels (p<0.05). Of 
note, crude ALP activity of powdered cements exposed cells increased 
significantly over control levels starting from day 6 in post-confluency culture, but 
until day 21 this increase resulted from their higher induction of cell proliferation.  
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Fig. 4: Alkaline phosphatase (ALP) activity of MC3T3-E1 cells cultured on 1 mg mL-1
ZnCPC and ZnSrCPC powdered cements for several days (0, 1, 3, 6, 14 and 21) 
post-confluency achievement. The ALP activity was expressed as the increase in 
p-nitrophenol aborbance per min per microgram of protein (∆OD.min-1.mg-1). 
Results presented are the mean of two independent experiments. 
This effect was annulled when data was presented per mg of total protein content, 
therefore excluding the proliferation variable, with results mainly reflecting 
variations in the state of cell maturation leading to differential ALP activities. 
When collecting cells lysates for analysis of their ALP activity, it was noted that 
non-exposed control cells were more easily detached from the plastic than cells 
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exposed to ZnCPC and ZnSrCPC, suggesting that they may exhibited alterations 
in adhesive capacities. Hence, further studies assayed differential adhesion 
capacities of MC3T3-E1 cells exposed to the cements powders.  
Upon 0, 3, and 14 DPC cell culture, a time-dependent increase in the capacity of 
MC3T3-E1 cells to adhere to a plastic support was observed (Fig. 5), further 
decreasing until day 21. Both ZnCPC and ZnSrCPC cement powders were able to 
increase the cells adherence properties, in comparison with non-exposed control 
cells. Powdered ZnCPC was even slightly more effective, with the ZnSrCPC 
cement appearing to behave in an intermediate position between control and 
ZnCPC exposed cells at days 0 and 3, what may relate to the higher number of 
ZnSrCPC proliferating cells, known to be less adhesive.   
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Fig.5: ZnCPC and ZnSrCPC-dependent MC3T3-E1 cells adhesion capacities. The 
capacity of cells to adhere to a plastic support for 1 h was measured following 
cells exposure to the cement powders for 0, 3, 14 and 21 days post-confluency. 
At each experimental day, 1x105 cells were seeded into 24-well plates and left to 
adhere for 1 h at 37°C. Media was further collected  and the number of non-
adherent ressuspended cells counted (x). The percentage of adherent cells was 
calculated (1x105 - x), taking the initial 1x105 cells as 100%. Results presented 
are the mean ± SE of three independent experiments.  
The effect of the powdered cements on collagen protein synthesis, secretion and 
fibrillar deposition was studied by immunoblot and immunocytochemistry analyses. 
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In terms of immunoblot bands profile, collagen is somewhat complex (Fig. 6). 
Monomeric Type-I procollagen consists of α1 (~140KDa) and α2 (~130KDa) 
chains, which are intracellular processed (signal peptide cleavage, hydroxylation 
of proline and lysine residues, glycosylation of lysine residues). Alpha chains can 
intracellularly associate into dimers (~270KDa) and trimers (~400KDa; triple helix 
consisting of two α1 and one α2 chains). There is some covalent cross-linking 
already within these forms, which are not breakable by SDS-PAGE denaturing 
conditions [34]. All these cell-associated Type-I pro-collagen forms were present in 
all samples and a time-dependent profile for the various cellular procollagen forms 
could be observed (Fig. 6A.I). Between 0, 3 (proliferation period) and 14, 21 
(maturation period) DPC, a high increase (3-4 fold-increase) in the levels of 
cellular pro-collagen is noted, especially for the dimeric β(I) and trimeric γ(I) forms. 
Levels of cell-associated Type-I pro-collagen go in the following order: Control > 
ZnSrCPC > ZnCPC, except at 3 DPC. Nonetheless, these levels were much more 
similar at 14 and 21 DPC following extensive samples sonication, which permits 
the visualization of cell layer-associated fibrils and its breakdown products (Fig. 
6A.II). Further, this allowed detecting an increase in the formation of collagen 
fibrils for ZnSrCPC at 3 DPC, observable in all triplicate determinations. 
Remarkably, there were ZnSrCPC-induced alterations in the electrophoretic 
migration of all procollagen monomer and dimeric bands (Fig. 6A “*”), revealing 
higher levels of post-translational procollagen modifications. This also occurred at 
lower extent for β chains in ZnCPC samples.  
Intracellular procollagen is shipped to the trans-Golgi network (TGN) to be medium 
secreted. Extracellularly, γ chains are enzymatically processed into tropocollagen, 
promoting their aggregation into cell layer-associated collagen microfibrils and 
fibrils [35]. Hence, the levels of medium soluble procollagen were also analysed 
(Fig. 6B). It could be observed that procollagen secretion (peaking at 3 DPC) 
precedes as expected, trimeric procollagen, tropocollagen and fibrils formation 
(abundant from 14 DPC onward). Figure 6B shows higher procollagen secretion 
for ZnCPC and ZnSrCPC-exposed cells at 3 DPC, and lower from 14 DPC 
onward, suggesting higher depletion of intracellular collagen at 3 DPC.  
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In order to confirm the immunoblot observations at 3 DPC, and as collagen 
antibodies exhibit its higher degree of specificity under non-denaturing native 
conditions, cells were subject to microscopy analysis of Type-I collagen cellular 
distribution (Fig. 7). Similarly to the immunoblot results of Fig. 6, the overall levels 
of intracellular collagen were in the following order: ZnSrCPC ≈ Control > ZnCPC, 
but differently distributed. While for control cells, procollagen was accumulated 
inside intracellular granule-like densities, for ZnCPC and ZnSrCPC-exposed cells 
the intracellular procollagen-containing vesicles were smaller and more numerous. 
These results suggest the occurrence of CPC-induced alterations in collagen 
secretion, from regulated to more constitutive-like. Further and more remarkably, 
the extracellular cell-associated collagen fibers were generally longer and denser 
for the ZnSrCPC, confirming an earlier/enhanced aggregation of tropocollagen into 
fibrils and fibers. Control and ZnCPC presented similar collagen extracellular 
fibers. 
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Fig. 6: Immunoblot analysis of cell-associated and medium secreted Type-I collagen with 
time in post-confluency culture. MC3T3-E1 cells lysates (A) and conditioned media 
(B) were collected at days 0, 3, 14 and 21 of post-confluency culture (DPC). 
Samples were resolved under reducing conditions and Type-I collagen was 
immunodetected. Once several insoluble fibers could be denoted in the samples 
microtubes, to detect higher collagen aggregates (fibrils and fibers), cells lysates 
were further sonicated for partial fibers breakdown (A, lower blot). Note that collagen 
proteins profiles and levels are equal in pre-plated (prepP, cells initially plated) and 
control 0DPC cells, as expected. α1(I) and α1(II), procollagen monomeric chains, 
unprocessed (arrowhead) and processed (arrow); β, procollagen dimeric forms; γ, 
procollagen trimeric forms; F, collagen fibers. Migration of molecular weight markers 
is indicated to the right. 
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Fig.7: Confocal microscopy analysis of intra and extracellular Type-I collagen at 3 days 
post-confluency (DPC). Cells exposed or not (C) to 1mg/ml ZnCPC and ZnSrCPC 
for 3 days in post-confluency cultures (a total of 6 days of exposition) were subject 
to immunocytochemistry procedures to analyze type I collagen distribution (green 
fluorescence) by confocal microscopy. Two representative microphotographs for 
each condition are presented. DAPI (blue fluorescence), nuclear marker. Bar, 10 
µm.   
Histological analysis demonstrated that the studied CPC cements were both 
osteoconductive and biocompatible. Taking advantage of the fluorescent 
properties of hemotoxylin [36], and as confocal microscopy can bring higher 
sensitivity than wide field microscopy, histological and histomorphometric analyses 
of in vivo cements implants were conducted using a confocal laser scanning 
microscope. Hemotoxylin is an acidic basophilic dye that stains intracellular and 
extracellular proteins (but not nuclei or lipids), with fluorescence emissions in 
C1 ZnSrCPC1 ZnCPC1 
C2 ZnSrCPC2 ZnCPC2 
3 DPC 
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green and red. Hence, in fluorescent microscopy, the organic protein material 
appears red (or alternatively green) and the nuclei and lipids appear black. 
Microphotographs of implant cross-sections revealed that newly formed bone (NB) 
was growing from the periphery inwards (Fig. 8), being deposited into the old 
bone, circumscribing the bone defect. Further, organic protein-containing matrix 
(Mx) was also observed (Fig. 8), although at higher amounts at 1 month of 
implantation and less after 2 months.  
Fig. 8: Confocal fluorescent micrographs of histological H&E stained sections, showing 
the tissue osteogenic response to Norian SRS (a), ZnCPC (b,d,g) and ZnSrCPC 
(c,e,f,h) cements after 1 (a-c) and 2 (d-h) months of implantation. NB: new bone; 
Mx: protein matrix; OTB: old trabecular bone; CS P: cross-section periphery; OT: 
osteocytes; arrows/OT in g,h: osteoclast-like cells. 
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Three different osteogenic profiles were denoted for Norian, ZnCPC, and 
ZnSrCPC cements. For Norian and ZnCPC cements at 1 month of implantation, 
new bone was found at higher amounts in the more peripheral areas than in the 
center (Fig. 8 a, b). The central zones of the section had black areas and areas 
filled with unorganized matrix enriched in cells, probably being active remodeling 
areas of cement and bone callus (Fig. 8 a, b). These areas were almost absent in 
the ZnSrCPC 1 month implants, where osteoclasts could only be found sparsely 
and at lower cell densities, around old or newly formed bone, and throughout the 
cross-sections. The differences observed suggest that ZnSr cement resorption 
had occurred at a higher rate during the first month of implantation, accompanied 
by bone formation. Further, bone deposition appeared to be increasing in 
organization in the following order: Norian < ZnCPC < ZnSrCPC. In the latter, new 
bone was mainly found in trabeculae-like concentric structures and crossing the 
section, while for ZnCPC similar structures could also be found, although mainly at 
the periphery of the implant and with larger ‘empty’ cavities within. For Norian, the 
new bone was mainly deposited in less circular and lengthy structures (Fig. 8 a-c).  
Following 2 months of implantation, the concentric lamellae deposition into 
trabecular bone becomes obvious (Fig. 8 d,e) and closed circular trabeculae are 
the main structures found, especially in the ZnSrCPC implants. At this time period, 
at the periphery of the cross-sections it was not possible to distinguish new bone 
from host bone (old trabecular bone). The continuity between new and old bone 
and within the newly formed trabeculae was notorious for the ZnSrCPC and is 
highlighted (Fig. 8 e, f; * marks the same structure in contiguous 
microphotographs; see also supplemental Fig. S1). Fig. 8 g and h show magnified 
structures of Fig. 8 d and e, where arrows indicate osteocytes’ (OT) black nuclei. 
These are mature osteoblasts that are trapped inside bone, occupying small 
cavities known as lacunae at the junctions of the lamellae, visible in all photos of 
new formed bone. The layers of deposited lamellae are also visible.  
Several histological features can be observed in Fig. 9. Osteoclast-like cells are 
found within areas of unorganized matrix, mainly at the center of the section 
(Norian and ZnCPC), but also at the periphery (ZnSrCPC). These probably 
182
correspond to active areas of osteoid secretion by osteoblasts, and of cement, 
mineral and bone callus resorption by osteoclasts (Fig. 9 a, indicated by arrows). 
For all implants, rows of cuboid epithelial cells could be found at the periphery of 
several sections, possibly denoting mesenchymal pre-osteoblastic cells (Fig. 9 b). 
Ossification centers (nuclei of calcification and new bone formation) could be 
found especially for both ZnCPC and ZnSrCPC cements (Fig. 9 c). For ZnCPC, 
and especially for ZnSrCPC, osteoblast-like cells (OB, arrowheads) could be 
observed producing and mineralizing organized matrix that lays foundation for new 
bone formation (Fig. 9 d). This matrix is found in very close relation with the new 
bone being formed, before osteoblasts became imprisoned in the latter and 
differentiate into osteocytes.  
The percentage of area occupied by new protein-containing organic material was 
determined and presented in Fig. 10. Several differences were found, in 
correlation with the previous histological observations. At 1 month of cement 
implantation, total protein area increased as following: Norian < ZnSrCPC < 
ZnCPC. Detailed analysis clarified that while for ZnSrCPC this proteinaceous 
organic material was almost exclusively new bone, for ZnCPC this equally 
corresponded to new bone and matrix. From 1 to 2 months of implantation, the 
percentage of matrix in the implant decreased as osteogenesis continued, 
although more evident for ZnSrCPC, with a notorious increase in the amount of 
new bone. The latter reached 50.0 ± 5.1% of total area, while ZnCPC reached 
34.7 ± 8.7%. The area of ZnSrCPC ‘empty spaces’ also decreased as new bone 
formation increased reinforcing that, with time of implantation, cement was being 
resorbed as new-bone formed. Concomitantly, fluorescence intensity of the 
organic material filling the implant was also determined and used as an indirect 
measure of protein density. As it can be observed from the microphotographs (Fig. 
8), the intensity of newly formed bone is much higher than of the surrounding 
matrix, due to its much higher density and volume. New bone fluorescence 
intensity increased for both ZnCPC and ZnSrCPC cements between 1 and 2 
months of implantation, as expected. This indicates an increase in bone average 
density, probably due to remodeling activity. The concomitant decreases in matrix 
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average intensity may be related to resorption of initially unorganized protein 
matrix and bone callus, which contributed to the formation of new trabecular bone.  
Fig. 9: Confocal fluorescent micrographs of H&E stained sections, showing histological 
details of the tissue osteogenic response to Norian SRS(a1), ZnCPC (a2,c2) and 
ZnSrCPC (a3,c1,d) cements after 1 and 2 months of implantation. mth: month; 
CPC: representative of all three cements; OC: osteoclast-like cells, easily 
indentified by their multiple nuclei and highly proteinaceous cytoplasm (arrows); 
NB: new bone; EC: epithelial cells; Mx: matrix; ON: ossification nucleus; OB: 
osteoblast-like cells; OT: osteocytes; L: lamellae. Images from a to d2 were taken 
with a 10x objective and zoomed 1.5-2x, except d2 that was zoomed 4x; d3
represents a image projection of a z-stack, taken with a 100x objective.   
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Fig. 10: Histomorphometric analysis of H&E stained sections of ZnCPC, ZnSrCPC and 
Norian SRS cements for 1 and 2 months of implantation: (a) defect area (%) of 
new bone formed, the matrix and the total areas and (b) fluorescence intensity of 
new bone and matrix areas. 
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4. Discussion 
The present study examined and compared the in vivo response of two brushite-
forming Zn and ZnSr-containing CPCs and a commercial apatite CPC, after 
implantation in trabecular bone in pigs. Additionally, the in vitro proliferation and 
differentiation responses of osteoblastic cells (MC3T3-E1 cell line) to the cements 
were also evaluated. Osteoblasts play a central inhibitory role in the 
pathophysiology of osteoporosis where reduced bone mass and deterioration in 
bone microarchitecture lead to enhanced skeletal fragility. Osteoporosis results 
from a negative balance between the bone-forming activities of osteoblasts and 
the resorptive activities of osteoclasts. Inadequate osteoblast activity may result 
from a relative deficiency in proliferation or differentiation of osteoprogenitors, or 
excessive apoptosis.  
The osteoblastic MC3T3-E1 cell line was used for in vitro studies. This cell line has 
been established from C57BL/6 mouse calvaria and selected on the basis of high 
ALP activity in the resting state. Cells have the capacity to differentiate into 
osteoblasts and osteocytes and have been demonstrated to secrete collagen and 
to form calcified bone tissue in vitro, being adequate to study the cellular and 
molecular responses to the biomaterials tested. 
Dose-dependent cell viability and proliferation of MC3T3-E1 osteoblastic-like cells 
cultured on both ZnCPC and ZnSrCPC cement samples confirmed their 
biocompatibility and capability of induction of cellular proliferation under 
physiological pH (Fig. 2). These results are consistent with previous studies, 
where it has been reported that the zinc-releasing CPC significantly promoted 
osteoblastic MC3T3-E1 cell proliferation in vitro at zinc content of 1.20 wt % [37, 
38]. Furthermore, exposition to ZnSrCPC powder led to the highest dose-
dependent levels of proliferation (Fig. 2c), and cells grown in the presence of 
ZnSrCPC  blocks showed higher levels of proliferation, than for ZnCPC (p<0.05) 
(Fig. 2d). These data reveals that Sr is a good osteoblastic proliferation inducer, 
what was visually confirmed by the higher cellular density of ZnSrCPC cultures 
(phase contrast microphotographs of Fig. 3), and is in agreement with previous 
studies indicating that Sr-containing ionic cements are more osteoconductive than 
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Zn-containing ionic cements [39]. Noteworthy, the differences observed relatively 
to control non-exposed cells depending the type of cement samples (powder or 
block) used for cell culture tests most probably reflect initial variations of the cells 
media pH. While for powdered cements media pH did not change and cement-
exposed cells had increased O.D. levels over control levels, the presence of 
cement blocks initially lead to a decrease in pH and concomitantly decreased 
initial cell viability. Nonetheless, when pH increased and stabilized around 7.4 
following the 2nd day in culture after media substitution, the cellular proliferation 
profiles of control cells and ZnSrCPC were not only similar but ZnSrCPC even 
exhibited a higher proliferation rate (2.3 vs 1.7 fold-increases for control cells and 
ZnSrCPC between days 2 and 8). Further results implicated ZnCPC and ZnSrCPC 
in osteoblastic differentiation processes. The cements were able to increase 
MC3T3-E1 cells ALP activity over control levels at later periods in culture (Fig. 4), 
which strongly indicate a higher maturation state for these cells. Similarly, Otsuka 
et al. [40] have observed that MC3T3-E1 cells ALP activity is lower in the first 1-2 
weeks in culture and further increases until day 35, and related this increase with 
the cells maturation state. MC3T3-E1 cells maturation is reached following ~14 
days in culture [41, 42], being previously found at a more proliferative state. 
Further, ALP is used as an indicator of cells differentiation acquisition [43]. The 
present results indicated that MC3T3-E1 cells differentiation start/strongly occurs 
around the 14th day in culture, when ALP activity increases (Fig. 4). Further, as it 
can be depicted from the resazurin studies (Fig. 2d), cells proliferated into ~10 
days when exposed to cement blocks, and the results on protein content 
(determined for ALP assays, data not shown) showed an increase in total protein 
content until 14 days in culture, and further decrease until the last day tested (28th
DPC). Results also proved that both ZnCPC and ZnSrCPC cements increase 
osteoblastic cells differentiation in terms of ALP activity, especially from the 21st
DPC culture on. Further, as ZnCPC and ZnSrCPC results are virtually equal, as 
expected Zn ions appear to be the relevant inducers of ALP activity, which is a Zn-
dependent enzyme present in most mammalian tissues [25]. 
ZnCPC and ZnSrCPC cements proved to induce other physiological relevant 
property, which may underlie their observed high in vivo osteogenic capacities. 
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These cements were observed to be able to increase osteoblasts intrinsic cell-to-
matrix adhesion capacities (Fig. 5). This was first observed visually when 
collecting cells lysates for ALP determination, where cells grew in biofilms 
attached more tightly to the plastic support for ZnCPC and ZnSrCPC exposed 
cells, suggesting higher expression of extracellular matrix and/or adhesion 
proteins. Confirmation arrived from the cell adhesion assays, with cells previously 
exposed to the cement powders exhibiting higher adhesive capacities, either 
intrinsic (non-depending on their secreted extracellular matrix, ECM) or due to 
ECM secretion (Fig. 5). Of note, during the proliferative period (until two weeks 
post-confluency), the ZnSrCPC-exposed cells adhesiveness were slightly lower 
than for the ZnCPC cells. This perfectly correlates to its higher induction of cells 
division and with the fact that cells in division are more loosely connected to the 
support than interphase cells. Further, the higher number of cell membranar 
protuberances observed for ZnCPC cells (Fig. 3) suggests a high number of focal 
adhesion points. Interestingly, all three cultures exhibited a decrease in their 
adhesive capacities from the 14th to the 21st DPC in culture, when cells started 
their differentiation process. At these later periods, decreased intrinsic adhesive 
properties may correlate with increased dependence on an extracellular matrix. 
Indeed, this corresponds to the period of higher deposition of extracellular 
collageneous matrix, as observed in Fig. 6A. Immunoblot and 
immunocytochemistry methods revealed cements-induced alteration MC3T3-E1 
collagen production, secretion and extracellular fibers formation. In synthesis, 
cements enhance collagen secretion in the pre-differentiation period (3 DPC, Fig. 
6B), which correlates well with their subsequent higher collagen fiber formation in 
the differentiation period (14 and 21 DPC, Fig. 6A.II). Further, ZnSrCPC induces a 
higher rate of collagen aggregation into fibers already at 3 DPC, as confirmed by 
both immunoblot and immunocytochemistry analyses (Fig. 6A.II and 7). Indeed, in 
ZnSrCPC exposed cells, Type-I collagen fibers were observed to be longer and 
denser suggesting an earlier/enhanced aggregation of tropocollagen into fibrils 
and fibers. This may be related with the delayed SDS-PAGE migration profiles of 
procollagen in ZnSrCPC cell lysates, which reflects its higher level of procollagen 
post-translational modifications (hydroxylation and subsequent glycosylation of 
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hydroxylysine). Indeed, hydroxyproline and hydroxylysine, derived from proline 
and lysine hydroxylation, respectively, occur at the RER and are necessary for the 
formation and stabilization of collagen, playing key roles in collagen stability [44]. 
Hence, ZnSrCPC appears to induce overhydroxylation of proline and/or lysine 
amino acids, potentially accelerating collagen cross-linking and fiber formation, 
and explaining results at 3 DPC.  
Type-I collagen is the most abundant type of collagen in bone, being the most 
abundant protein component in the ECM. Given that ZnSrCPC induces Type-I 
collagen deposition into the ECM and increases the number of collagen-secreting 
osteoblasts, and as the first stage for bone formation by osteoblasts is collagen 
secretion.  
Implants were performed in trabecular bone due to its higher metabolic rate per 
unit of volume, when compared to cortical bone. Further, rates of change in bone 
density are likely to be greater at sites that are predominantly trabecular [45]. 
Moreover, it has been observed that trabecular bone density decreases faster than 
that of compact bone as osteoporosis progresses [46]. Of note, no inflammation or 
other complications associated with the implanted materials were observed 
throughout the observational time periods. 
Histological and histomorphometrical analyses revealed that, with increased 
implantation periods, new bone regenerated and gradually penetrated into the 
implant. The pattern of trabecular bone that was formed in the implantation area 
was qualitatively similar to the adjacent old trabecular bone in the sections’ 
periphery. New bone grew towards the implant centre, replacing fluorescent-black 
spaces and suggesting that cement was being first resorbed in the implantation 
periphery. This is expected, as it is the site of contact between the implant and old 
bone, mesenchymal cells, and macrophages that ultimately differentiate into 
osteoclasts. Reduction of protein-containing organic matrix from 1 to 2 months, 
along with increased new bone formation to relative high levels (Fig. 8 and 9) also 
reflects that ZnCPC and ZnSrCPC were good osteoconductive biomaterials. Zn 
and Sr proved to be good inductors of osteoprogenitor cell proliferation and 
differentiation, as upon 1 month intensive bone remodeling was undergoing in the 
adjacent bone matrix of the original drill hole. Further, results indicated that Sr is a 
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more potent inhibitor of osteoclastic activity than Zn, as much fewer osteoclast-like 
cells could be found in ZnSrCPC implants. Partial substitution of Zn ions by Sr ions 
in ZnSrCPC revealed to be beneficial, as cement resorption and organized bone 
formation were faster and higher for this cement. Constantz et al. [15] have 
observed that cement resorption is due to macrophages and macrophage-derived 
osteoclastic cells, after the complete transformation of brushite into carbonated 
apatite. Indeed, for ZnCPC at 1 month of implantation, we could find dispersed 
areas of cell-mediated resorption and remodeling, such as osteoclast-driven 
resorption and osteoblast-mediated osteoid formation. These areas were found 
central to the implant and relatively distant to the zones of new bone deposition, as 
previously noted by other authors [47]. Similar qualitative results were obtained for 
Norian (Fig. 8 and 9), also suggesting that cement and primary matrix were still 
being resorbed at those zones at 1 month of implantation, although at much less 
extension (Fig. 8). Moreover, there was a higher amount of ‘empty space’ (which 
includes cement) for Norian than for ZnCPC, reinforcing that Norian cement was 
by far being resorbed at lower rate than ZnCPC. For ZnSrCPC however, cement 
resorption was rapid, as at 1 month of implantation few areas of remodeling 
activity of ‘empty spaces’ and unorganized matrix could be observed. Of note, the 
larger solubility of brushite compared to apatite is one essential reason for the 
faster resorption of the brushite matrix. While apatite cements, such as Norian, 
remain almost unchanged throughout study periods of 6 months, brushite cements 
are resorbed at a rate between 60% and 90% amid 2-6 months of study periods 
[47].  
In osteogenic terms, for the ZnCPC cement a high percentage of new bone is 
found at the periphery of the implant but not at the centre after 1 month of 
implantation. For ZnSrCPC cement, however, new bone was found evenly 
distributed throughout the implant, which included several trabeculae-like 
structures already crossing the entire histological sections. Upon 2 months of 
implantation, high levels of bone regeneration could be noted for ZnCPC and 
especially for ZnSrCPC, where contiguous trabeculae crossing the histological 
sections could be found, suggesting the completion of the osteoregenerative 
process mediated by brushite conversion into apatite.     
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5. Conclusions 
The biocompatibility and in vivo performance of brushite-forming Zn- and ZnSr-
substituted β-TCP cements injected into trabecular bone cylindrical defects in pigs 
was successfully demonstrated.  
MC3T3-E1 osteoblastic-like cells exposed to the powdered cements proliferated 
more, showed higher adhesiveness capacities and higher ALP activity, in 
comparison with control cells. Furthermore, they presented higher Type-I collagen 
secretion and fiber formation, at pre-differentiation and differentiation periods, 
respectively. Proliferative and collagen ECM deposition properties were more 
evident for cells grown in ZnSrCPC than in ZnCPC.  
In vivo assays of the ZnCPC and ZnSrCPC osteogenic regenerative properties 
were carried out, using carbonated apatite cement (Norian SRS) as a control. 
Results indicate that the investigated ZnCPC and ZnSrCPC cements are 
biocompatible, osteoconductive, and good candidate materials to use as bone 
substitutes. Moreover, the presence of Sr has enhanced the rate of cement 
resorption and new bone formation.  The new ZnCPC and ZnSrCPC cements 
revealed better in vivo performance in comparison to the control carbonated 
apatite cement. 
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Annexes 
Fig. S1: Several epifluorescent microphotographs were taken of contiguous sections of 
(a) ZnCPC and (b) ZnSrCPC cements after 2 months of implantation. 
(microscope Zeiss LSM 510 META) 
197
  
4 Conclusions 
The present work aimed at developing ionic-substituted calcium phosphate bone 
cements to better mimic the elemental composition of the mineral part of the bone 
and evaluating the effects of the ionic substitutions in all the relevant properties. 
The partial replacement of calcium by magnesium, strontium and zinc was 
investigated in more detail due to their reported beneficial effects on stimulating 
bone formation with a direct proliferative effect on osteoblastic cells in vitro. The 
results obtained revealed that Sr-substituted cements exhibited an overall better 
performance in all relevant properties.
The results obtained prove that aqueous precipitation is a suitable technique to 
prepare several single phase ionic-substituted (Mg, Sr, Zn) β-TCP by heating 
doped Ca-deficient apatite compositions at temperatures of about 800ºC. The 
incorporation of the doping elements into in the β-TCP structure was confirmed by 
changes in the lattice constant values (a-axis, c-axis and volume) that can be 
correlated to the ionic sizes of the doping elements relative to that of the element 
that has been replaced and to their incorporated amounts.  
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The degree of lattice disturbance by the substituted ions revealed to have 
implications in terms of thermal stability of the β-TCP phase and, therefore, in the 
ease and extent of β-TCP → α-TCP phase transformation at higher temperatures 
(1450-1550ºC). Moreover, the lattice strains due to incorporation of larger size 
cations, such as Sr, favoured the milling process and made the starting SrCPC 
powder more reactive towards the setting liquid in comparison to undoped α-TCP 
or doped with other cations.  
Aqueous solutions of citric acid with added rheological modifiers (PEG or HPMC) 
were shown to be suitable liquids for preparing cement pastes from the studied 
materials with good moulding ability, flow behaviour and setting properties. Initial 
setting time increased with increasing liquid-to-powder ratio (LPR) and in the 
presence of rheological modifiers due to their specific roles at the solid/liquid 
interface. Rheological measurements under oscillatory mode revealed a useful 
tool to assess the structural evolution along the setting process, complementing 
the information given by other techniques such as Vicat and Gilmore needles. 
Flow measurements enabled selecting the experimental conditions for workable 
cement pastes (LPR in the range of 0.30-0.34 mL g-1) and for good injectability 
even under a relatively low maximum applied force of 100 N. The cement pastes 
could be fully injected for LPR > 0.36 mL g-1 without any filter pressing effects. 
Isothermal calorimetry enabled the identification of a two-step hardening process: 
(i) the dissolution of the starting powders and nuclei formation of intermediate 
amorphous phases; and (ii) the nucleation and growth of brushite crystals.  
Wet compressive strength of the cement specimens (after immersion in PBS 
solution for 48 h) was in the range of values reported for trabecular bone (10-30 
MPa).  
Cell cultures revealed that bone cements are non toxic, bioactive and 
biocompatible and stimulate osteoblastic-like cells proliferation. In addition, they 
presented higher adhesiveness capacities, ALP activity, Type-I collagen secretion 
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and fiber formation, in comparison with control cells. The osteogenic regenerative 
properties studies using a pig model showed that the implanted cements are 
biocompatible, osteoconductive, and stimulate new bone formation.  
All these properties make the newly developed brushite-forming CPCs good 
candidates for applications in repair of bony and periodontal defects, and as bone 
substitutes/fillers. 
Future perspectives 
The results obtained so far form a stable base from which minor modifications 
should provide improved functional bone substitutes. The main shortcoming of the 
developed cements is still related to the insufficient mechanical properties, 
especially for load bearing clinical applications. Therefore, further studies will be 
required to upgrade the CPCs for applications in vertebroplasty and kyphoplasty. 
Complementary studies could also be performed aiming at: 
• Evaluating the effects of other ionic species existing as trace elements in 
bone composition; 
• Implementation of various methods of cement mixing, such as vacuum 
mixing, centrifugation and mechanical mixing in order to improve 
workability/injectability at lower LPR. Due to time and equipment limitations, 
only manual mixing at atmospheric pressure was employed in this study; 
• Detection of influence of the most relevant experimental variables in cement 
preparation on cell adhesion and growth-related factors (e.g. collagen, 
laminin); 
• Evaluation of the suitability of CPCs as drug delivery systems for an array 
of pharmacological agents, cytokines and growth factors, which stimulate 
reparative bone formation. 
